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Summary 
 
Campylobacter concisus is a heterogenic bacterium which normally colonises the human oral 
cavity. It has been associated with oral cavity infections including gingivitis and 
periodontitis. It has also been isolated from other sites including enteric infections mainly in 
the elderly, immunocompromised patients, and children less than 24 months of age. To date 
there are little data about the mode of transmission, reservoir, and pathogenic potential of C. 
concisus. This bacterium is genotypically divergent with two or more genetic subgroups 
(genomospecies), however it is not known if a particular genomospecies is more associated 
with infections. This study investigated genetic diversity and colonisation of C. concisus 
amongst families with infants and newborn babies and other healthy individuals.  
 
In this study, C. concisus strains were isolated from gum swabs of healthy volunteers of 
different age groups ranging from 1 week-50 years of age. The strains were collected from 7 
different families and other unrelated healthy individuals. A total of 47 C. concisus oral 
strains, including 9 strains from infants before teething were isolated. The isolated strains 
were grouped into genomospecies (A and B) according to PCR amplification of the 23s 
rDNA. Interestingly, all infants were colonised with genomospecies B before teething except 
one infant whom was colonized with different C. concisus isolates from genomospecies A 
and B. Furthermore, three infants were followed up after teething and were all found to be 
colonised by genomospecies A isolates as well as genomospecies B. In general, 60% of C. 
concisus strains belonged to genomospecies A, while genomospecies B composed 40% of the 
strains. However, genomospecies B was found to be the dominant within children.  
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To investigate the phenotypic and genotypic relationship between C. concisus strains, SDS-
PAGE was performed for each family on the outer membrane proteins (OMPs) of isolates 
from each member. Non-teething infants were also analysed separately. The dendrograms 
generated from SDS-PAGE profiles of the isolated C. concisus strains, showed that the 
OMPs were not identical even for the strains isolated from members of the same family. The 
only exception was the two strains isolated from twin infants within one of the families in this 
investigation. 
This study also investigated motility as a virulence factor in C. concisus including the 
presence of the flagellin genes flaA, flaB and flaC and their expression and also the motility 
speed of selected C. concisus strains. Fifteen C. concisus clinical strains isolated from 
children suffering from gastroenteritis at the Royal Children’s Hospital, Melbourne, and two 
reference strains (ATCC 51561 and ATCC 51562) in addition to the oral strains from this 
study were tested. Using specific PCR primers, designed according to C. concisus 13826 
published whole genome to amplify the full gene nucleotide sequence, flaA was amplified in 
some strains (26.5%) regardless of the genomospecies while flaB was detected in 
genomospecies B strains only (34.4%). In contrast, flaC was detected in all C. concisus 
clinical and oral isolates tested. New primer sets from shorter regions (<300 bp) of all these 
genes were designed from the conserved region in each gene to be used for gene expression. 
Conserved regions of flaA, flaB and flaC and their expression were thus studied for the first 
time in C. concisus grown in brain heart infusion broth (BHI). The expression of flagellin 
genes was investigated using RT-PCR compared to the reference strain C. concisus ATCC 
51561. flaA was significantly up-regulated in only one C. concisus oral strain, while  flaB was 
significantly up-regulated in two C. concisus strains including the strain with up-regulated 
flaA. However, only flaC gene expression was significantly up-regulated in all tested C. 
concisus strains.  
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Virulence characteristics related to motility, adhesion and invasion were investigated in 
selected C. concisus oral strains. The motility speed was measured using a modified method 
from Differential Dynamic Microscopy (DDM). Adhesion and invasion assays were also 
performed in an in vitro model using the human epithelial cell line INT-407. A C. concisus 
strain isolated from a healthy child (RMIT O17) was found to be significantly more invasive 
than the other tested strains. The motility speed of the tested strains varied, however C. 
concisus RMIT-O17 was found to be more motile than the other tested strains. 
To conclude, Cape Town filtration protocol is suggested to be the best way to isolate C. 
concisus from clinical and oral samples. C. concisus genomospecies B was found to first 
colonise the human oral cavity. Our results suggest that there are variations in the expression 
of flagellin genes within C. concisus strains and these genes are heterogeneous in different 
genomospecies. The flaC primer set used in this study can be used as a species-specific 
primer set to detect new C. concisus isolates. Based on flagellin genes tested in this study, 
knock-out mutants of flaA, flaB and flaC genes would be necessary to investigate the role of 
these genes in motility. 
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Chapter One - Introduction 
Chapter One 
Introduction 
 
1.1 The genus Campylobacter  
 
The first Campylobacter species to be isolated was C. fetus, from a sheep in 1906 and called 
Vibrio fetus by Smith and Taylor (Smith et al., 1919), and was then renamed Campylobacter 
fetus in 1973 after it was shown as microaerophilic Vibrio (Veron et al., 1973). The genus 
Campylobacter is now placed in the Epsilonproteobacteria (Logan et al., 1994), and its 
family is Campylobacteraceae (Vandamme et al., 1991a), which includes the genera 
Campylobacter, Arcobacter and Sulfurospirillum. The closest genera are Helicobacter and 
Wolinella, which are from Helicobacteraceae (Vandamme, 2000). Campylobacters were 
thought to be only veterinary pathogens until the 1970s, when they were shown to be isolated 
from stools of patients with acute enterocolitis (Skirrow, 1977). There are approximately 25 
known species, and 11 subspecies in the Campylobacter genus (Murray et al., 2009). 
Currently, the Campylobacter genus comprises several species and subspecies such as C. 
curvus, C. fetus subsp. fetus, C. gracilis, C. helveticus, C. hyoilei, C. hyointestinalis subsp. 
hyointestinalis, C. jejuni subsp. jejuni and C. jejuni subsp. doylei (Gorkiewicz et al., 2003). 
C. coli was first classified C. hyoilei and was isolated from lesions of porcine proliferative 
enteritis (On, 2001).  
 
Campylobacters can be found at different sites including the intestinal tract and the oral 
cavity of humans and animals as normal flora or as pathogens (Garcia et al., 1983, 
Vandamme, 2000). C. pylori, which is a human gastric pathogen was also included in the 
genus in 1984 (Marshall et al., 1984), however this organism was later relocated in the genus 
Helicobacter according to the 5S and 16S RNA sequence data and DNA-DNA hybridization 
(Goodwin et al., 1989). Campylobacter upsaliensis was added to the genus Campylobacter. 
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Wolinella curva was described in early 1980s and then added to the Campylobacter as C. 
curvus (Vandamme et al., 1991b). C. concisus was first described by Tanner et al. (1981), as 
small asaccharolytic, non-pigmenting gram-negative rods, and was first isolated from a 
person with gingivitis and periodontitis. C. mucosalis has been described to be most similar 
to C. sputorum and was named as C. sputorum subsp. mucosalis (Roop et al., 1985); sharing 
a highly similar phenotype and a common source (pig intestine) (Harrington et al., 1999). 
Hence, C. mucosalis is now distinguished from C. sputorum by negative arylsulfatase activity 
test. The study suggested that C. mucosalis is more strongly related to C. concisus compared 
to other Campylobacter spp (Vandamme et al., 1989). 
 
Campylobacter spp. cells are normally motile, spiral-curved rods with a size of 0.5-0.8 µm by 
0.2-5.0 µm and most members of Campylobacter genus are microaerophilic (Griffiths et al., 
1990). They can grow at a wide range of temperature including 25ºC, 37ºC and 42ºC. Under 
certain conditions, Campylobacter spp. may become round or coccoid and the shape is 
considered as viable but non-culturable (Rollins et al., 1986). Campylobacter ordinarily grow 
in a microaerophilic condition, however some species require anaerobic conditions or 
hydrogen in order to grow under microaerophilic conditions, such as C. concisus. Oxidase 
activity can be found in all Campylobacter species except C. gracilis (Wassenaar et al., 
2006). The following table (Table 1.1) shows the valid species and subspecies in 
Campylobacter genus as of April 30, 2013, their common hosts and associated diseases in 
humans and animals. 
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Table 1. 1 List of valid Campylobacters, their common hosts and disease associations.  
Campylobacter spp. Host species Associated human 
diseases 
Associated animal 
diseases 
C. avium Poultry None as yet None as yet 
C. canadensis Whooping cranes None as yet None as yet 
C. coli Pigs, poultry, 
ostriches, cattle, 
sheep 
Gastroenteritis Gastroenteritis, 
infectious hepatitis 
C. concisus Humans, domestic 
pets 
Gastroenteritis, 
periodontitis 
None as yet 
C. cuniculorum Rabbits None as yet None as yet 
C. curvus Humans Periodontitis, 
gastroenteritis 
None as yet 
C. fetus subsp. fetus Cattle, sheep, 
reptiles 
Gastroenteritis, 
septicaemia 
Spontaneous abortion 
C. fetus subsp. 
venerealis 
Cattle, sheep Septicaemia Infectious infertility 
C. gracilis Humans Periodontitis None as yet 
C. helveticus Dogs, cats Periodontitis Gastroenteritis 
C. hominis Humans None as yet None as yet 
C. hyointestinalis 
subsp. hyointestinalis 
Cattle, deer, pigs, 
hamsters 
Gastroenteritis Gastroenteritis 
C. hyointestinalis 
subsp. Lawsonii 
Pigs None as yet None as yet 
C. insulaenigrae Seals, porpoises None as yet None as yet 
C. jejuni subsp. 
doylei 
Humans Septicaemia, 
gastroenteritis 
None as yet 
C. jejuni subsp. jejuni Poultry, cattle, 
pigs, ostriches, 
wild birds 
Gastroenteritis, 
Guillain-Barré 
syndrome 
Spontaneous abortion, 
avian hepatitis 
C. lanienae Cattle None as yet None as yet 
C. lari subsp. 
concheus 
Shellfish Gastroenteritis None as yet 
C. lari subsp. lari Wild birds, dogs, 
poultry, shellfish, 
horses 
Gastroenteritis, 
septicaemia 
Avian gastroenteritis 
C. mucosalis Pigs None as yet None as yet 
C. peloridis Shellfish Gastroenteritis None as yet 
C. rectus Humans Periodontitis None as yet 
C. showae Humans Periodontitis None as yet 
C. sputorum Humans, cattle, 
pigs, sheep 
Gastroenteritis, 
abscesses 
Spontaneous abortion 
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C. subantarcticus Birds in the 
subantarctic 
None as yet None as yet 
C. upsaliensis Dogs, cats Gastroenteritis Gastroenteritis 
C. ureolyticus Humans Gastroenteritis, 
Crohn's disease 
None as yet 
C. volucris Black-headed gulls None as yet None as yet 
 
Table, modified from On (2013). 
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1.1.1 Hydrogen-requiring Campylobacters 
 
Some emerging species of Campylobacter including C. concisus, C. showae, C. rectus, and  
C. curvus, require hydrogen or formate to grow. These organisms can be found as normal 
flora in the human mouth, and are associated with gum diseases, although a causative role of 
these organisms has not been determined. These Campylobacter species have also been 
isolated from stool samples in patients with gastroenteritis, septicaemia, and other conditions 
(Lasticova et al., 2002). Hydrogen-dependent strains are very difficult to recover using 
standard culture techniques that are routinely used in most laboratories (Lastovica, 2006), 
however,  the number of the isolated strains can be increased using Cape Town protocol 
(Lasticova et al., 2002). 
 
Campylobacter, Helicobacter and Arcobacter strains require H2-enriched microaerophilic 
conditions to grow, however some Arcobacter strains can also grow aerobically. Hence, the 
aerobic growth can be used to differentiate Arcobacter from Campylobacter and 
Helicobacter strains (Lastovica, 2006). The membrane filtration method can be used to 
isolate all known Campylobacter, Arcobacter, and Helicobacter species. This method was 
found to be a simple, efficient, and cost-effective isolation protocol. It is used onto media, 
without antibiotic and incubation at 37ºC in an H2-enriched microaerobic condition. This 
filtration method is the most appropriate method for isolating some hydrogen-dependent 
Campylobacter species like C. concisus, C. rectus and C. curvus (Lastovica, 2006). 
 
A very recent study by Casanova et al. (2015) indicated that the number of C. concisus 
isolated from stool cultures was unusually increased and provoked a pseudo-outbreak. Two 
different microaerobic conditions were used, gas generator packs (5% O2, 10% CO2, and 85% 
N2), or with evacuation and gas replacement of anaerobic jars (5% O2, 8% CO2, 15% H2, and 
72% N2). In contrast to the microaerobic gas generator packs previously used, which cannot 
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produce hydrogen, the resulting atmosphere of the new system (evacuation and gas 
replacement of anaerobic jars) contains approximately 15% H2 (Casanova et al., 2015). Some 
Campylobacters, like C. concisus, exhibit optimal growth with 6% (v/v) hydrogen 
(Fitzgerald, 2011). The growth of C. concisus with the previous methodology (gas pack) 
yielded weak or no growth. In contrast, C. concisus grew more optimally in H2-enriched 
atmosphere. Changing the culture condition to an H2-enriched atmosphere enhanced the C. 
concisus growth was deemed to be responsible for the increased isolation rate and the 
pseudo-outbreak (Casanova et al., 2015). Hydrogen-enriched atmosphere is currently used by 
our research group at RMIT University. 
 
1.1.2 Isolation and Identification of Campylobacter spp. 
 
Through the last few decades, Campylobacter spp. isolation methods have been improved. 
Isolation of thermophilic Campylobacter spp. from stool samples normally relies on some 
selective antibiotics and growth at 42ºC, to inhibit contaminating flora. Pre-enrichment 
procedures followed by culture on selective media are used for bacterial isolation, whether 
from food and environmental samples, or any other samples with low numbers of stressed 
bacteria. Most enrichment media of Campylobacter contain antimicrobials agents including 
cefoperazone, cycloheximide and vancomycin to inhibit growth of flora. Campylobacter 
species are found to be highly sensitive to peroxides, although they have superoxide 
dismutase and catalase. Some media are highly beneficial for Campylobacter species growth 
such as sheep or horse blood, and H2-enriched atmosphere conditions. Sensitive 
Campylobacter spp. including C. hyointestinalis, C. upsaliensis, C. mucosalis or C. 
jejuni subsp. doyle may not be isolated with the use of selective antibiotics and a high 
incubation temperature. As some of these species grow slowly, incubation time is often 
extended (Wassenaar et al., 2006). 
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The Cape Town protocol, a method developed by Le Roux et al. (1998), was used in isolating 
Campylobacter spp. from blood and stool samples. A suspension from the stool sample is 
applied on a 0.6-µm filter placed on agar plates containing 10% horse blood. Blood samples 
can be applied directly to the plate without filtration. The plates are then incubated in an H2-
enriched atmosphere condition. The colonies of Campylobacter spp. are buff coloured or 
dirty yellow. C. helveticus spreads, forms thin flats films, becoming visible after 6 days. 
Gram staining confirms the cell morphology. The cells of C. mucosalis are quite short and 
stubby, while C. hyointestinalis cells are large and slightly curved. C. concisus, C. rectus, C. 
curvus and C. ureolyticus are straight or less curved (Wassenaar et al., 2006).  
Several media can be used to grow Campylobacter spp., but Modified charcoal, cefoperazone, 
desoxycholate agar (mCCDA) is the recommended medium. The blood-containing media and 
charcoal-containing media are the two main groups of selective media. Preston agar, Skirrow 
agar, Butzler agar and Campy-cefex are examples of blood-containing media, while mCCDA, 
Karmali agar and CAT agar (cefoperazone, amphotericin and teicoplanin) are from charcoal-
containing media (O.I.E., 2008). CAT agar medium is used to grow C. upsaliensis (Aspinall 
et al., 1993). The study by Piersimoni et al. (1995) demonstrated that CCDA medium along 
with the filtration is the best method for the optimal recovery of Campylobacter spp. 
Biochemical tests can be used to identify and differentiate Campylobacter spp. These include 
catalase, urease, hippurate hydrolysis, nitrate reduction, indoxyle acetate hydrolysis, growth 
in bile esculin, growth in 1% glycine, and growth in 3.5% NaCl. C. sputorum can be 
distinguished by growing in 3.5% NaCl. C. fetus and C. sputorum are the only reported 
species for the growing with bile esculin, with C. sputorum able to grow and C. fetus unable 
to grow. C. jejuni can be easily differentiated from other Campylobacter spp. as it is the only 
Campylobacter spp. that can hydrolyse hippurate (Wassenaar et al., 2006). Campylobacter, 
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Helicobacter and Arcobacter species can be differentiated from other bacteria (including both 
gram-negative & gram-positive), with these bacteria lacking L-Alanine amino-peptidase (L-
ALA) found to be in most gram-negative bacteria (Hoosain et al., 2009).  
1.2 Campylobacter spp. in humans 
 
C. jejuni is a well-known cause of human gastroenteritis. Similarly, C. coli is responsible for 
causing 1–25% of all Campylobacter diarrheal diseases. Emerging Campylobacter species 
like C. concisus, C. upsaliensis and C. ureolyticus have been found to be associated with a 
range of gastrointestinal diseases including periodontitis, gastroenteritis and Inflammatory 
Bowel Disease (IBD). Members of the Campylobacter genus can colonise several hosts 
including humans and domesticated pets, as well as both farm and wild animals. 
Campylobacter spp. can also be found in contaminated food, leading to high risk of 
transmission of infection to humans (Man, 2011). 
1.2.1 Campylobacter spp. as colonisers  
 
C. jejuni and C. coli, the most common Campylobacter spp. can colonise a wide range of 
sites in the human body and have been found in blood, cerebrospinal fluid, gall bladder, 
peritoneal fluid, urine and retroperitoneal abscesses  (Blaser et al., 1986). The intestinal tract 
of humans was shown to be colonised by a number of Campylobacter species including 
C. concisus, C. curvus, C. gracilis, C. hominis, C. mucosalis, C. showae, C. upsaliensis and 
C. ureolyticus (Inglis et al., 2011).  
 
C. rectus was found to colonise the human mouth, as detected in saliva and plaque samples 
healthy children (Umeda et al., 2004). A number of Campylobacter spp., namely C. concisus, 
C. sputorum bv. sputorum, C. curvus, C. rectus, C. gracilis, and C. showae, have been 
isolated from the oral cavity of humans (Kamma et al., 2000a, Kamma et al., 1994). 
C. fetus can also be isolated from the intestinal tract of humans. It can also colonise the 
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intestinal tracts of a range of animals including sheep and turtles (Harvey et al., 1983). C. 
fetus subsp. fetus and C. fetus subsp. venerealis were also isolated from the blood as well as 
abscess samples (Petersen et al., 2007). 
 
1.2.2 Campylobacter spp. as pathogens 
 
C. jejuni and C. coli are closely-related species, and both are a common cause of acute 
enteritis worldwide (Olson et al., 2008). The infection outcomes can vary, and for example, 
acute watery or bloody diarrhoea is reported in developed countries such as USA and UK. A 
high infectious dose is required to cause human diseases caused by these organisms (Black et 
al., 1993). C. jejuni and C. coli can use colonisation, attachment, invasion, and toxin 
production to initiate disease (Cróinín et al., 2012). C. jejuni infections can subsequently 
result in development of Guillian-Barre´ Syndrome (GBS). This syndrome presents as an 
acute neurological disease, due demyelination of peripheral nerves and can lead to ascending 
paralysis. Development of GBS was seen in approximately 0.05% of patients with C. 
jejuni infections in the USA (Nachamkin et al., 1998). Thirty-three Campylobacter outbreaks 
were previously reported in Australia in a period between January 2001 and December 2006, 
affecting 457 persons. Among these outbreaks, there were 8 foodborne outbreaks, 4 at aged 
care facilities and 3 at school camps (Unicomb et al., 2009). A campylobacteriosis outbreak 
was later reported with C. jejuni (Gardner et al., 2011). C. jejuni was also found to cause 
gastroenteritis and IBD (Newman et al., 1980). C. coli can also cause gastroenteritis and 
acute cholecystitis (Blaser et al., 1986). 
The clinical manifestations of C. jejuni and C. coli infections include fever followed by 
diarrhoea. Bacteraemia and systemic infections can be found as intestinal illness specifically 
in immunocompromised patients, but in most cases, the infections are localised to the 
intestine. Diarrheic stools including watery and mildly bloody stools obtained from affected 
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people in developed countries were found to have leukocytes and erythrocytes. The disease is 
self-limiting and no antibiotic treatment is required. Diarrhoea caused by Campylobacter spp. 
may usually last up to one week, and the organism be excreted for several weeks (Melamed 
et al., 1983, Perlman et al., 1988). 
Skirrow et al. (1993) reported that in 257 cases bacteraemia was caused 
by Campylobacter enteritis. The study found that the highest percentage was 
from C. jejuni or C. coli (89%), and 8.6% was from C. fetus, C. lari, and C. upsaliensis. C. 
upsaliensis is recognised as a human pathogen, causing bacteraemia and acute or chronic 
diarrhoea. C. upsaliensis has been isolated in high numbers from diarrhoea and blood cultures 
of paediatric patients in South Africa (Lastovica, 2006, Lastovica et al., 2008, Lastovica et 
al., 1989), has been haemolytic uremic syndrome (Carter et al., 1996), and spontaneous 
abortion in humans (Gurgan et al., 1994). The association between C. rectus and diseased 
subgingival sites was reported (Macuch et al., 2000). C. sputorum has also been suggested to 
cause bacteraemia (Tee et al., 1998). 
 
To date, C. fetus is the most recognised Campylobacter spp. in animals. The C. 
fetus subsp fetus main reservoir is the GIT of cattle and sheep. This subspecies can also be 
obtained from other animal faeces (Duncan et al., 2014, Van Bergen et al., 
2005). C. fetus subsp. fetus is a rare cause of disease in humans and can cause bacteraemia, 
cellulitis, endocarditis, and meningoencephalitis, and abortion (Lastovica et al., 2008). 
Human-to-human transmission of C. fetus is suggested to be more common in susceptible 
newborn babies (Wagenaar et al., 2014). 
 
C. helveticus and C. hyointestinalis have been reported to cause diarrhoea, while C. 
upsaliensis, C. ureolyticus and C. mucosalis are more strongly associated with gastroenteritis 
cases (Bullman et al., 2012, Inglis et al., 2011). Furthermore, C. upsaliensis was previously 
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found to cause campylobacteriosis with manifestations including fever, diarrhoea with or 
without blood, and vomiting (Goossens et al., 1990). A number of Campylobacter spp. are 
linked to chronic IBD and C. hominis, C. showae, and C. ureolyticus have been isolated from 
intestinal biopsies from of children with Crohn’s disease (CD) (Zhang et al., 2009). C. 
concisus was also isolated in a high detection rates in the patients with Crohn’s disease (CD) 
and ulcerative colitis (UC) (Hansen et al., 2011, Mahendran et al., 2011). A number of 
studies have investigated the association between C. concisus and oral diseases including 
periodontitis (Haffajee et al., 1984, Macuch et al., 2000), suggesting that C. concisus is an 
opportunistic pathogen. 
 
1.2.3 Campylobacter spp. as a part of the human oral cavity microbiota 
 
Several Campylobacter spp. colonise the human oral cavity including C. concisus, C. 
gracilis, C. rectus, and C. showae. C. rectus and C. gracilis are suggested to be associated 
with periodontitis (Abiko et al., 2010, Macuch et al., 2000). Macuch et al. (2000) isolated C. 
rectus in 90% of adult subjects with periodontitis, 20% of patients with gingivitis and 10% of 
healthy subjects (Macuch et al., 2000). C. rectus was also detected in high numbers in 
subgingival plaque or saliva samples of youths and adults groups suffering from advanced 
periodontal diseases, compared with healthy individuals or those who suffering from initial 
periodontitis (Lopez et al., 2011, Von Troil-Linden et al., 1995). The study by Umeda et al. 
(2004) also showed C. rectus detected in saliva and plaque samples in 95% of healthy 
children with permanent, mixed or deciduous teeth (Umeda et al., 2004). This suggested that 
C. rectus is able to colonise oral cavities in children at a young age, with no clinical 
symptoms (Man, 2011). 
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C. gracilis was detected in high numbers, in permanent teeth of children and youth groups 
suffering from caries progression. It was also detected in permanent teeth of healthy controls. 
C. showae was also detected in low numbers in plaque from white-spot or dental lesions of 
children with caries, compared to healthy individuals (Aas et al., 2008). However, Macuch et 
al. (2000) argued there was no association between C. gracilis or C. curvus and periodontal 
diseases (Macuch et al., 2000). Based on these studies, it can be suggested that not all of oral 
Campylobacter spp. are pathogenic (Man, 2011).  
1.3 Campylobacter concisus 
 
Campylobacter concisus was first isolated in 1981 from a person suffering from gingivitis 
and periodontitis. C. concisus is an asaccharolytic, fastidious, slow-growing gram-negative 
rod shaped bacterium. It is motile with one or two polar flagella (Paster et al., 1986, Tanner 
et al., 1981), and requires microaerophilic conditions containing around 4% CO2 and 7.5% 
H2 to grow (Vandamme et al., 1989). The isolation of C. concisus has mostly been from 
children with diarrhoea and immunocompromised patients, however C. concisus has also 
been isolated from healthy people (Schlenker et al., 2009). Initially believed to be a human 
isolate of "Vibrio succinogenes", C. concisus was later renamed by Holdeman et al. (1984). 
V. succinogenes and related organisms that derive energy by reduction of fumarate or nitrate 
with formate or hydrogen were then reclassified as Bacteroides gracilis, C. concisus, or in a 
new genus, Wolinella (Holdeman et al., 1984).  
 
The first isolation of C. concisus in Australia was in the study by Russell (1995). The study 
was conducted on children with diarrhoea at the Royal Children’s Hospital (RCH), 
Melbourne, with an aim to isolate hydrogen-requiring campylobacters (Campylobacter like 
organisms; CLO). Among the 39 characterised CLO strains, 56% were later identified as C. 
concisus (Russell, 1995). C. concisus is divided into at least two different genomospecies that 
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are phenotypically not discriminable, but genetically different when analysed by DNA-DNA 
hybridisation (Vandamme et al., 1989) and AFLP analysis (On et al., 2000). Several studies 
have confirmed the heterogeneity of C. concisus, and confirmed its classification into two 
major genomospecies (A and B), using 23S rDNA PCR (Istivan et al., 2004, Kalischuk et al., 
2011). To date, only few reports are available regarding the source and route of transmission 
of C. concisus.  
1.3.1 The prevalence of C. concisus as a normal flora 
 
C. concisus was suggested as one of the Campylobacter spp. members to colonise the human 
oral cavity with higher numbers than initially predicted. C. concisus was more frequently 
isolated from healthy oral sites than diseased sites, and was found in higher proportions from 
shallow than deep sites. Within diseased sites, C. concisus was isolated more frequently from 
persons with initial periodontitis than other clinical groups, which led to describing it as an 
opportunistic pathogen (Macuch et al., 2000).   
Using culture and PCR methods, C. concisus prevalence in the saliva samples of healthy 
individuals and IBD patients was investigated and in samples from 18 patients with IBD (13 
with CD and 5 with UC) and 59 healthy subjects who were not taking antibiotics at the time 
of sample collection. C. concisus was detected in 97% of saliva samples of healthy individual 
and in all saliva samples of IBD patients by PCR. However, C. concisus was isolated by 
culturing from 75% (44/59) of the healthy subjects; 85% (11/13) of the CD patients and all 
(5/5) UC patients. The high prevalence of C. concisus found in healthy individuals suggested 
that C. concisus is a normal part of the human oral microflora. The study also suggested the 
possibility that some oral C. concisus strains may colonise the lower part of GIT and are 
involved in some enteric diseases, including IBD (Zhang et al., 2010). 
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1.3.2 C. concisus in adults 
 
C. concisus has firstly been described in gingival crevices of a person suffering from a mouth 
disease (Tanner et al., 1981). A Belgian study also isolated C. concisus from enteritis cases in 
adults, and the isolation rate was 1.5% among the total number (Zhi et al., 1996). C. concisus 
was also isolated from stool and blood samples of children and adults with and without 
diarrhoea (Vandamme et al., 1989). 
Mahendran et al. (2011) studied the prevalence C. concisus in CD adult patients from 
biopsies from different sites including ileal, cecal, colonic, and rectal sources. They found 
that the prevalence of C. concisus was significantly higher in colonic biopsies (53%; 8/15) as 
compared with controls (18%; 6/33). The study also identified C. concisus in UC patients 
with a significantly higher prevalence (69%; 9/13), compared with controls (36%; 12/33) 
(Mahendran et al., 2011). The relationship between C. concisus and UC was further 
investigated in another study. It was also found that the prevalence of C. concisus was 
significantly higher in biopsies of patients with UC (33.3%; 23/69) as compared with controls 
(10.8%; 7/65) (Mukhopadhya et al., 2011). A study by Nielsen et al. (2013) included 8302 
patients (20-67 years); found 441 C. concisus isolates among 400 patients diarrhoeic stool 
samples. C. concisus was isolated from all age patients. The study found that 10% of C. 
consisus patients had co-infections dominated by Salmonella enterica and Clostridium 
difficile. It has also been found that three patients with C. concisus had co-infections with 
Plesiomonas shigelloides, Yersinia enterocolitica, or Shigella sonnei, respectively. Only 2 
patients had C. concisus and C. jejuni/coli in their samples (Nielsen et al., 2013). However, 
the pathogenic role of C. concisus is still unclear. 
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1.3.3 C. concisus in children 
 
A Belgian study by Lauwers et al. (1991) reported that C. concisus can be isolated from 
faecal samples of children and adults suffering from diarrhoea. C. concisus was isolated from 
the stools samples of 1.5% of adults and 2.4% of children. Interestingly, only 9% of C. 
concisus-positive children were >5 year old, while the majority (54%) of C. concisus-positive 
children were <1 year old (Lauwers et al., 1991). Russell (1995) successfully isolated C. 
concisus from children with gastroenteritis who were admitted to the Royal Children’s 
Hospital (RCH), Melbourne, Australia. The children in this study had clinical manifestations 
including diarrhoea, vomiting, fever, and abdominal pain and were between 2 and 30 months 
old. The majority of C. concisus strains were isolated from children under 2 years old 
(18/19). The age distribution found in this study was similar to the global data of C. jejuni 
and C. coli infections. The study also suggested that there was a potential seasonal 
distribution for C. concisus infections, as the majority of C. concisus cases (85%) were 
identified from July to January (Russell, 1995). 
In a similar study, Van Etterijck et al. (1996) compared C. concisus isolation rates in children 
with and without diarrhoea. Using DNA fingerprinting, C. concisus was isolated from 95% of 
children in the same care centre; however there was no significant difference in the isolation 
rates between patients with diarrhoea (13.2%) and controls (9%,). This study concluded that 
there was no clear pathogenic role for C. concisus in enteritis (Van Etterijck et al., 1996). 
However, a later study reported a significant difference with increased prevalence of C. 
concisus in faecal samples of children suffering from CD (65%), compared to healthy 
individuals (33%) and non-IBD controls (37%). Furthermore, all Campylobacter spp. 
prevalence was also found to be higher in children with CD (72%) than the healthy controls 
(30%) and non-IBD controls (30%) (Man et al., 2010b). 
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A Scottish study of 100 recruited children, isolated C. concisus from 3 intestinal biopsies of 
children with IBD (2 CD and 1 UC), however no C. concisus was isolated from controls. 
Using the sequence analysis, there was no significant difference in the prevalence of C. 
concisus in IBD patients (38.6%, 17/44) compared with the controls (38.1%, 16/42) (Hansen 
et al., 2011). However, Zhang et al. (2009) previously found a significant occurrence of C. 
concisus and higher levels of antibodies against C. concisus in CD children than controls. The 
group investigated the possible role of C. concisus in newly diagnosed paediatric CD and 
children with newly diagnosed CD (51%), C. concisus DNA (P < 0.0001) and C. 
concisus specific IgG antibody levels (P < 0.001) were significantly higher, compared with 
controls (2%). Moreover, C. concisus strain UNSWCD was first isolated from an intestinal 
biopsy of a CD child (Zhang et al., 2009). Given these conflicting reports, it is not yet 
possible to draw a causative link between C. concisus and IBD, however it remains a 
possibility that some strains are more pathogenic than others. 
 
In a study performed by Kamma et al. (2000b), C. concisus was detected in low numbers in 
the deciduous teeth of children, with higher numbers in the molars than incisors teeth. This 
group investigated the composition of subgingival microbiota in children with primary 
dentition aged 4-5 years (Kamma et al., 2000b). In the same year, the group published 
another study on children with mixed dentition aged 7-8 years and C. concisus was detected 
more frequently in permanent than deciduous teeth (Kamma et al., 2000a). Both studies more 
frequently isolated C. concisus from bleeding sites and suggesting an association of 
colonisation within these sites (Kamma et al., 2000a, Kamma et al., 2000b). 
1.3.4 C. concisus in other sources 
 
C. concisus has been reported to be isolated from unusual and systemic sites in rare cases 
including from a foot ulcer of a patient with diabetes mellitus (Johnson et al., 1987, Johnson 
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et al., 1985). It was also detected in synovial fluid (SF) samples from patients with reactive 
arthritis and other forms of post-infectious arthritis using RT-PCR (Cox et al., 2003). In 
addition, C. concisus was isolated from a 65-year-old male with a history of carcinoma of the 
right-sided maxillary sinus with intracranial growth using 16S rRNA sequencing analysis. 
The patient developed a brain abscess due to polymicrobial flora including C. concisus (De 
Vries et al., 2008). C. concisus has also been isolated from children’s blood samples and the 
isolation from such sites, which are normally considered to be sterile can justify their clinical 
significance, therefore further investigations are required (Lastovica et al., 2008, Lastovica et 
al., 2014).  
1.3.5 C. concisus in animals 
 
C. concisus was initially suggested to be adapted in human only (Engberg et al., 2005). 
However, Petersen et al. (2007) successfully isolated C. concisus from a cat’s saliva samples. 
Chaban et al. (2010) isolated C. concisus from 9.5% (6/65) of diarrheic dogs. Ninety seven 
percent of diarrheic dogs and 58% of healthy dogs had detectable levels of Campylobacter 
spp. including C. jejuni, C. coli, C. concisus and C. showae. 
 
The first isolation of C. concisus from food was in chicken and beef by Lynch et al. (2011), 
who collected 550 meat samples from chicken, pork and minced beef in a 12 month period. 
C. concisus was then isolated in 10% of chicken and 3% of beef. The presence of C. concisus 
in poultry products in this study was considered to be significant (Lynch et al., 2011). Based 
on these studies, it was suggested that chickens, and not domestic pets, were more likely to be 
the reservoirs of C. concisus, with infection suggested to be via zoonotic transmission. 
Moreover, the presence of C. concisus in the human saliva supports a route of transmission 
from person to person (Kaakoush et al., 2012). 
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1.4 Isolation and Identification of C. concisus 
 
As C. concisus is a fastidious organism its isolation from clinical samples by culture 
techniques is not always successful. The Cape Town protocol was developed to isolate 
Campylobacter spp. from stool samples. It uses a membrane filter on an antibiotic-free agar 
plate. The plate is then incubated at 37ºC in hydrogen-enriched microaerophilic conditions. 
This protocol was found to dramatically improve the number of Campylobacter and related 
genera Arcobacter and Helicobacter isolated from paediatric patients stool samples 
(Lasticova et al., 2002). This protocol was developed by Le Roux et al. (1998) at the Red 
Cross Children’s Hospital (RXH) in Cape Town, South Africa. When other conventional 
methods were used, Campylobacter spp. were only isolated from 7.1% of paediatric patients’ 
diarrheic samples. However, the percentage was dramatically increased to 21.8% after using 
the Cape Town protocol (Le Roux et al., 1998). This protocol has been modified (no filter is 
used) and shown to be effective for the isolation of Campylobacter and related genera from 
blood, pleural aspirates, and other clinical specimens, and for the isolation of H. pylori from 
gastric biopsy specimens (Lastovica, 2006).  
 
The filtration method has been shown to be more effective for C. concisus strains as they 
normally grow slower than C. jejuni strains. Hydrogen-enriched environment is required for 
C. concisus to grow and it grows better at 37ºC than at 42ºC. Faecal samples or other samples 
including saliva can be cultured by preparing suspensions of a known dilution (1:2 to 1:10) in 
PBS (pH 7.4), or in brain heart infusion (BHI) broth. The plate should be incubated under 
hydrogen-enriched microaerophilic conditions (7% H2, 7% CO2 7% O2 and the balance of 
N2). This method can be performed in two different ways; by using an anaerobic gas pack 
and an anaerobic jar without a catalyst, or by using the procedure of evacuation replacement, 
which evacuates the jar to -0.7 bar and re-gassing to the pressure of atmospheric with a gas 
mixture of 10% hydrogen, 10% carbon dioxide and a balance nitrogen. Three to five days 
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incubation period is the optimal duration before opening the jar. The colonies of C. concisus 
are small (1-2 mm), round, entire, greyish and semi-translucent.  In studies in our laboratory, 
wet mounts of C. concisus are normally prepared in PBS or brain-heart infusion broth and C. 
concisus cells can be seen as very small, slightly curved rods with rapid darting motility 
under the microscope. C. concisus also forms long rods and may also be found in coccoid 
forms, like other Campylobacter spp. (Istivan et al., 2010). 
1.4.1 Biochemical and conventional identification of C. concisus 
 
Conventional phenotypic and biochemical tests can be used to identify C. concisus colonies 
(Table 1.2), including colony morphology, Gram stain, organism motility, oxidase, catalase 
hydrogen auxotrophy, H2S production, indoxyl acetate hydrolysis, DNase production, 
susceptibility or resistance to specific antibiotics, hippurate hydrolysis, nitrate reduction and 
the ability to grow on MacConkey agar (Engberg et al., 2005, Lastovica, 2009, On et al., 
1996). C. concisus can be differentiated from C. mucosalis by the test of sensitivity to 
cephalothin and nalidixic acid, the ability to grow at 25ºC and 42ºC, and colony colour (On, 
1994). C. concisus, isolated in a pure culture from the stool sample of young male suffering 
from a chronic lymphatic leukaemia was initially misidentified as C. mucosalis because the 
diagnosis was based on the biochemical reactions and susceptibility tests only. It was then 
recognized as C. concisus using a 16S rRNA sequencing (Anderson et al., 1996). Under the 
electron microscopy, C. concisus cells can be seen as curved rods, with a size of 0.5-1 x 2-6 
μm and possessing a single polarised flagellum (Figure 1.1) (Zhang et al., 2014). Figure 1.2 
shows a gram-stained smear for a 5 day old C. concisus culture with short and long pale pink 
stained curved rods. 
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Table 1. 2 Phenotypic characteristics of C. concisus.  
Phenotypic characteristic Reaction* 
Tanner et al. 
(1981) 
Bergey’s manual 
(Vandamme et al., 2005) 
Active motility A A 
Growth on minimal media - N 
Growth in air +CO2 N - 
Growth stimulated by 
formate and fumarate 
A - 
Growth stimulated by nitrate N - 
Growth at 25ºC - N 
Growth at 42ºC - M 
Growth in the presence of: 
Sodium fluoride A M 
Oxgall A F 
Sodium deoxycholate A - 
Phenol N - 
Janus green A - 
Basic fuchsin A - 
Crystal violet A - 
Safranine A F 
Alizarine red S A - 
Azure II A - 
Potassium cyanide M - 
Methyl orange A - 
KMnO4 - N 
End products: 
H2S A N# 
Formate N - 
Acetate F - 
Lactate N - 
Succinate A - 
Pyruvate N - 
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Hydrogen A - 
Nitrous oxide N - 
Reduction of: 
Nitrite A - 
Nitrate - F 
Selenite - F 
Benzyl viologen A - 
Neutral red A - 
Activity: 
Oxidase A M 
Urease N N 
Catalase N N 
Benzidine A - 
Lysine and ornithine 
decarboxylase 
N - 
Indoxyl acetate hydrolysis - N 
Hippurate hydrolysis - N 
Arylsulfatase - - 
Pyrazinamidase - - 
*A, 95–100% positive; M, 60–93% positive; F, 14–50% positive; N, 0–11% 
positive; not available,  #Trace quantities. 
 
Table, modified from Kaakoush et al. (2012). 
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Figure 1. 1 Electron microscopy image of C. concisus. The bacterium is a slightly curved 
rod (0.5-1 x 2-6 μm) and has a polar flagellum. Magnification 24000x (Zhang et al., 2014). 
 
 
 
 
Figure 1. 2 Campylobacter concisus gram-stained smear, showingboth the normal short, 
and the long curved bacterial cells from the same colony. Magnification 1000x (Istivan et al., 
2010). 
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1.4.2 Molecular identification of C. concisus strains 
 
1.4.2.1 Grouping of C. concisus by 23S rDNA  
 
The molecular typing of C. concisus strains using 23S rDNA sequences was initially 
performed by Bastyns et al. (1995b). A PCR assay using 23S rDNA was developed to detect 
306 bp in 12 C. concisus strains as well as other closely related Campylobacter spp. A 
combination of three primers, a forward primer MUC1 and two reverse primers CON1 and 
CON2 were used. The forward primer MUC1 was designed as a specific primer for both C. 
mucosalis and C. concisus (Bastyns et al., 1995a). The combination of the two reverse 
primers was used because some strains were undetectable with MUC1-CON1 only. This PCR 
assay was able to distinguish C. concisus strains from other Campylobacter spp. including C. 
mucosalis (Bastyns et al., 1995b).  
 
The 23S rDNA PCR was then modified by Istivan et al. (2004) using combinations of either 
MUC1-CON1 or MUC1-CON2 and used to group 19 clinical C. concisus isolates from RCH 
(Melbourne, Australia) as well as two reference strains (ATCC 51561 and ATCC 51562).  
The study  classified these C. concisus strains into two different genomospecies, A and B. Six 
C. concisus strains (28.5%) and the reference strain ATCC 51561 were belonging to 
genomospecies B, while the majority of the strains (71.5%) and the reference strain ATCC 
51562 were belonging to genomospecies A (Istivan et al., 2004). The sequences of these two 
reverse primers, CON1 and CON2 were found to be significantly different although both 
yield a similar-sized PCR fragment (306 bp), there is a major genomic difference within the 
23s rDNA nucleotide sequences of two genomospecies where the reverse primers are binding 
between the se as indicated in Figure 1.3. The figure shows the alignment of the 23s rDNA 
nucleotide sequences between C. concisus ATCC51561 representing genomospecies B and 
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ATCC51562 representing genomospecies A. The figure also indicates the locations where the 
forward and reverse primers can bind during PCR amplification. 
 
The results of this study support  the complex nature of C. concisus as they demonstrated two 
different molecular genotypes (which were named genomospecies, A and B), amongst the 
Australian C. concisus isolates with the majority of these isolates belonging to 
genomospecies A (Istivan et al., 2004). Two subsequent studies in Demark and Canada on 
faecal samples obtained from diarrhoeic and healthy individuals used the method of Istivan et 
al. (2004), and found that genomospecies B isolates were the dominant (67%) while 
genomospecies A isolates composed 33% of the total isolates (Engberg et al., 2005, 
Kalischuk et al., 2011). It is worth to mention that the distribution of C. concisus 
genomospecies can be affected by geographical factors. 
 
 
 
Figure 1. 3 Alignment of 23S rDNA nucleotide sequence of C. concisus ATCC 51561 
(genomospecies B) and C. concisus ATCC 51562 (genomospecies A), showing the forward 
primers, MUC1 and 2 reverse primers, CON1 (genomospecies A) and CON2 (genomospecies 
B). The forward primers are identical, while there is 9 bp difference in the reverse primers. 
24 
 
Chapter One - Introduction 
1.4.2.2 Protein profiling of C. concisus 
 
The SDS-PAGE protein profiles were performed by Tanner (1986) to differentiate between 
C. concisus and other small asaccharolytic, non-pigmenting gram-negative rods of the human 
oral cavity, as they were difficult to discriminate from each other. All tested species showed 
73% intraspecies similarity using correlation coefficients’ clustering analysis and C. concisus 
showed different protein patterns (Tanner, 1986). In a following study, Vandamme et al. 
(1989) also used SDS-PAGE and found that C. concisus protein profiles were diverse 
(Vandamme et al., 1989). Both studies were in an agreement between the grouping of 
electrophoresis after a numerical analysis of the protein profiles and the taxonomic groups.  
The genetic diversity in the SDS-PAGE protein profiles between faecal and oral C. concisus 
isolates was also investigated by (Aabenhus et al., 2002). Based on the protein patterns, 85% 
of C. concisus faecal strains were different from the C. concisus oral reference strain ATCC 
33237. The study was then able to allocate the strains into two major groups. The first group 
included the C. concisus strains similar to the C. concisus oral type strain ATCC 33237, while 
the second group included the C. concisus strains whose protein profiles were different from 
that of the C. concisus type strain (Aabenhus et al., 2002). 
Istivan et al. (2004) also used SDS-PAGE to study the outer membrane protein profiles 
(OMPs) and whole cell lysates of 19 C. concisus clinical isolates. Five different protein 
profiles were found for C. concisus outer membrane proteins (OMP) extracts, compared with 
the C. mucosalis reference strain protein profile. At least 3 C. concisus protein profiles 
showed a significant similarity. An identical protein profile was observed with the majority of 
genomospecies B strains with an exception with the reference strain ATCC 51561 and RCH 
14. Genomospecies A C. concisus strains were found to be more divergent in their SDS-
PAGE protein profile (Istivan et al., 2004). 
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The protein profiles of total cell lysates of eight C. concisus strains, including UNSWCD and 
BAA-1457, were also investigated by Kaakoush et al. (2011a) using SDS-PAGE. The two 
strains, UNSWCD and BAA-1457, were previously found to be different in the size of their 
genome (1.8 Mb and 2.1 Mb, respectively) (Deshpande et al., 2011). The protein profiles of 
the strains were analysed by Phoretix 1D software, clustering the strains based on their 
banding profiles. C. concisus strain BAA-1457 was found to be highly divergent from all 
other seven strains with an average similarity of 56.8%, suggesting that this strain is atypical 
in its nature (Kaakoush et al., 2011a). Based on the studies presented above, C. concisus is 
shown to be a heterogeneous species.  
1.4.2.3 Other molecular techniques for C. concisus identification 
 
DNA–DNA hybridisation was first used to identify C. concisus isolates from diarrheic 
children by Vandamme et al in 1989. The study confirmed that the faecal C. concisus strains 
exhibit between 42 and 50% of DNA–DNA hybridisation values with the oral strains 
concluding that C. concisus is a genetically diverse species (Vandamme et al., 1989). Given 
this and according to the guidelines of taxonomy then, On et al. (2000) suggested that the 
diarrheal and oral isolates should be dissimilar, although they may not be phenotypically 
distinguished. Hence, C. concisus  should be considered as a “complex species comprising at 
least two genomospecies” (On et al., 2000) 
 
The genetic diversity of C. concisus has also been investigated using Randomly Amplified 
Polymorphic DNA (RAPD), and showed that C. concisus strains isolated from 35 of 37 
children with diarrhoea (94.6%) had distinct RAPD profiles. Forty-nine different types of 
PCR banding patterns were found, while the same DNA pattern was reported with two 
different children, and other children were observed to harbour unique strains (Van Etterijck 
et al., 1996). Matsheka et al. (2006) also used RAPD analysis with the (GTG)5 
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oligonucleotide as a primer to type 100 C. concisus isolates collected from 2 adults and 98 
children with diarrhoea. This method indicated that 86% of the isolates were genotypically 
different. Twenty-five of these heterogeneous isolates were previously analysed by PFGE and 
were shown to have distinctive  profiles (Matsheka et al., 2002). The remaining strains (14%) 
could be classified to five distinct RAPD profiles (Matsheka et al., 2006). 
 
Matsheka et al. (2002) used Pulsed Field Gel Electrophoresis (PFGE) with the NotI 
restriction enzyme to assess the C. concisus genetic diversity of 53 strains isolated from 
faecal samples from children with gastroenteritis. Ninety-six percent of the C. concisus 
strains (51/53) were shown to have different NotI macro-restriction fragments, whereas the 
other 2 strains were resistant to the NotI digestion. Between 1 and 14 restriction fragments 
comprised the patterns, with type and reference strains of two well-defined genomospecies of 
oral and faecal isolates comprising 6 and 12 fragments, respectively (Matsheka et al., 2002). 
 
Soon after the previous study Petersen et al. (2007) developed a PCR-DGGE method, as a 
semi-nested PCR that allows a sensitive detection of Epsilobacteria, with separation of 
species using DGGE to detect and identify Epsilobacteria including Campylobacter, 
Helicobacter and Arcobacter species in saliva samples from humans, dogs and cats. This 
PCR-DGGE method was able to identify C. concisus in all human saliva samples (11/11) and 
in only one cat’s saliva sample (Petersen et al., 2007). 
 
The genotype of 62 C. concisus clinical isolates, 56 diarrheal strains, 4 oral strains, the oral 
type strains CCUG 13114, and the intestinal type strain CCUG 19995, were investigated 
using amplified length fragment polymorphism (AFLP) analysis method (Aabenhus et al., 
2005a). All tested strains were shown to have unique profiles; however, strains were 
allocated into four different clusters by phylogenetic tree which were suggested to be four 
distinct genomospecies, which could be linked to their pathogenic potential (Aabenhus et al., 
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2005a). Kalischuk et al. (2011) also used AFLP analysis to compare the genotypes of 23 
different C. concisus isolates, from diarrheic and asymptomatic healthy individuals. Isolates 
were found to belong to one of two phylotypic clusters; with 34% similarity between each 
other. All AFLP cluster 1 isolates belonged to genomospecies A and included LMG7788 type 
strain. AFLP cluster 2 assigned 17 C. concisus isolates, a single isolates belonged to 
genomospecies A (5.9%), 12 isolates (70.6%) belonged to genomospecies B, 3 isolates were 
assigned to both genomospecies A and B (17.6%), and the last isolate did not fit into any of 
the previous groups. Although, these AFLP results contradicted what was previously shown 
in the study by Aabenhus et al. (2005a), the majority of those C. concisus isolates (90.3%) 
were classified into two main clusters (Kalischuk et al., 2011). 
 
Kaakoush et al. (2014a) performed Real-time PCR to determine the levels of 
C. concisus DNA and exotoxin 9/Dnal (a putative virulence factor) in faecal samples of CD 
patients and healthy controls and to link these levels with the abundances of microbial genera 
identified in the same subjects. C. concisus DNA was detected in faecal samples of CD 
patients (83.3%) and healthy controls (76.7%). However, the level of C. concisus DNA was 
145-fold more common in faecal samples from CD patients than healthy controls. The level 
of exotoxin 9/DnaI was also higher in CD patients, ~18-fold than in healthy controls. These 
findings suggested that CD patients had a higher abundance of C. concisus, and that their 
strains may be more virulent. The correlation between C. concisus levels and exotoxin 9 
levels was only found in CD patients, which suggested that healthy controls may be colonised 
with non-virulent C. concisus strains (Kaakoush et al., 2014a). 
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1.5 C. concisus as a potential pathogen 
 
1.5.1 The possible role of C. concisus in oral diseases 
 
Several studies on C. concisus suggested the possible role of this bacterium in gingivitis and 
periodontitis. Moore et al. (1987) performed a study to compare the subgingival bacterial 
flora in children and adults with gingivitis, and in healthy controls and subjects with different 
levels of periodontitis. C. concisus was more frequently isolated from children and adults 
with gingivitis, compared with healthy controls or subjects with periodontitis (Moore et al., 
1987). Haffajee et al. (1984) also reported the association between the level of C. concisus 
with a gain in tooth attachment in a person with periodontitis, while Tyrrell et al. (2003) 
successfully isolated C. concisus from a patient with halitosis. The isolation rate of C. 
concisus in individuals suffering from initial periodontitis (68%) was significantly higher 
than in healthy individuals, those with gingivitis, or established periodontitis, 35%, 32%, 
32%, respectively (Macuch et al., 2000). 
The immune response to C. concisus in mouth disease and controls has also been 
investigated. Ebersole et al. (1985) studied systemic antibody levels to several oral 
microorganisms involved in periodontal diseases including C. concisus. Level of antibody 
to C. concisus were found to be higher in subjects with periodontal diseases than healthy 
subjects, confirming what was seen in the previous study (Taubman et al., 1992). C. concisus 
was also found to be significantly associated with the bleeding sites of the permanent teeth 
(Kamma et al., 2000a, Kamma et al., 2000b), supporting a previous study by the same group, 
indicating that C. concisus was associated with bleeding in young adults with periodontitis 
(Kamma et al., 1994, Nakou et al., 1998). The incidence of C. concisus was also significantly 
higher in smokers than non-smokers (Kamma et al., 1997, Kamma et al., 1999). 
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Although there are several reports on the detection and isolation of C. concisus from people 
with periodontal disease, the evidence to support the role of C. concisus in oral disease is 
limited, as most of those reports only concentrated on isolates of this bacterium from the 
diseased oral sites, rather than from healthy controls. Therefore, it is still unclear whether C. 
concisus is just part of the normal flora, an opportunistic pathogen or an oral pathogen 
(Kaakoush et al., 2012). 
1.5.2 The possible role of C. concisus in gastroenteritis 
 
The role of C. concisus in gastrointestinal diseases has been more widely investigated as 
compared to its role in oral diseases. The link between C. concisus and IBD in human has 
been reported. C. concisus has a significantly higher prevalence in intestinal biopsies and 
stool samples collected from IBD patients compared to controls (Mahendran et al., 2011, 
Man et al., 2010b, Mukhopadhya et al., 2011, Zhang et al., 2009). C. concisus has been 
frequently detected in, or isolated from, diarrheal stool samples (Aabenhus et al., 2002, 
Engberg et al., 2000, Lastovica, 2006, Nielsen et al., 2013). 
 
C. concisus was also isolated from faecal samples of children with enteritis, some of them 
suffering from diarrhoea. The study suggested that this species can cause diarrhoea, 
specifically in immunosuppressed patients (Van Etterijck et al., 1996). However, no 
significant difference was found between C. concisus isolation rates from diarrheal and non-
diarrheal faecal samples (Engberg et al., 2000, Van Etterijck et al., 1996). C. concisus was 
detected in 9% of dog’s diarrheal stool samples and 0% in non-diarrheal samples using PCR. 
The role of C. concisus in diarrheal disease remains unclear (Chaban et al., 2010).  
 
Newly diagnosed CD children in Australia were reported to be significantly positive (82%) 
for Campylobacter as compared with 23% of controls by PCR. C. concisus, C. showae, C. 
hominis, C. gracilis, C. rectus, C. ureolyticus, and C. jejuni were detected in CD patients, 
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however the prevalence of C. concisus was significantly higher in patients with CD (51%) 
compared with controls (2%). This is the first report of association between C. concisus and 
paediatric CD (Zhang et al., 2009).  
 
A recent study by Hansen et al. (2013) did not successfully detect a significant difference in 
the prevalence of C. concisus and all Campylobacter spp. DNA in cohorts of children with 
UC and controls. The prevalence in the UC children was 30.8% (4/13) and 69.2%, 
respectively, while it was 38.1% (16/42) and 76.2%, respectively in the controls (Hansen et 
al., 2013). These results suggest that there is no role of C. concisus in paediatric UC, however 
further studies are required to confirm these observations in larger groups of paediatric 
patients (Kaakoush et al., 2014c). 
 
Von Rosenvinge et al. (2013) studied the microbiota of human stomach fluid and C. concisus 
was found to be highly active (444% increase in transcriptomic activity) within the gastric 
fluid. In addition, the study stated that the presence of H. pylori was not associated with 
significant differences in C. concisus levels (Von Rosenvinge et al., 2013). In a study to 
investigate the prevalence of C. concisus in Barrett’s esophagus patients, C. concisus was 
isolated from 57% of esophageal biopsies and but not from the controls (Macfarlane et al., 
2007). Further studies are required to determine whether this bacterium can play a role in the 
development of Barrett’s esophagus (Lastovica et al., 2014). The pathogenic potential and 
virulence mechanisms employed by C. concisus are of significant interest in an association 
with IBD. Although C. jejuni is the most investigated species of all Campylobacter spp., it is 
predicted that C. concisus shares some similar mechanisms of C. jejuni pathogenesis 
(Kaakoush et al., 2014c). 
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1.5.3 C. concisus and Antimicrobial Susceptibility 
 
Few studies have been performed to determine the antimicrobial susceptibility of C. concisus 
and other non-jejuni and -coli campylobacters. Twenty C. concisus isolates were tested for 
antimicrobial susceptibility using Etest to determine the minimum inhibitory concentrations 
(MICs) of six antimicrobial agents, though other methods were previously performed such as 
disk diffusion and broth microdilution. Due to the limited data on standardised susceptibility 
for Campylobacter spp., only two MICs were described, being MIC50 and MIC90, as well as 
the percentages and ranges of resistance of the six antibiotics tested. Both MIC50 and MIC90 
represent the MICs that completely inhibited the visible growth of 50% and 90% of the 
strains, respectively. The Clinical Laboratory Standards Institute (CLSI) does not recommend 
to include specific breakpoints for defining resistance in Campylobacter spp. Therefore, this 
study used CLSI criteria of Staphylococcus spp. for erythromycin and tetracycline on 
Campylobacter spp. Among the different Campylobacter spp. strains, 95% were found to be 
susceptible to erythromycin and ciprofloxacin (0.25 mg/L MICs). However, 80% were found 
to be resistant to nalidixic acid with 32 mg/L MICs. C. concisus and C. fetus isolates were 
susceptible to ampicillin, gentamicin and tetracycline with 5% of C. concisus been resistant 
to gentamicin, ciprofloxacin and erythromycin. As such, it was suggested that erythromycin 
be the recommended treatment for campylobacteriosis caused by C. concisus and C. fetus 
during severe intestinal infections (Vandenberg et al., 2006). A comparable study on C. 
concisus was performed in Denmark by Aabenhus et al. (2005b) using the E-test method and 
reported that among 109 tested C. concisus isolates, there were some with resistance to 
ampicillin (2%), tetracycline (3%), ciprofloxacin (5%) and erythromycin (7%) (Aabenhus et 
al., 2005b). 
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In another study thirty-four C. concisus isolates were tested with eleven different antibiotics. 
All of them were found to be completely susceptible to all tested antibiotics, including 
ampicillin, tetracycline, gentamicin, ciprofloxacin, erythromycin and nalidixic acid (Engberg 
et al., 2005). However, C. concisus was always reported to be completely resistant to 
nalidixic acid (Vandamme et al., 1992). Vandenberg et al. (2006) reported that 80% of C. 
concisus isolates were found to be resistant to nalidixic acid, which was a similar to what was 
found by Van Etterijck et al. (1996) who found 51% of C. concisus isolates were resistant in 
Belgium. Another study stated that C. concisus was sensitive to three antimicrobial agents: 
amoxicillin, metronidazole and clindamycin, with E-test MICs of 0.500 mg/L, 1.500 mg/L, 
and 1.500 mg/L, respectively (De Vries et al., 2008). 
As infections with Campylobacter spp. are mostly self resolving, and only a few studies have 
been performed on C. concisus treatments. Erythromycin is currently the first choice for the 
initial treatment of intestinal campylobacteriosis caused by C. concisus and C. fetus (Skirrow, 
1990, Vandenberg et al., 2006). Rifaximin has been suggested to be effective with 
Campylobacter species without side effects (Guslandi, 2009). Rifaximin works to inhibit 
bacterial RNA and then protein synthesis by blocking the enzymatic activity of bacterial 
DNA-dependent RNA polymerase and is effective against both gram-negative and gram-
positive bacteria (Scarpignato et al., 2005).  
1.6 Virulence factors in Campylobacter spp. 
 
Several virulence factors have been studied in Campylobacter spp., especially in C. jejuni. 
Cytolethal distending toxin (CDT) is produced by some gram-negative bacteria including 
Campylobacter spp. and is considered to be a virulence factor (Smith et al., 2006). The toxin 
can cause eukaryotic cells to arrest in the G2/M phase of cell cycle, which may lead to 
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apoptosis (Pickett et al., 1996). It was demonstrated that CDT(+) C. jejuni strains were able 
to adhere and invade epithelial cells more efficiently than CDT(-) strains (Jain et al., 2008).  
 
Several other toxins have been identified in Campylobacter spp. It was found that orf6 gene 
has a role in C. jejuni 81116 toxin production, and contains an RTX toxin-activating protein 
C signature. Orf6 protein may only be involved in C. jejuni cytotoxin activation rather than 
being an active toxin (Liu et al., 2007). An RTX toxin was also found in C. rectus, C. 
concisus and C. ureolyticus (Burgos-Portugal et al., 2012, Gillespie et al., 1993, Kaakoush et 
al., 2010). RTX proteins are pore-forming toxins synthesised by several Gram-negative 
bacteria. RTX-mediated cytotoxicity has two phases; which are a membrane insertion phase 
and adsorption onto the target cell surface (passive phase) (Lally et al., 1999). Gatsos et al. 
(2012) examined CHO cell-active, Vero cell-inactive cytotoxin that may mediate the 
inflammatory diarrhoea due to C. jejuni, by one of six candidate proteins (Cj0114, Cj0289c, 
Cj0778, Cj0834c, Cj0998c and Cj1240c) that have potential cytotoxic activity (Gatsos et al., 
2012). The capsular polysaccharide (CPS) was found to play an important role to protect C. 
jejuni against host defence. Some studies suggest that a CPS-deficient C. jejuni mutant 
lacking the kpsM gene was unable to resist against serum killing (Bacon et al., 2001, Maue et 
al., 2013).  
 
Biofilm formation is one of many survival mechanisms used by microorganisms to resist 
biological, environmental and physical stresses and also to persist and sustain in a several 
range of ecological niches. Biofilms may have an important role in infections caused by 
Campylobacter spp. (Kaakoush et al., 2014b). Some researches on C. jejuni biofilm 
formation have focused on how C. jejuni can survive within a biofilm state.  A study on C. 
jejuni survival within the biofilm suggested that this bacterium can persist for an extended 
period of time through localised biofilms formed in the water (Buswell et al., 1998). Joshua 
34 
 
Chapter One - Introduction 
et al. (2006) reported that microaerobic bacteria in flocs (unattached aggregates) can survive 
for long periods, up to 24 days at room temperature, while planktonic bacteria can survive 
half of this period. Thus, the biofilm growth mode can provide protection against the 
environmental stresses (Joshua et al., 2006).  
 
Other Campylobacter spp. have also been shown to form biofilms on glass, stainless steel and 
polystyrene including C. concisus, C. curvus, C. rectus, C. showae, C. mucosalis and C. 
gracillis. C. upsaliensis, C. sputorum, C. hyointestinalis and C. helveticus were found to form 
biofilms on stainless steel. The biofilm formation of eight microaerophilic Campylobacter 
spp. including C. jejuni, C. coli, C. lari, C. fetus, C. hyointestinalis, C. upsaliensis, C. 
sputorum and C. helveticus was tested. Of these, C. jejuni 81-176 was the only strain that 
produced a visible biofilm on several surfaces. Six Campylobacter spp. that can anaerobically 
grow including C. concisus, C. curvus, C. rectus, C. showae, C. mucosalis and C. gracillis 
also produced a visible biofilm on multiple surfaces. On the other hand, C. coli ATCC 33559 
did not form biofilms on plastic, steel or glass (Gunther et al., 2009). 
 
1.6.1 Motility as a virulence factor in Campylobacter spp. 
 
C. jejuni has two different viscosity-dependent modes of motility into caecal mucosal 
scrapings from mice (Lee et al., 1986). C. jejuni was found to rely on its flagellum for 
propulsion at low viscosity, like any other flagellated bacterium. However, it is likely that the 
spiral morphology is important in concert with changes in flagellar conformation and/or 
rotation, when the viscosity is high (Ferrero et al., 1988). The swimming direction of C. 
jejuni is reversed in a back and forth pattern with a relatively short straight moving path, in 
high viscosity media (Shigematsu et al., 1998). Therefore, the two types of motility could 
play a role in the different regions of the mucus layer of gastrointestinal tract. Viscosity is 
thought to increase between the lumen and the epithelial surface. Darting motility may raise 
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the number as well as the time of contacts between C. jejuni and the epithelium, thus 
increasing the adherence to or invasion of those cells (Szymanski et al., 1995). Colonisation 
of the gut mucosa is based on the ability of the bacteria to attach to gut epithelium and the 
rapid motility, with the campylobacter spiral shape allowing the bacterium to penetrate the 
mucus layer of intestinal cells. The flagella are very important as virulence factors, as 
aflagellate bacteria cannot colonise cells in vivo (Aguero-Rosenfeld et al., 1990). 
 
The flagellum of Campylobacter spp. includes two homologous flagellins, FlaA and FlaB. 
The FlaA is very important for adherence, colonization of GIT, and invasion. C. jejuni seems 
to have fimbriae-like elements and cell surface proteins (PEB1, CadF), which help to 
function in attachment, colonisation and invasion (Dolg et al., 1996). The invasive antigen 
(Cia) of Campylobacter spp. is also secreted through the flagellum and used to facilitate 
motility (Dasti et al., 2010). FlaA was found to be important for flagellin and motility, 
however, FlaB requirement varies between species (Josenhans et al., 1995, Suerbaum et al., 
1993). C. jejuni flagella can export the Cia and it is delivered to the host cells cytosol. 
Campylobacter is then able to attach to the epithelial cells (Larson et al., 2008, Neal-
Mckinney et al., 2012). The importance of the flagellum in invasion of host cells has 
previously been reported and aflagellated C. jejuni mutants have a significantly reduced 
internalisation into host cells in vitro (Wassenaar et al., 1999).  
 
The flagellum of C. jejuni (Figure 1.3) involves three major parts including a basal body, a 
filament and a hook. FlaA, FlaB, which are the components of the flagellin filament, are O-
linked glycosylated proteins. In C. jejuni, the flagella system is composed of the major 
flagellin (FlaA) and the minor flagellin (FlaB) (Logan et al., 1987). Any mutation in the flaA 
gene may lead to a truncated flagellum, loss of motility and loss of the ability to colonise in 
human and animals (Wassenaar et al., 1991), and an ability to invade the intestinal cells in 
36 
 
Chapter One - Introduction 
vitro (Yao et al., 1994). C. jejuni with mutations in the flagellin gene flhB is affected in 
motility and flagellin expression. Therefore, this gene is important for C. jejuni flagellar 
biogenesis (Matz et al., 2002). Studies using knock-out mutants have shown that the stator 
elements, motA and motB were found to be responsible to obtain the energy for motility 
(Dean et al., 1984). Sigma28 is included in the transcription of a small subset of the major 
flagellin gene (flaA). Sigma54 is however, involved in the transcription of many genes 
encoding the flagellar rod, basal body, and the minor flagellin (flaB) (Jagannathan et al., 
2001). 
Some flagellin genes have been found to have important roles in the bacterial biofilm 
formation. For instance, Kalmokoff et al. (2006) showed that an aflagellate flhA mutant was 
found that it could not form the pellicle liquid culture interface and it also was no longer able 
to attach to a solid matrix and produce biofilm formation. The delay in pellicle formation was 
also found to be due to inactivation of some genes that known to affect the flagellar filament 
such as flaA, flaB, and flaG or that affect the adhesion like flaC (Kalmokoff et al., 2006). 
This was also supported by a study performed by Reeser et al. (2007), which indicated that C. 
jejuni flaA/B and luxS mutants were dramatically reduced in the ability to produce the biofilm 
formations compared to the wild-type. This suggested that flagella have a very important role 
in the optimal production of biofilm (Reeser et al., 2007). Using electron microscopy, the 
flagella were also found to behave as connectors between individual bacteria (Moe et al., 
2010). 
1.6.1.1 The structure of flagellum 
 
The motility system of Campylobacter spp. includes the flagellum and the chemosensory 
system, which influences flagellar rotation in response to environmental conditions. Between 
25 and 30 conserved proteins constitute the flagellum with additional factors required for 
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synthesis or secretion of these components. The chemosensory components are less 
conserved and can include several chemoreceptors and signalling proteins. Overall, 40 to 100 
different proteins are essential to form a rotating, chemoresponsive flagellum (Lertsethtakarn 
et al., 2011). The description of flagellar structure and biosynthesis 
of Campylobacter and Helicobacter species are similarly described for well-studied systems 
of Salmonella species and E. coli (Chevance et al., 2008, Macnab, 2003, Minamino et al., 
2008). Two main broad substructures divide the flagellum: the hook-basal body (HBB) 
complex and the extracellular filament. The HBB complex is also divided into three 
structures, these are located at the cytoplasm and inner membrane, the periplasmic rod and 
associated ring structures, and the surface-localized hook (Lertsethtakarn et al., 2011). FlaA 
and FlaB have been found to be included in the flagellum of Campylobacter and FlaA is more 
important for motility (Dasti et al., 2010).The hook of Helicobacter contains FlgE protein 
(O'toole et al., 1994). 
The base of flagella contains the motor, the cytoplasmic C ring or switch complex, the 
flagellar type III secretion system (T3SS), and the MS ring. The MS ring is a homomultimer 
of FliF with a functional flagellar T3SS, composed of FlhA, FlhB, FliO, FliP, FliQ, and FliR 
within the central membrane patch of the ring (Figure 1.3). The flagellar T3SS also export 
some proteins that are part of flagellum beyond the inner membrane. The C ring functions as 
the switch of flagellum and helps in secretion. Together, FliG, FliM, and FliN or FliY form 
this complex, though Epsilonproteobacteria include both FliN and FliY (Lowenthal et al., 
2009). FliG was found to be a responsible for the switch rotary component, turning the 
flagellum either clockwise or counter-clockwise (Sarkar et al., 2010). FliY may have 2 
functions, sharing homology with FliN and has a partially redundant function in H. 
pylori (Lowenthal et al., 2009). The base motor components include MotA and MotB, which 
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work together to link proton flow and torque generation for flagellar rotation (Minamino et 
al., 2008). 
 
The first rod secreted proteins are FliE, FlgB, and FlgC. These proteins polymerise on the 
periplasmic surface of the MS ring to form a hollow tube. Other secreted proteins like FlgF 
and FlgG rod proteins can also polymerise on the tip of the developing flagellar structure 
(Lertsethtakarn et al., 2011). The P ring in the peptidoglycan and the L ring in the outer 
membrane are formed by FlgI and FlgH. These rings can form around the rod, which likely 
then support these cell envelope components (Kamal et al., 2007, Ryan et al., 2005). 
In Salmonella species, FliK, is not only responsible to switch export from hook to filament 
proteins, but also works to controlling hook length (Minamino et al., 1999). FliK also works 
to measure the hook length. Simultaneous contact of FliK with FlgD through the N and C 
termini, which presents at the tip of the growing hook and also with FlhB at the flagellar 
base, indicating that an ideal length hook has formed (Erhardt et al., 2010).  
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Figure 1. 4 Major components of the flagellar structure C. jejuni and H. pylori. The 
components are coloured based on the respective genes classification in the transcriptional 
regulatory cascade for the organisms. The proteins encoded by genes whose transcription was 
not analysed or is still known to be outside the flagellar transcriptional hierarchy are coloured 
as grey (Lertsethtakarn et al., 2011). 
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1.6.1.2 C. concisus motility genes 
 
To date, there are limited data about C. concisus motility. Flagellin A has never been studied 
in C. concisus.  There are some similarities between the flagellar systems of C. jejuni and C. 
concisus. The system of C. jejuni flagellar secretion has a significant role in its virulence 
(Kaakoush et al., 2010), and this may also be the case for C. concisus. Nuijten et al. (1990) 
have identified two flagellin genes, flaA and flaB of C. jejuni 8116 (Nuijten et al., 1990). The 
group also identified the presence of at least four distinct immunogenic regions of flagellin 
proteins of C. jejuni (Nuijten et al., 1991).  
 
Kaakoush et al. (2010) used proteomics, mass spectrometry (MS) and comparative 
bioinformatics to predict putative virulence factors of C. concisus. Two motility secreted 
proteins have been identified: flagellin B encoded by ccc13826_2297 and the flagellin-like 
protein FlaC, encoded by ccc13826_2187 (Kaakoush et al., 2010). FlaB is included in the 
immunoreactive proteins detected in 10 C. concisus-positive CD patients. It is therefore one 
of the predominant antigens recognised by all patients’ sera, including FlaB, ATP synthase 
F1 alpha subunit, and OMP18. The sequence of C. concisus flaB has been compared with 
other members of Campylobacters, with 83% identity with C. curvus, 78% with C. rectus, 
60% with C. lari and 57% with both H. pylori and C. jejuni (Kovach et al., 2011). 
 
The flaC gene is conserved in several Campylobacter spp. including C. jejuni, C. coli, C. lari 
and C. upsaliences. C. jejuni NCTC 11168 has a conserved flaC gene. A homologous 
sequence of flaC is also present in C. coli, C. lari and C. upsaliensis. C. coli strains tested 
also secrete a FlaC-like protein. The flaC gene appears to have evolved in Campylobacter 
spp., after the divergence of Helicobacter. The motility of flaC mutant has been compared 
with wild type, flaA and flgF mutant, and the motilities of a flaC and the wild type cells are 
similar, while a flgF mutant was non-motile (Song et al., 2004). A FlaC orthologue is not 
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present in H. pylori (Parkhill et al., 2000). flaA mutants were previously reported to have low 
motility (Guerry et al., 1992). The flaC gene does not appear to be essential for the formation 
of the flagellum or motility, and a flaC null mutant of C. jejuni TGH9011 maintained ability 
to adhere to HEp-2 cells, but was defective in cellular invasion capability (Song et al., 2004). 
C. concisus UNSWCD secreted flagellin-like protein FlaC, encoded by ccc13826_2187 
(Kaakoush et al., 2010). Moreover, Holo-(acyl carrier protein) synthase, encoded by 
ccc13826_2069 interacts with FlaC, a flagellin-like protein. It was suggested that the 
presence of virulence factors in C. concisus secreted proteins, interact with the host cell more 
readily than membrane-bound proteins, providing supporting evidence to suggest that C. 
concisus is a gastrointestinal tract pathogen (Kaakoush et al., 2010). 
1.6.1.3 Mechanism of C. concisus motility  
 
The C. concisus flagellum is important for motility and can be used to mediate adhesion host 
cells. For instance, C. concisus uses its polar flagellum to adhere to host microvilli (Kaakoush 
et al., 2011b, Man et al., 2010a). Lavrencic et al. (2012) tested the motility of 8 C. concisus 
strains by growing them on solid agar and liquid media, all were found to be motile and five 
strains (UNSWCD, UNSW1, UNSW2, UNSW3 and UNSWCS) had a higher level of 
motility than the other three strains (BAA-1457, ATCC 51561 and ATCC 51562) (Lavrencic 
et al., 2012). Four of the five high motile strains (UNSWCD, UNSW1, UNSW2 and 
UNSW3) were previously isolated from chronic gastroenteritis patients, while one high and 
two lower motile strains (UNSWCS, BAA-1457 and ATCC 51562) were from acute 
gastroenteritis patients. One strain from a healthy individual (ATCC 51561) had a low 
motility level (Kaakoush et al., 2011b). These findings suggested that the motility level might 
have an effect on the outcome of disease. However, other pathogenicity factors may play a 
role in the virulence (Lavrencic et al., 2012). 
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The motility of C. concisus was shown to increase when the bacterium was cultured in 
bacteriological media with a high viscosity (concentration of 20.0 viscosities and 74.7 
centipoises). This may contribute to their ability to adapt toward the viscosities present in the 
outer and inner mucus layers of the colon (Lavrencic et al., 2012). The following figure 
(Figure 1.4) shows some similarities and differences between the pathogenic potential of C. 
jejuni and C. concisus. To date, the known mechanisms of C. concisus pathogenesis include 
adherence, invasion, motility, biofilm formation intracellular survival and toxin production 
(Kaakoush et al., 2014c). 
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Figure 1. 5 Similarities and differences in the biology and pathogenic potentials between 
the established pathogen C. jejuni and C. concisus. RBC, red blood cell; T4SS, type IV 
secretion system; T6SS, type VI secretion system; TLRs, toll-like receptors; TLR5, toll-like 
receptor 5 (Kaakoush et al., 2014c). 
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1.6.2 Adhesion and invasion as virulence factors in Campylobacter spp.  
 
A number of adhesion and invasion related factors have been identified in Campylobacter 
spp. The plasmid-encoded virB11 gene is a marker associated with the virulence of 
Campylobacter spp. (Bacon et al., 2002). A mutation in one of the four genes in this plasmid 
(the plasmid – the virB11 homologue genes) can lead to a 6-fold decrease in adherence as 
well as an 11-fold decrease in invasion compared with the wild-type strain. The cj0588 gene 
was also found to encode a protein included in the adherence to the human epithelial Caco-2 
cells (Salamaszynska-Guz et al., 2008). Motility is also needed for invasion of intestinal 
epithelial cells in vitro and for increasing adherence and invasion, under viscous conditions 
(Szymanski et al., 1995). Studying using well-defined mutants indicated that flaA is not 
essential for adhesion; however it is necessary for invasion (Grant et al., 1993). As discussed, 
motility and the spiral shape are considered important virulence factors in vivo. 
 
Attachment to the epithelial surfaces is very important for the bacteria as it assists with 
invasion, translocation through intestinal barrier, and induction of damage to the host cells. 
Flagella play an important role during Campylobacter spp. attachment (Everest et al., 2002). 
A number of C. jejuni adhesions were found to mediate attachment to the host cells. JlpA, 
CadF and FlpA are known to be receptors of host cells (Rubinchik et al., 2012). Flagella 
proteins were determined to mediate adhesion in order to invade intestinal cells (Mcsweegan 
et al., 1986). C. jejuni with flaA disruption (No flagellum, non-motile) had weaker in 
invasion and adhesion capability (0.5% and 1.5% of the level relative to the wild-type, 
respectively) (Yao et al., 1994). Another study showed that the mutant strain of C. jejuni 
NCTC 11186 (-flaA, +flaB) showed a reduction in the level of invasion of INT-407 cells 
(Wassenaar et al., 1991). Another study performed by Konkel et al. (2004) indicated that C. 
jejuni with mutations in flgB or flgC, flgE2 or both flaA and flaB were unable to secrete CiA 
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proteins (invasion antigens) of Campylobacter (Konkel et al., 2004). These finding suggest 
that C. jejuni flagella could mediate the adhesion protein secretion (Kaakoush et al., 2014b). 
Several proteins were found to have important roles in C. jejuni attachment such as flagellin, 
JipA, CadF, FlpA, PEB1, PEB3, PEB4, CapA, CapB, Cj1349, Cj0091, TlyA and P95 
(Rubinchik et al., 2012). A study on a C. jejuni mutant with no PEB1 showed that this strain 
of C. jejuni had reduced capacity to attach to HeLa cells (50-100 times less) compared with 
the wild-type strain (Pei et al., 1998). Several Campylobacter spp. were found to be capable 
of internalisation by host cells by a transcellular mechanism; meaning they can invade the 
epithelial cells and transcytose through intestinal barrier. Moreover, Campylobacter spp. 
were also found to be internalised by host cells by invasion of monolayers across a 
paracellular mechanism, meaning they can translocate through the intestinal barrier between 
two adjacent epithelial cells (Kaakoush et al., 2011b, Man et al., 2010a, Nielsen et al., 2011). 
 
Everest et al. (1992) used the Caco-2 cell line model to study the adhesion and invasion of 
intestinal epithelia by C. jejuni and C. coli clinical isolates. The tested strains were from two 
clinical groups of patients, suffering from either colitis or watery (non-inflammatory) 
diarrhoea. All C. jejuni and C. coli strains were able to adhere to Caco-2 cells. There was a 
correlation between the invasion of Caco-2 cells and the isolation of the strain from patients 
with “non-inflammatory” disease. It was suggested that these strains were isolated from the 
patients with colitis but the inflammatory cells in stool were missed or absent at the time of 
diagnosis. Isolation of non-invasive strain from non-inflammatory diarrhoeic patients could 
be a reflection of strain differences. Furthermore, the correlation between the invasion ability 
and colitis supports the role of invasion in the pathogenesis of Campylobacter spp. (Everest 
et al., 1992). 
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Both in vivo and in vitro studies show that C. jejuni is able to invade the intestinal cells and 
then damage the tissue in infected humans (Van Spreeuwel et al., 1985). Additionally, in 
vitro studies showed that C. jejuni can also invade several intestinal cell lines such as non-
polarised INT-407, HEp-2, MKN-28 or Caco-2 (Krause-Gruszczynska et al., 2011, Novik et 
al., 2010, Oelschlaeger et al., 1993). The invasion ability of the C. jejuni 11168H wild-type 
and the non-motile C. jejuni 11168H rpoN mutant was analysed. The C. jejuni 11168H rpoN 
non-motile mutant was able to interact with and invade Caco-2 in significantly lower 
numbers of bacteria than the wild-type strain under both microaerobic and aerobic 
conditions. The study suggested that motility is very important for the interaction and 
invasion of C. jejuni, especially in early stages (Mills et al., 2012). 
 
It was shown that invasion antigen B (ciaB) gene has an important role in C. jejuni invasion 
in host cells and a null mutation in ciaB showed a non-invasive phenotype (Konkel et al., 
1999). Neal-Mckinney et al. (2012) reported that CiaC is also required for optimal invasion 
of host cells by C. jejuni, and induces cytoskeletal rearrangement of host cells (Neal-
Mckinney et al., 2012).  
 
C. coli was also found to invade several human cell lines such as HeLa, T84, and Caco-2 
cells, and also the monkey kidney epithelial cell line, Vero cells (Malagon et al., 2010, Zheng 
et al., 2006, Zheng et al., 2008). C. coli was reported to be significantly more invasive at a 
lower temperature, although it is able to grow and move at 42ºC (Aroori et al., 2013). Arce et 
al. (2010) found that C. rectus was able to invade human and murine trophoblastic cells. 
Moreover, the expression of pro-inflammatory cytokines IL-6 and TNF-α were significantly 
up-regulated. This in combination with the capability to invade trophoblastic cells, provides a 
link to the adverse pregnancy outcomes connected with human oral diseases including 
periodontitis (Arce et al., 2010). 
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C. fetus is able to invade and then exit from Caco-2 cells, and can translocate in an apical-to-
basolateral and a basolateral-to-apical direction through the monolayer of Caco-2, within one 
day, with no any alteration in the permeability of the monolayer (Baker et al., 2010). On the 
other hand, C. hominis, C. showae and C. ureolyticus were found to attach to, but not invade 
Caco-2 intestinal cells (Man et al., 2010a). Based on these findings, it was suggested that not 
all campylobacters are able to invade.  The nature of adhesion and invasion exhibited by 
some species implies that adhesion and invasion are used by Campylobacter spp. members to 
colonise and persist in the host GIT (Kaakoush et al., 2014b). 
 
1.6.2.1 Adhesion and invasion of C. concisus 
 
Kaakoush et al. (2010) found that CadF (Campylobacter adhesion to fibronectin) is secreted 
by C. concisus 13826, although the precise proteins involved in C. concisus invasion and 
attachment are still unclear (Kaakoush et al., 2010). CadF and other proteins like JIpA and 
FlpA have been proposed to be used by C. jejuni to attach the host cells (Rubinchik et al., 
2012).  
Both transcellular and paracellular invasion mechanism have been described for C. concisus. 
Bacterial cells penetrating the epithelial cell membrane usually induce a membrane ruffling 
effect on entry and were found to be included in the invasion by transcellular mechanisms. 
Electron microscopy studies have revealed that C. concisus prefers to attach and congregate 
at the intercellular junction of the Caco-2 cells or near these cells (Kaakoush et al., 2011b, 
Man et al., 2010a, Nielsen et al., 2011). 
 
Man et al. (2010a) investigated the invasion of several C. concisus strains including C. 
concisus UNSWCD, UNSWCS, ATCC 51561 and ATCC 51562 strains. Using scanning 
electron microscopy, it was shown that the initial contact of C. concisus UNSWCD strain 
with the host cells was initiated by flagellum-microvilli interaction. The flagellum can attach 
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to the microvillus and wrap around it, allowing the bacterium to attach and anchor to the 
epithelial cell. Bacteria then invaded the host cells from the non-flagellated end. C. concisus 
was able to invade Caco-2 cells, create the membrane effect on the epithelial cells, and 
damage barrier functions using preferential attachment at the cell-cell junction.  C. concisus 
UNSWCD (from CD patient) was the most invasive tested strain against Caco-2 cells (0.14% 
± 0.04% SEM), and was 46 and 201 times higher than C. concisus UNSWCS and C. concisus 
ATCC 51562 levels, respectively. C. concisus ATCC 51561 did not invade Caco-2 cells 
(Man et al., 2010a). 
 
 
Kaakoush et al. (2011b) also studied the same C. concisus strains with 4 other C. concisus 
strains to examine the adherence to and invasion of the epithelial cell line Caco-2. C. 
concisus UNSWCD was the most efficient within the 3 CD strains, followed by UNSW3 and 
then UNSW2 (Kaakoush et al., 2011b), supporting the earlier study by Man et al. (2010a). 
The invasion level of C. concisus UNSW1 (one of the new strains) was similar to the C. 
concisus UNSWCD level. No invasion was reported in two strains, C. concisus BAA-1457 
(acute gastroenteritis) and C. concisus ATCC 51561 (healthy subject), whereas C. concisus 
ATCC 51562 and C. concisus UNSWCS (both from acute gastroenteritis sources) had no 
detectible invasion compared to chronic disease causing strains. No significant differences 
were seen between C. concisus UNSW1 (chronic gastroenteritis), C. concisus UNSW2 (CD), 
C. concisus UNSW3 (CD), C. concisus UNSWCS and C. concisus BAA-1457, compared to 
C. concisus UNSWCD (CD). However, both C. concisus ATCC 51561 (healthy individual) 
and C. concisus ATCC 51562 (acute gastroenteritis) were significantly different from these 
strains (Kaakoush et al., 2011b). 
 
Burgos-Portugal et al. (2014) investigated differential invasive phenotypes of C. concisus 
further with autophagy. The process was involved in clearing intracellular C. concisus from 
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within epithelial cells of the host. The group detected intracellular C. concisus persisting 
within autophagic vesicles. Weakly invasive C. concisus strains showed inhibition of 
autophagy, leading to dramatic accumulation within epithelial cells. This finding suggests 
that strains with low capacity for invasion appear to be killed quickly by autophagy once they 
invade host cells (Burgos-Portugal et al., 2014). These findings suggest the possibility that 
highly invasive strains may have some virulence factors inhibiting the autophagy pathway. 
This is supported by the finding that important genes within the autophagy pathway such as 
LAMP1, cathepsin D and cathepsin S were found to be down-regulated following infection 
with the highly invasive C. concisus strain (Burgos-Portugal et al., 2014, Kaakoush et al., 
2011b). 
Based on the previous studies, the virulence mechanisms of C. concisus were suggested to be 
classified into two important pathotypes. They are adherent and invasive C. concisus (AICC), 
and adherent and toxinogenic C. concisus (AToCC). These pathotypes are functionally and 
genetically dissimilar to non-pathogenic strains. For instance, they are characteristically 
different in the intracellular survival, pararacellular survival and pathogenesis, compared with 
the commensal strains (Kaakoush et al., 2014c). The classification of the two pathotypes C. 
concisus (AICC, AToCC), and the commensal C. concisus strains is similar to the 
classification of E. coli subtypes that are strongly associated with ileal CD (Darfeuille-
Michaud et al., 2004, Darfeuille-Michaud et al., 1998). Based on functionality, AICC strains 
have ability to survive intracellularly, while the AToCC strains may produce a zonula 
occludens toxin (zot) to target the tight junctions of the host cells (Figure 1.5). The 
association between AICC and AToCC pathotypes, and IBD aetiology requires further 
investigation (Kaakoush et al., 2014c). 
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Figure 1. 6 AICC and AToCC pathogenic mechanisms; AICC attach to and invade the 
epithelial cells and induce immune responses by host epithelial cells. They can survive in the 
epithelial cells by subverting autophagy. The AToCC strains attach to and invade the 
epithelial cells. They can produce a Zot, that targets the tight junctions of the host cells, 
although they are efficiently eliminated from within the host cells by autophagy (Kaakoush et 
al., 2014c). 
 
 
 
 
 
 
51 
 
Chapter One - Introduction 
1.6.3 Other putative virulence factors of C. concisus 
 
The cytolethal-distending toxin (CDT) is the most characterised toxin in C. jejuni.  It was 
shown to cause progressive cellular distension, and then death, in Chinese hamster ovary 
(CHO), Hep-2 and HeLa cells (Bang et al., 2004, Johnson et al., 1988). Engberg et al. (2005) 
investigated CDT in C. concisus and detected a CDT-like effect in all three healthy subjects’ 
C. concisus isolates and C. concisus-type strain, and in 90% (35/39) of C. concisus isolates 
from patients with diarrhoea. 
 
A C. concisus haemolysin has been identified, and cell-associated haemolytic activity was 
observed in isolates from children with diarrhoea. Istivan et al. (2004) characterised the 
haemolysin and found it to be an outer-membrane phospholipase A (OMPLA), which induces 
a very strong cytolytic effect on Chinese hamster ovary (CHO) cells, and vacuolation of these 
cells (Istivan et al., 2004). A follow-up study on these C. concisus strains demonstrated that a 
secreted hemolysin is present (Istivan et al., 2008). A heat labile-secreted haemolytic activity 
was detected in C. concisus fresh cultures using a liquid haemolysin assay that tested cell-free 
supernatants (S) and retentates (R; 10kDa). The influence of iron on the haemolytic activity 
was also studied and the activity of haemolysin was reduced to 40% and to 25% of total 
blood haemolysis when 10 µM FeCl2 and 20 µM FeCl2 respectively, were contained in the 
medium. The study suggested that the iron-regulated hemolysins are virulence factors in C. 
concisus and may play a role in the diseases caused by this organism (Istivan et al., 2008). 
 
Zonula occudens toxins (Zot) are known tight junction toxins. Pathogens like Vibrio cholerae 
and Neisseria meningitidis use Zot to increase the permeability of the tissue (Fasano et al., 
1995). Some studies on Zot homologs in the host-related Campylobacterales suggested that 
this toxin is only present in C. concisus and may have a role in its pathogenesis. These 
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findings support the hypothesis that the expression of Zot in C. concisus contributes to 
attachment and invasion of host cells via a paracellular mechanism, by targeting the cell-tight 
junctions (Kaakoush et al., 2010). Two genes encoding zonula occudens toxins (Zot) in C. 
concisus 13826 (CCC13826_2075 and CCC13826_2276) were reported. These Zot genes 
were found to be a unique to C. concisus and are not encoded in genomes of other 
Campylobacter species. The study also identified two hypothetical proteins encoded by 
ccc13826_0191 and ccc13826_1210 with 47% and 46% similarity to the C. concisus Zot, 
respectively (Kaakoush et al., 2010).  
 
The prevalence of the Zot gene was tested in 56 oral C. concisus isolates from IBD patients 
and healthy subjects. The Zot gene was found in 30% of the strains, of these; zot was present 
in 40% of healthy subject strains and 55% of active IBD patient strains. Some of active IBD 
patient’s oral cavities carried multiple Zot-positive C. concisus strains (Mahendran et al., 
2013). The sequences of Zot genes of C. concisus 13826 and V. cholera 86015 were 
compared and the biological active domain of V. cholera Zot protein (FCIGRL) was not 
found in C. concisus 13826 Zot (Kaakoush et al., 2010). However, the C. concisus Zot was 
found to share conserved motifs not only with the V. cholera Zot receptor binding domain but 
also with human zonulin receptor binding domain (Wang et al., 2000), suggesting that Zot of  
C. concisus can increase the intestinal permeability by a similar mechanism to those in the 
human zonulin and V. cholerae Zot (Goldblum et al., 2011). Zhang et al. (2014) also 
suggested that the action of Zot in oral C. concisus can trigger the onset or relapse of the IBD 
and that some oral C. concisus strains can acquire the Zot from a virus (prophage). It was also 
suggested that the C. concisus oral strain that colonises the intestinal tract may release Zot 
because of the prophage, which may lead to a prolonged primary epithelial wall defect that 
triggers the development of IBD (Zhang et al., 2014), although no clear evidences were 
provided. 
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Kaakoush et al. (2010) also identified several secreted proteins and putative virulence factors 
of C. concisus using proteomics, MS and comparative bioinformatics methods. A total of 
eighty-six secreted proteins were successfully identified and divided into three groups. The 
first group was related to the physiology of bacterium and its survival (metabolic proteins), 
while the second one was involved in host-related functions (the virulence factors). The last 
group was those proteins associated with protection that against environmental stresses 
(oxidative stress response proteins) (Kaakoush et al., 2010). CjaA, CjaC and S-layer-RTX 
were also found to be secreted by C. concisus UNSWCD. CjaA and CjaC are known to be 
immunodominant in C. jejuni and they are possibly included in the surface-exposed proteins 
that are homologs of ABC-transport proteins. Several virulence and colonisation factors, 
which are present in other Campylobacter spp. were also found, such as Twitching motility 
protein, Fibronectin-binding protein CadF, Outer membrane protein 18, Invasin InvA, 
Hemolysin TlyA and Invasion protein CiaB (Kaakoush et al., 2010). 
 
C. concisus has been observed to aggregate in huge numbers on the surfaces of intestinal 
epithelial cells. The aggregation appears to be induced by the presence of mucin (Kaakoush 
et al., 2011b, Man et al., 2010a). Lavrencic et al. (2012) found that some C. concisus strains 
isolated from GIT diseases patients, can produce biofilm as efficiently as healthy individual’s 
C. concisus isolates (Lavrencic et al., 2012). It was suggested that biofilm formation by C. 
concisus was a general strategy to colonise the natural environment. It is unclear if inhibition 
of biofilm formation reduces the ability of Campylobacter spp. including C. concisus to 
infect or colonise the host cells (Kaakoush et al., 2014b). Some C. concisus strains have been 
sequenced and analysed. The genetic basis of previously reported differences in invasion was 
then investigated (Deshpande et al., 2011, Deshpande et al., 2013). C. concisus UNSWCD, a 
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strain isolated from CD patient was found to have a plasmid (30 kb) encoding several 
virulence-associated genes (Deshpande et al., 2011, Kaakoush et al., 2011b). 
 
Although C. concisus is suggested to be associated with oral and GIT diseases, there is no 
causal link and only a few virulence factors been identified. In order to understand the role of 
C. concisus as a component of the oral flora and as a potential pathogen, we need to have a 
better understanding of its genetic diversity; the expression of putative virulence factors,  and 
the possibility of the presence of pathogenic strains. To date, there is no previous study on the 
colonisation patterns of C. concisus in oral cavity of children before teething within a specific 
family unit with parents and siblings.  
 
Therefore, the aims of this study are to: 
 Investigate the carriage rate of C. concisus in healthy volunteers in different ages to 
determine the age of acquisition and any differences between genomospecies in 
relation to colonisation. 
 Investigate if C. concisus strains isolated from the same family unit members are 
related. 
 Investigate motility as a virulence factor in C. concisus in addition to other virulence 
characteristics. 
 Investigate if C. concisus isolated from healthy individuals possess virulence 
characteristics.
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Chapter Two 
General Materials and Methods 
 
This chapter describes general methods used in this study. Other specific methods are 
described in the relevant chapters.  
 
2.1 General Procedures used prior to experiments 
 
All glassware were cleaned using Pyroneg detergent (Diverey Pty Ltd, Melbourne, Australia), 
and soaked for several minutes. Glassware was washed thoroughly with tap water and rinsed 
with deionized water before use. The chemicals and reagents used in the experiments were of 
analytical laboratory grade. All solutions were prepared using deionised water and were 
obtained by filtration through a Millipore Milli-Q-water System (Merck, Australia). All PCR 
and RT-PCR reactions were prepared using molecular grade water (Qiagen, Australia). All 
sterilisation including media, reagents, glassware, and pipette tips was performed by 
autoclaving at standard conditions (121ºC for 15 mins) unless specified. Micro pipettes were 
used to accurately measure and dispense small volumes of liquid. All solutions were 
dispensed using Finnpipette (Pathtech, Australia) for all volumes ranging from less than 0.5μl 
to 1000μl and these were calibrated regularly as per manufactures recommendations. 
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2.2 Chemicals and Equipment 
 
2.2.1 General Materials 
 
Reagent Supplier 
Acetic acid                                                                   Sigma-Aldrich Pty. Ltd., Australia 
Acetone                                                                        Sigma-Aldrich Pty. Ltd., Australia 
Acrylamide, 40% (W/V) solution                                Astral Scientific Pty. Ltd, Australia  
Agarose (DNA grade)                                                  Bioline, Australia 
Albumin, bovine serum                                                Sigma-Aldrich Pty. Ltd., Australia 
Ammonium acetate                                                      Ajax Chemicals Ltd, Australia  
Ammonium chloride                                                    BDH Chemicals, Australia  
Ammonium hydroxide                                                Sigma-Aldrich Pty. Ltd., Australia 
Ammonium persulfate                                                Bio-Rad Laboratories, Australia 
Ammonium sulphate                                                  Sigma-Aldrich Pty. Ltd., Australia 
Bacteriological Tryptone                                                             Cell BioSciences, Australia  
Brain-Heart infusion broth                                        Oxoid, Australia 
Brilliant Blue G (For Coomassie Blue)                    Sigma-Aldrich Pty. Ltd., Australia 
Bromo-phenol blue                                                    Sigma-Aldrich Pty. Ltd., Australia 
Brucella Broth                                                            Oxoid, Australia  
CampyGen Sachet (Gas Pack)                                  Oxoid, Australia 
Columbia agar base                                                 Cell BioSciences, Australia 
Columbia Broth                                                        Cell BioSciences, Australia 
Copper sulphate                                                       Merck, Australia 
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Dimethylsulphoxide (DMSO)                                 Merck, Australia 
Dulbecco's Modified Eagle's Medium 
(DMEM) 
Thermofisher, Australia  
Ethanol                                                                     Merck, Australia 
Ethidium bromide                                                    Sigma-Aldrich Pty. Ltd., Australia 
EDTA (Ethylene diamine tetra acetic acid)           Merck, Australia 
Fetal bovine serum (FBS) Life Technoloies, Australia  
Ficoll-400 Reagent                                                  Merck, Australia 
Folin-Ciocalteau reagent                                           Sigma-Aldrich Pty. Ltd., Australia 
Formaldehyde                                                         Merck, Australia 
Gentamicin sulfate                                                    Sigma-Aldrich Pty., Ltd, Australia  
Glycerol                                                                    Merck, Australia 
Glycine                                                                      BDH Chemicals, Australia  
HEPES buffer (1M) (N-2-hydroxyethyl 
piperazine-N-2-ethane sulfonic acid)                                                 
Life Technologies, Australia  
Horse Blood (Defibrinated)                                     Oxoid, Australia  
Hydrochloric acid (32%)                                                  Merck, Australia  
Hydrogen peroxide (30 %) BDH Chemicals, Australia 
Immersion oil (Gurr) BDH Chemicals, Australia 
ISOLATE II RNA MINI Kit Bioline, Australia 
Isopropanol                                                            Merck, Australia 
Lambda DNA                                                         New England Biolab, Australia 
Lysozyme                                                                Astral Scientific Pty. Ltd, Australia 
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Magnesium chloride (Hexahydrate)                          BDH Chemicals, Australia 
Magnesium Sulfate                                                    BDH Chemicals, Australia 
β-Mercaptoethanol                                                   Sigma-Aldrich Pty. Ltd., Australia  
Methanol                                                                 BDH Chemicals, Australia  
Microaerophilic gas mixture                                    Linde Gas, Australia  
MyTaq DNA Polymerase                                      Bioline, Australia 
Nuclease-Free Water Qiagen, Australia 
Orange G                                                           Merck, Australia 
ParaFilm                                                              InterPath, Australia 
Petri dish                                                            VWR international, Australia  
Phosphate buffer saline (PBS) tablets                 Astral Scientific Pty. Ltd, Australia 
Potassium chloride                                             BDH Chemicals, Australia  
Protein Prestained standards marker    Bio-Rad, Australia 
PstI (100 U/µl) Biolab, Australia 
Sarkosyl (N-laurylsarcosine)                               Merck, Australia 
SensiFASTTM SYBR No-ROX’ kit Biolabs, Australia 
Skim milk                                                           Coles, Australia 
Sodium acetate                                                     BDH Chemicals, Australia  
Sodium bicarbonate                                          Cytosystems Pty Ltd, Australia 
Sodium Carbonate                                               Merck, Australia 
Sodium chloride                                                  Merck, Australia  
Sodium dodecyl sulfate (SDS)                            Merck, Australia 
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Sodium hydroxide                                              Merck, Australia  
Sodium Potassium Tartrate                                Merck, Australia 
Sulphuric acid                                                    BDH Chemicals, Australia  
TEMED 
(N,N,N’,N’tetramethylethylenediamine)    
Bio-Rad, Australia 
Tetro cDNA Synthesis kit  Bioline, Australia 
Tissue culture flask (25 cm2, 75 cm2)                                VWR, Australia 
Tris-HCl                                                              Merck, Australia  
Triton-X-100                                                      Sigma-Aldrich Pty., Ltd, Australia  
trypan blue                                                         Sigma-Aldrich Pty., Ltd, Australia 
Trypsin – EDTA                                                  Life Technoloies, Australia  
Tryptone                                                             Cell BioSciences, Australia  
Turbo DNA-freeTM kit Life technologies, Australia 
Ultrapure water Bioline, Australia 
UltraPure Tris-base                                            Sigma-Aldrich Pty. Ltd., Australia 
Wizard Genomic DNA Purification Kit           Promega, Australia 
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2.2.2 General Equipment  
  
Equipment                                                                      Supplier  
Anaerobic jar: 
(i) 2.5 & 3.5L jars 
(ii) 9 & 48 plates jars 
 
Oxoid, Australia 
Don Whitely, Australia 
Balances: 
(i) Analytical balance 
(ii) Balance (0.1-500g) 
 
Sartorius GMBH, Australia 
U-Lab, Australia 
Camera (With 18-200mm lens)                                          Canon, Australia 
Cell counting chamber                                                         Life Technologies, Australia 
Cell Counter                                                                        Life Technologies. Australia 
Cellulose Acetate Filter (0.65 µm)                                         Sartorius GMBH, Australia 
Centrifuges: 
(i) Microcentrifuge  
(ii) Bench top centrifuge 
(iii) High-Speed centrifuge 
(iv) Ultra-Speed centrifuge 
 
ProSciTech, Australia 
Eppendorf, Australia 
Thermofisher, Australia 
Beckman, USA 
Centrifuge tubes: 
(i) 1.5ml Eppendorf centrifuge tube 
(ii) 10ml centrifuge tube 
(iii) 15ml centrifuge tube 
(iv) 50ml centrifuge tube 
 
VWR, Australia 
VWR, Australia 
VWR, Australia 
VWR, Australia 
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Clone Manager Software Scientific & Educational Software, USA 
Cover slips                                                                  Mediglass, Australia  
Cryoval Mcfarlane Medical, Australia 
Cuvette                                                                        Eppendorf, Australia. 
DNA Thermocycler (for PCR)                                      G-Storm, England  
Electrophoresis Power Supply: 
(i) PowerPac Basic  
(ii) EPS 3000xi 
 
Bio-Rad, Australia 
Bio-Rad, Australia 
Electrophoresis Units: 
(i) DNA 
   (a) Mini Gel 
   (b) Midi Gel 
(ii) Protein 
   (a) Mini Protein II gel system 
 
 
Bio-Rad, Australia 
Bio-Rad, Australia 
 
Bio-Rad, Australia 
Filters: Syringe Filters (0.22µm, 0.45µm) Sarstedt, Germany 
GELDOC system                                                                  Bio-Rad, USA 
Incubators: 
(i) Bellsouth 100 air incubator 
(ii) Tissue culture (5% CO2) incubator 
 
Bellsouth, USA 
Forma Scientific, USA 
Loop; normal plastic & L-shape                                           Interpath, Australia 
Microscopes: 
(i) Light microscope 
 
Olympus optical, Japan 
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(ii) Inverted Optical ix71 Olympus optical, Japan 
Needle (sterile 18G, 19G, 21G)                                     Terumo Pty, Ltd., Australia 
pH meter                                                                             Metrohm, Swiss 
Plate (24 well, 96 flat well)                                               Greiner Bio-One, Australia 
Pipette (10µl, 20µl, 200µl, 1000µl, 10ml)                        Thermofisher, Australia 
Pipette (MultiChanel)                                                           BrandTech Scientific, USA 
Phoretix 1D software Phoretix International, UK 
Prism 6 Software GraphPad Software, Inc., USA 
Rectangle Capillaries (For DDM test) Bioscientific Pty Ltd, Australia 
Rotor-Gene Q (Real-Time PCR)                                       Qiagen, Australia 
Scanner (SDS-PAGE imaging)                                         Canon, Australi 
Shaker (with incubation service)                                      Bioline Global, Australia 
Slides                                                                                LivingStone, Australia 
Sonicator                                                                          Branson Sonic Power Co., USA 
Spectrophotometer (For OD600)                                       Eppendorf, Australia 
SpectroStar Omega Reader (ELISA reader 
for Protein Concentration)                                          
BMG-LabTech, Australia 
Syringe (1 ml, 5 ml, 10 ml, 20 ml, 50 ml)                           Livingstone International, Australia  
Swab (Copan Eswab, For sample collection) COPAN, Italy 
Tips (Sterile filtered 10µl, 20µl, 100µl, 
200µl, 1000µl) 
VWR, Australia 
Tips (10µl, 200µl, 1000µl)                                                 VWR, Australia 
Vortex mixer (V ml)                                                            Ratek Instruments, Australia 
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Water Bath                                                                        Ratek Instruments, Australia 
Weight Trays  Mirella Research, Australia 
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2.2.3 General solutions and buffers 
 
2.2.3.1 Ammonium acetate 
 
The 10M solution was made up by dissolving ammonium acetate (NH4 Ac) in dH2O.  
 
2.2.3.2 Ammonium persulfate (APS) 
 
Freshly prepared by dissolving APS (10% w/v) solution in dH2O, and used immediately. 
 
2.2.3.3 Coomassie Brilliant Blue Stain  
 
Prepared by mixing methanol (10% v/v), acetic acid (50% v/v) in dH2O. Brilliant blue G 
(0.05% w/v) was then mixed to the mixture. 
 
2.2.3.4 De-staining solution (for SDS-PAGE gels)  
 
Prepared as ethanol (10% v/v) and acetic acid (10% v/v) in dH2O. 
 
2.2.3.5 EDTA 
 
Prepared as 1mM, 100mM, and 0.5M by dissolving EDTA in dH2O. 
 
2.2.3.6 Ethidium bromide (EtBr)  
 
Prepared as 6 mg EtBr (Sigma-Aldrich, Australia) in 2 L dH2O. 
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2.2.3.7 Formaldehyde (2%) 
 
Prepared by diluting formaldehyde solution (40%) (Merck, Australia) in dH2O. 
 
2.2.3.8 Gel loading dye (10x) 
 
It was prepared by dissolving 50 mM Tris-HCL (Merck, Australia) in sterilised dH2O and 
adjusted pH to 8.0. Ficoll 400 (10% v/v), EDTA (10 mM), glycerol (50% v/v), SDS (1% 
w/v), and orange G dye (Merck, Australia) (0.5% w/v) were then added to the solution. The 
solution was aliquoted into 1.5 ml tubes and stored at RT. 
2.2.3.9 Lambda (λ) PstI DNA ladder  
 
It was prepared by mixing 108µl λDNA (50μg), 18µl PstI restriction enzyme (100U), 90μl 
10x restriction enzyme Buffer H, 90 μl BSA (10mg/ml) and 900 μl dH2O. The mixture was 
incubated overnight at 37ºC. An 88μl of 10x gel loading dye (2.2.3.8) was then added to the 
mixture. The solution was aliquoted into 1.5 ml tubes prior to storing at -20ºC. 
2.2.3.10 Lysozyme 
 
It was prepared from ultra-pure grade lysozyme (Astral Scientific, Australia) by dissolving 
lysozyme powder in RNAse-free water to make a final concentration as 1mg/ml and kept at -
20ºC. 
2.2.3.11 Phosphate buffered saline (PBS) 
 
It was prepared by dissolving 1 PBS tablet (Astral Scientific, Australia) in 100ml dH2O to be 
1x. The buffer was then sterilised by autoclaving.  
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2.2.3.12 Resolving gel buffer 
 
It was prepared by dissolving Tris-HCl (1.5M) in dH2O and pH was then adjusted to 8.8. 
 
2.2.3.13 Running buffer (10x) 
 
The SDS-PAGE running buffer (10x) was prepared by dissolving Tris-HCl (0.25M, pH 8.8), 
glycine (1.92M) and SDS (1% w/v) in dH2O. The mixture was diluted to 1x before use. 
2.2.3.14 Sample Buffer (for protein gels) 
 
Sample buffer (5x) was prepared by mixing glycerol (10% v/v), bromophenol blue (0.02% 
w/v), β-mercaptoethanol (5% v/v) and Tris-HCl (0.125M, pH 6.8) in dH2O. 
2.2.3.15 Sarkosyl detergent (for outer membrane proteins)  
 
Prepared by dissolving 1.88% Sarkosyl (N-laurylsarcosine) in 12.5mM Tris-HCl and pH was 
then adjusted to 7.4.  
2.2.3.16 Stacking gel buffer  
 
It was prepared by dissolving 0.5M Tris-HCl in dH2O and pH was adjusted to 6.8.  
2.2.3.17 50X TAE buffer (Tris-Acetate-EDTA)  
 
 It was prepared by mixing 2M Tris base (242.2g/L), 1M Acetic acid (60mL/L), 0.1M EDTA 
(37.2 g/L) and dH2O up to 1 L. The buffer was diluted to 1x prior to use. 
2.2.3.18 TE buffer 
 
It was prepared by dissolving Tris-base (10 mM) and EDTA (1 mM) in RNAse-free water 
and the pH was adjusted to 8. The buffer was then filtrated using sterilised filter (0.22 µm). 
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2.2.4 Enzymes stocks 
 
2.2.4.1 Taq DNA polymerase  
 
MyTaq DNA Polymerase was purchased from Bioline (Australia) as 5U/μl stock and was 
stored at -20ºC. 
2.2.4.2 5xTaq Reaction Buffer 
 
 It was as 5x MyTaq Reaction Buffer (Bioline, Australia) and stored at -20ºC. 
 
2.3 Microbiological Methods 
 
2.3.1 Bacterial strains 
 
Twenty Campylobacter spp. strains were used for this study from the RMIT University stock 
collections. Fifteen C. concisus clinical isolates (RCH strains) were isolated from faecal 
specimens of children with gastroenteritis at the Royal Children’s Hospital (RCH, 
Melbourne, Australia) in periods between 1995 and 2004 as explained by Istivan et al. 
(2004). All C. concisus clinical strains histories including 2 reference strains are indicated in 
Table 2.1. Some Campylobacter strains other than C. concisus strains were also used in this 
study and they are listed in Table 2.2. C. concisus oral strains were isolated from healthy 
people in different age groups (4 weeks – 50 years old) as will be fully explained in chapter 
3. 
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Table 2. 1Campylobacter concisus strains used in this study 
Strain Source and clinical history References 
ATCC 51561 Faeces, 24Y, female CCUG 20034,Sw, (Vandamme et al., 1989) 
ATCC 51562 Faeces, 7M, male, D CCUG 20700,UK, (Vandamme et al., 1989) 
RCH 3 Faeces, 1Y, male, D& V, 3 d RCH, Au, (Istivan et al., 2004) 
  RCH 4 Faeces, 1Y, female, D& V, 5 d 
RCH 5 Faeces, 5M, female, D, 5 d 
RCH 6 Faeces, 2Y, male, D, 3 d 
RCH 7 Faeces, 16M, male, D& V, 7 d 
RCH 9 Faeces, 2Y, male, D& fever, 7 d 
RCH 11 Faeces, 2Y, male, D, 4 d 
RCH 12 Faeces, 30M, male, D, 20 d 
RCH 15 Faeces, 5M, female, D& V, 9 d 
RCH 19 Faeces, 2Y, female, D& V, 5 d 
RCH 20 Faeces, 10M, female, D&V, 14 d 
RCH 23 Faeces, <15Y, G RCH, Au, (Istivan, Personal 
communication)  RCH 24 Faeces, <15Y, G 
RCH 25 Faeces, <15Y, G 
RCH 26 Faeces, <15Y, G 
Y; years and M; months, W; weeks of age, H; Healthy, d; days of symptoms, D; diarrhoea, 
V; vomiting. 
Country of isolation: Sw; Sweden, UK; United Kingdom, Au; Australia. 
Table modified from Istivan et al. (2004). 
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Table 2. 2 Other Campylobacter spp. strains used in the study 
Classification Strain and origin Source 
C. mucosalis ATCC 43264, (Pig intestine) USA, (Vandamme et al., 1989) 
C. jejuni 81116, (Human gastroenteritis) RMIT, Au, (Palmer et al., 1983) 
C. coli NCTC 11366, (Human faeces) RCH, Au, (Istivan et al., 2004) 
 
ATCC; American Type Culture Collection, RCH; Royal Children Hospital, Melbourne. 
NCTC; National Collection of Type Cultures. 
Country of isolation: Au; Australia, USA; United States of America. 
Table modified from Istivan et al. (2004). 
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2.3.2 Bacteriological media 
 
All used media were prepared according to manufacturer’s instructions. Standard conditions 
sterilization was performed at 121ºC for 15 minutes. Media was then poured into sterile Petri 
dishes under germ-free conditions and left for 20 minutes in a laminar flow cabinet. Liquid 
media was ready to use after sterilising and cooling at RT. Media used in this study were as 
following: 
 
2.3.2.1 Brain Heart Infusion Broth (BHI) medium 
 
Brain heart infusion broth powder (Oxoid, Australia) as 3.7% (w/v) was dissolved in dH2O 
and autoclaved at standard conditions. The media was aliquoted into 50 ml tubes prior to 
storing at 4-8ºC. 
 
2.3.2.2 Brucella semi-sold medium 
 
Brucella broth powder (BD, Australia) as 1.4% (w/v) containing 0.4% agar base was 
dissolved in dH2O and sterilised by autoclaving using standard conditions. It was cooled to 
approximately 50°C. Around 25 ml of the medium were then poured into sterile Petri dishes 
(90 mm). The plates were left at room temperature to solidify for 1-2 h prior to storage at 4-
8ºC. 
 
2.3.2.3 Columbia agar medium 
 
Columbia agar powder (Cell BioSciences, Australia) as 4.1% (w/v) was dissolved in dH2O 
and autoclaved at standard conditions. It was then processed as described in 2.3.2.2. 
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2.3.2.4 Columbia broth medium 
 
Columbia broth powder (Cell BioSciences, Australia) as 3.5% (w/v) was dissolved in dH2O 
and autoclaved at standard conditions. The media was then aliquoted as in 2.3.2.1. 
2.3.2.5 Horse Blood Agar (HBA) medium 
 
Columbia agar powder (Cell BioSciences, Australia) as 4.1% (w/v) was dissolved in dH2O 
and sterilised by autoclaving using standard conditions. It was cooled to approximately 50°C. 
The media was then supplemented with 5% (v/v) Horse blood (Oxoid, Australia) and mixed 
thoroughly.  It was then processed as described in 2.3.2.2. 
 
2.3.2.6 Tryptone/skim milk storage medium 
 
Skim milk powder (Coles, Australia) as 10% (w/v), 1% (w/v) tryptone (Cell BioSciences, 
Australia) and 10 mM Tris-base were dissolved in dH2O. The mixture pH was adjusted to 7.5 
and each 10 ml was then aliquoted into a small glass container. The media was autoclaved at 
109ºC for 10 min prior to storing at 4-8ºC.   
 
2.3.3 Bacterial cultural conditions 
 
All Campylobacter spp. strains used in this work were grown on HBA (2.3.2.5), unless 
otherwise specified. The plates were the incubated for 2-4 days at 37ºC under microaerophilic 
conditions in a gas mixture consisting of 6% O2, 8% CO2, 6-8% H2 and a balance of nitrogen 
in anaerobic jars (Oxoid, Australia and Don Whitely Scientific, Australia) without anaerobic 
catalyst. C. jejuni and C. coli strains were also grown in a jar with using CampyGen Sachet 
(GasPack) in the same atmosphere. For liquid cultures, all tested strains were grown in 
Columbia broth (Cell Biosciences, Australia) (2.3.2.4) or Brain-heart infusion (BHI) broth 
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(Oxoid, Australia) (2.3.2.1) media and incubated under the same conditions for 48 h. For 
semi-solid cultures, all tested strains were grown in Brucella broth with 0.4% agar (2.3.2.2) 
and incubated under the same conditions for 72h. 
 
2.3.4 Bacterial strains storage  
 
All Campylobacter spp. strains were stored at -80ºC into tryptone/skim milk medium 
(2.3.2.6). The bacterial growth was harvested from the HBA plates (2-4 days of incubation) 
using a plastic L-shape loop and suspended in a cryovial containing ~1 ml tryptone skim 
milk. The bacterial suspension was stored at -80°C. For short term storage, strains were 
stored at 4-8ºC on appropriate media plate. 
  
2.4 DNA Molecular Techniques 
 
2.4.1 Rapid boiling method to extract DNA templates for PCR 
 
A 2-4 days old bacterial colonies (approximately 107 CFU) was suspended in a 1.5ml 
microcentrifuge tube containing 100 µl of sterilised dH2O. The suspension was boiled using a 
block heater for 5 min and then cooled on ice for 10 min to disrupt the cells. Bacterial debris 
was removed by centrifugation at 12000xg for 5 min. The supernatant was then used as DNA 
template for PCR reactions purposes. 
 
2.4.2 Extraction of genomic DNA  
 
The 2-4 days old colonies from a pure bacterial culture were collected from a lawn culture on 
HBA plate and then suspended into 1 ml PBS. The suspension was centrifuged at 15000xg 
for 2 min at RT and collected the bacterial pellet. The pellet was then washed twice with 1 ml 
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PBS and centrifuged under the same conditions after each wash. The bacterial pellet was used 
for the DNA extraction according to Wizard® Genomic DNA Purification Kit instruction 
(Promega, Australia). At the end, between 50 µl and 100µl of DNA rehydration solution was 
added to the tube and the solution was either incubated at 65ºC for 1 h with periodically 
mixing the solution by gently tapping the tube or incubated overnight at 4ºC. The genomic 
DNA was then stored at -20ºC for long term storage. 
 
2.4.4 Determining of DNA concentration 
 
The concentration of the extracted genomic bacterial dsDNA was measured using Nanodrop 
2000 (Thermofisher, Australia) at absorbance of 260 nm and 280 nm. Two µl were placed on 
the machine and the DNA concentration was measured as ng/µl. 
2.4.5 Primer Design 
 
PCR and RT-PCR primers were designed using the Clone Manager Professional suite 
software (Scientific & Educational Software, USA). Primers were designed to have 40-60% 
of GC content with a TmºC in the range of 50-80ºC. The software was used to confirm that 
the corresponding designed primers were correctly having the criteria. The software was also 
used to align genes sequences and compare similarities between them. The primers’ 
sequences were selected from the genome sequence of C. concisus strain 13826 which is 
available online unless otherwise mentioned. All designed primers were then sent to 
GeneWorks Company (SA, Australia) to be built up.  
 
2.4.6 Polymerase Chain Reaction (PCR) 
 
PCR was performed by a PCR Thermal cycler Machine (G-Storm, Australia) in sterile PCR 
tubes. PCR Master Kit was supplied by Bioline (Australia) and used to set up the reaction. 
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PCR was performed using the general protocol described in the instruction manual. The 
details of the PCR reaction and cycling conditions are stated below. 
 
2.4.6.1 PCR amplification conditions  
 
All PCR reactions were performed using the following reagents: 
 
          
Reagent  Volume  
DNA template (8ng/ µl) 2.5µl 
Primer 1 (100ng/ µl) 0.5µl 
Primer 2 (100ng/ µl) 0.5µl 
10x reaction buffer 5µl 
AmpliTaq DNA polymerase (5 units/µl) 0.5µl 
H2O 16µl 
Total volume 25.0µl 
 
A negative control containing all previous reagents except DNA template, which was 
replaced with an equal volume of sterile dH2O, was used in all PCR amplifications to ensure 
the PCR mix purity. 
 
All PCR amplifications were performed using a DNA Thermocycler under the following 
conditions: 
 
Number of cycles Temperature Duration 
1 (denaturation) 95ºC 2 min 
30 (denaturation) 95ºC 15 sec 
30 (annealing) 58ºC 30 sec 
30 (extension) 72ºC 2 min 
1 (extension) 72ºC 7 min 
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2.5 Agarose gel electrophoresis 
 
2.5.1 Agarose gel preparation  
 
Agarose gel was prepared by dissolving DNA grade agarose powder (Bioline, Australia) in 
1x TAE buffer (2.2.3.17) and boiled using a microwave until totally dissolved. The 
percentage of agarose used was 1-1.5% (w/v) in 1x TAE buffer. Midigels (100 ml) and 
minigels (50 ml) were used. The agarose was then allowed to cool with shaking to 
approximately 55ºC. It was decanted into a casting tray and allowed to solidify for 25 min 
prior to use in electrophoresis. 
2.5.2 Gel electrophoresis, staining, visualisation and photography of gels 
 
PCR reactions including DNA templates were mixed with 10x loading dye (2.2.3.8) as 10:1 
(v/v) prior to electrophoresis. An electric field was applied as 40–100V for 1–3 hours and the 
DNA fragments were separated according to the size. The size of the DNA was estimated by 
running the samples against the λDNA marker (2.2.3.9). After electrophoresis, the gel was 
stained by placing in EtBr bath (2.2.3.6) for approximately 10 min. The gel was then 
destained by washing under running tap water for 20 min before viewing. DNA fragments 
were visualized under UV illumination using the Gel Doc imaging system (Bio-Rad, 
Australia). 
 
2.6 Protein analysis methods 
 
2.6.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)  
 
2.6.1.1 Extraction of bacterial outer membrane proteins (OMP) 
 
C. concisus strains were cultured on HBA under microaerophilic conditions for 2-4 days. 
Bacteria were then harvested from lawn culture using 1 ml of 10mM Tris-HCl (pH 7.4) per 
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agar plate (5-6 plates were used) and centrifuged at 2000xg for 5 min at RT. The bacterial 
pellet was resuspended in 5-10ml of 10mM Tris-HCl (pH 8) and was then sonicated on 
setting 6 for 6x30 sec bursts with cooling on ice between each sonication. The sonicated cells 
were centrifuged at 1000xg for 10 min at 4ºC to remove unbroken cells. The supernatant was 
then collected and centrifuged at 12000xg for 60 min at 4ºC to pellet the total membrane. The 
total membrane pellet was then resuspended with 8 volumes of sarkosyl detergent and 
incubated for 30 min at RT with mild shaking according to Filip et al. (1973) methods. The 
outer membrane proteins (OMP) were then collected using centrifugation at 12000xg for 30 
min at RT. The OMP pellet was finally resuspended in 0.1ml sterile water and stored at -
20ºC.  
 
2.6.1.2 Estimation of protein concentration 
 
The OMP protein concentration was determined using a modification of Lowry method as 
described by Markwell et al. (1978). The preparation of Lowry assay reagents was as 
summarised in the following steps: 
I. Reagent A: sodium carbonate (2% w/v), sodium hydroxide (0.4% w/v), sodium 
potassium tartrate (0.16% w/v) and SDS (1% w/v) were dissolved in dH2O. 
II. Reagent B: Copper sulphate (4% w/v) was dissolved in dH2O. 
III. Reagent C: was prepared by mixing of reagent A (50 ml) and reagent B (0.5 ml). 
This solution was prepared before use and only used fresh. 
IV. Reagent D: Folin-ciocalteau reagent was dissolved in dH2O (1:1). 
 
Several dilutions from standard albumin were performed to construct a standard curve. The 
dilutions were 0, 10, 20, 30, 40, 50, 70 and 100µl of protein standard (1mg/ml). The final 
volume of 200µl was completed by sterile dH2O. For OMPs, the volume of 200µl was made 
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by adding 10µl of protein to 190µl of dH2O. The blank was made by adding 10µl of cell 
lysate buffer (without bacterial cells) to 190µl of dH2O. Six hundred microlitres of reagent C 
was added to all prepared tubes (that include 200µl of blank, standard curve and OMP) and 
left at RT for 20 min. Sixty microlitres of reagent D was then added, mixed rapidly and left to 
stand at RT for 30 min. Two hundred microlitres of the mixture (for each tube) was pipetted 
into a 96-well plate and the samples concentrations were detected using SpectroStar Omega 
Reader (BMG-LabTech, Australia) and then compared to the protein standards. The standard 
curve was done using Microsoft Excel and the concentration was then calculated by the 
equation that obtained from the standard curve. 
 
2.6.1.3 Protein sample preparation  
 
Samples were prepared according to Laemmli (1970) methods with minor modifications. A 
total of 80mg/L protein concentration was used for each sample by diluting the OMP in 
sterile dH2O. A 10 µl of diluted protein samples was then mixed with 5µl of 5x-SDS sample 
buffer solution (2.2.3.14). The mixtures were then boiled for 5 min and cooled prior to 
loading into individual wells of SDS-PAGE gels using a micro-syringe or micro tips (10µl).  
 
2.6.1.4 Preparation of SDS-PAGE gels 
 
Mini-PROTEAN Tetra Cell electrophoresis system was used to perform SDS-PAGE 
electrophoresis to analyse protein samples. A 12 % (w/v) acrylamide of the resolving gel and 
4% (w/v) acrylamide of the stacking gel were prepared to make the protein gel. The 
composition of the resolving and stacking gels was as following:  
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Resolving gel for SDS-PAGE (12%) 
  
 
Distilled water 2.44ml 
1.5M Tris-HCl, pH 8.8 1.75ml 
10% (w/v) SDS stock 100μl 
Acrylamide (40% stock) 1.56ml 
10 % ammonium persulfate (fresh) 50μl 
TEMED 3μl 
 
Stacking Gel for SDS-PAGE (4%)  
 
Distilled water 1.58ml 
0.5M Tris-HCl, pH 6.8 0.625ml 
10% (w/v) SDS stock 25μl 
Acrylamide (40% stock) 0.25ml 
10 % ammonium persulfate (fresh) 25μl 
TEMED 2.5μl 
 
2.6.1.5 Running of SDS-polyacrylamide gels  
 
The setting used to run the mini systems in electrophoresis power supply (Bio-Rad, Australia) 
was 60V for 30 min followed by 180V for 50 min. The electrophoresis was stopped when the 
dye front was about 5-10 mm from the bottom edge of the gel. A protein standard marker (Bio-
Rad, Australia) was also run with each gel and the size range of the marker was 10-250 kD. 
2.6.1.6 Staining, destaining for SDS-PAGE, photography of gels and storing  
 
After the completion of electrophoresis, the gel was carefully removed from the apparatus 
and stained with coomassie blue stain (2.2.3.3) for 1-2h with mild shaking. The gel was then 
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removed and placed in destaining solution (10% ethanol and 10% acetic acid) overnight with 
mild shaking. Several changes of destaining solution were made. The gel was kept in 5% 
acetic acid at 4ºC for long storage. Image for each SDS-PAGE gel was taken either by Canon 
eos650 camera (Canon, Australia) or by a scanner (Canon, Australia). 
 
2.7 Tissue Culture 
 
The tissue culture work was performed in biological safety cabinet class II to decrease the 
contamination risks. All reusable containers used to store media and solution like glassware 
were cleaned by Pyroneg detergent, washed at least twice with dH2O and immersed in dH2O 
for overnight. Containers were then autoclaved and used to store tissue culture solutions. The 
sterile containers were re-autoclaved prior using in tissue culture. 
2.7.1 Tissue Culture solutions and media 
 
2.7.1.1 Antibiotic Stock Solutions 
 
Antibiotic solutions were prepared by dissolving the antibiotics in sterilized MQ-water at the 
preferred concentration. These stock solutions were stored at -20ºC. Antibiotic stocks were: 
 
2.7.1.1.1 Gentamycin 
 
It was prepared as 100mg/ml stock solution in sterile MQ-water, and then sterilised using a 
0.22µl filter and stored at –20ºC. It was then used in 400µg/ml final concentrations in 
DMEM/FBS in tissue culture experiment. 
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2.7.1.1.2 Penicillin-Streptomycin  
 
Penicillin Streptomycin (100mg/ml) from Life Technologies (Australia) was used to prevent 
the cell culture from any contamination. It was stored at -20ºC. 
2.7.1.2 Dimethyl sulfoxide (DMSO) 
 
A stock from Merck (Australia) and was filtered through 0.22 µm filter. 
 
2.7.1.3 Dulbecco’s Modified Eagle’s medium (DMEM) 
 
DMEM media (Life Technologies, Australia) was prepared by adding 10mL of 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (Life Technologies, 
Australia) to 500 mL DMEM (Life Technologies, Australia). The medium was well mixed by 
inverting the bottle several times. The DMEM medium was divided into 50mL sterile conical 
tubes and stored at 4ºC. The medium was then supplemented by adding 5mL of filtrated heat-
inactivated FBS (10% v/v) (Life Technologies, Australia) (2.7.1.4) to 45mL of DMEM in 
each tube (50ml DMEM/FBS). 
 
2.7.1.4 Inactivated Fetal Bovine Serum (FBS) 
 
The inactivation was performed to inhibit heat-labile complements in FBS (Life 
Technologies, Australia) prior to use in tissue culture media. Briefly, 500mL FBS bottle 
stored at -80ºC was thawed at 4ºC overnight and was then incubated in 37ºC water bath until 
thawied completely. The bottle was inverted several times and poured into 50mL falcon 
tubes. They were incubated in 56ºC water bath for 35 min and then allowed to cool down at 
RT for at least 30 min. The treated FBS tubes were stored at -20ºC. The heat treated FBS was 
filtrated using a 0.22µm filter prior to use in tissue culture. Inactivated FBS was filtrated 
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using 0.22µl filter and stored at -20ºC. It was used as 10% with DMEM (2.7.1.3) to prepare 
the complete medium (45mL DMEM + 5mL FBS).  
 
2.7.1.5 Triton -X- lytic solution 
 
A working solution of Triton X-100 detergent (0.3% v/v) was diluted in sterile PBS. The 
solution was sterilised by filtration using a 0.22µm filter and then stored at 4ºC.
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Chapter Three 
Oral Colonisation of C. concisus in healthy adults and children 
  
3.1 Introduction 
 
C. concisus was first described by Tanner et al. (1981) as a gram-negative microaerophilic 
curved bacteria. It was isolated from a person with periodontitis and gingivitis (Tanner et al., 
1981). While C. concisus has been detected in the saliva 100% of patients with IBD, it was 
however also detected in 97% of healthy subjects in the same study using a PCR method 
(Zhang et al., 2010), and in another study in healthy volunteers (100%) using PCR-DGGE 
methods (Petersen et al., 2007). 
 
In studies aimed to investigate the role of C. concisus in the acquisition of oral microflora, the 
composition of the subgingival microbiota including C. concisus was investigated in children 
aged 4-5 years with primary dentition. C. concisus was isolated in greater numbers the molars 
(5%) than incisors (2.5%), while it was isolated in low numbers in the children with 
deciduous teeth (Kamma et al., 2000b). In a later study, C. concisus was isolated more often 
in permanent (10%) than deciduous (3.8%) teeth in children aged 7-8 who with mixed 
dentition (Kamma et al., 2000a). Furthermore, C. concisus was in both studies associated 
with bleeding sites from where it was isolated, suggesting that the mouth infected sites may 
be at greater risk of the outbreak of disease in the future (Kamma et al., 2000a, Kamma et al., 
2000b). There are however, no published reports on isolation of C. concisus from the oral 
cavity of children before teething. Moreover, there are no previous reports on how toddlers 
can acquire C. concisus in early stages (e.g. from parents, siblings etc.). 
 
The genetic diversity and relationship between C. concisus strains have been investigated. 
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) has been used to 
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detect the protein profile diversity of C. concisus isolates (Istivan et al., 2004). Ninteen C. 
concisus clinical isolates were identified using amplification of the 23S rDNA gene by PCR. 
They were grouped into two groups, A and B (Istivan et al., 2004). C. concisus strains have 
also been identified by amplifying the ORF3 region (Istivan et al., 2004, Matsheka et al., 
2001). Analysis of DGGE profiles of bacterial samples from the dental plaque of cohorts 
children with and without gingivitis has revealed that 45% of healthy samples and 50% of 
gingivitis samples clustered together, suggesting that specific microbiota may be linked to 
health and disease (Gafan et al., 2005). Given that C. consicus has been linked to gingivitis 
and gastrointestinal disease, it is possible that some strains are more pathogenic. In this study, 
C. concisus isolates were collected from family units, and the relationship between strains 
was investigated.  
The aims of the experiments completed in this chapter were to study C. concisus isolates by: 
 
 Isolating C. concisus from subjects in different age groups, including families with 
infants. 
 Investigating the colonisation patterns of C. concisus, and whether a specific C. 
concisus genomospecies is dominant at different teething stages. 
 Identifying the similarities within C. concisus strains isolated from members of the 
same family using genomic and phenotypic techniques. 
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3.2 Materials and Methods 
 
3.2.1 Collection of C. concisus strains and isolation methodology 
 
Gum swabs were obtained from 28 healthy volunteers (0 month – 50 years old) including 16 
adults, and 12 children, 8 of whom were infants before teething using Eswab (COPAN, 
Italia). The Eswab was taken from the surface of the gum (front and back) and stored in 
Eswab medium prior to processing. Eswab medium (50-100 µl) was poured on a 0.65µm 
filter (Sartorius stedim, Australia), named Cape Town protocol filtration method, on HBA 
medium and left for 15-45 min. The filter was then removed and the filtrate was streaked 
using sterile loop. The plates were incubated under microaerophilic conditions for 2-4 days as 
explained in 2.3.3. A single colony was isolated and then subcultured under the same 
conditions. Genomic DNA was extracted and a stock was kept at -80ºC for each bacterial 
isolate. The isolates were then used for all biochemical, molecular and protein analysis and 
other tests. 
 
The C. concisus strains were isolated from gum swabs of healthy volunteers of different age 
groups ranging from 4 week - 50 years of age. The strains were collected from 7 different 
families and other healthy individuals. Through the families, the strains were isolated from 
parents and their children, including the infants prior to teething. Some C. concisus strains 
were also isolated from other healthy individuals not related to any family. Two C. concisus 
reference strains, ATCC 51561 and ATCC 51562 were used in all PCR tests included in this 
study (Table 2.1). C. mucosalis type strain ATCC 43264, C. jejuni 81116 and C. coli NCTC 
11366 were also used in all PCR tests as negative controls (Table 2.2). The histories of the 2 
C. concisus reference strains and other Campylobacter spp. used in this study are described in 
Tables 2.1 and 2.2. 
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3.2.2 Follow up for Newborn babies  
 
The swabs were taken each week from week one, until the bacterium was isolated 
(approximately 4-9 times). Three newborn babies (from 2 different families) were also 
followed up after teething to detect if they were colonised by other C. concisus 
genomospecies. Swabs were taken when the children reached 2 years of age. 
 
3.2.3. Confirmation of identification of C. concisus using biochemical tests and other 
conventional tests 
 
A standard inoculum of 107 cfu/ml was used to perform some phenotypic and biochemical 
tests to characterise C. concisus isolates only, described in Istivan (2005). C. concisus oral 
isolates were tested for growth conditions, oxidase and catalase production and Gram stain. 
 
3.2.4 Molecular identification of C. concisus 
 
3.2.4.1 PCR amplification of a 0.5-kb C. concisus species-specific fragment  
 
The identification of C. concisus oral isolates was confirmed by the PCR amplification 
protocol described by Matsheka et al. (2001) using forward 5F cisus and reverse primer 6R 
cisus to amplify a 0.5 kb specific region in the genome of C. concisus (Table 3.1).  
 
3.2.4.2 PCR amplification of 23S rDNA  
 
The genomospecies of C. concisus oral strains isolated in this study was confirmed using the 
23S rDNA PCR amplification protocol as described by Istivan et al. (2004), which was 
modified from the method used by Bastyns et al. (1995b).  Two reverse primers (CON1 and 
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CON2) were used independently with forward primer (MUC1) to group the C. concisus 
isolates into 2 different genomospecies (A and B). C. concisus type strains ATCC 51562 
(genomospecies A) and ATCC 51561 (genomospecies B) were used as controls. PCR 
amplification of the 23S rDNA in C. concisus oral isolates was performed as described in 
2.4.6 using the primer sets described in Table 3.1. 
 
Table 3. 1 DNA sequences of primers used in PCR amplifications for the molecular 
identification of Campylobacter concisus strains. 
Primer Primer Sequence Reference 
MUC1 5’-ATGAGTAGCGATAATTGGG-3’ (Bastyns et al., 1995b) 
CON1 5’-CAGTATCGGCAATTCGCT-3’ (Bastyns et al., 1995b) 
CON2 5’-GACAGTATCAAGGATTTACG-3’ (Bastyns et al., 1995b) 
5F cisus 5’-AGCAGCATCTATATCACGTT-3’ (Matsheka et al., 2001) 
6R cisus 5’-CCCGTTTGATAGGCGATAG-3’ (Matsheka et al., 2001) 
  
3.2.5 SDS-PAGE analysis for protein profiles of C. concisus strains  
 
The outer membrane proteins (OMP) of all C. concisus oral strains isolated in this chapter 
were extracted as described in 2.6.1.1 using the method of  Filip et al. (1973). SDS-PAGE 
was completed as detailed in sections between 2.6.1.2 and 2.6.1.6 using the method of 
Laemmli (1970). An SDS-PAGE gel was performed for each of the seven families and a 
separate gel was also performed for genomospecies B strains isolated from all infants before 
teething. 
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3.2.6 Data analysis for clustering SDS-PAGE images 
 
The SDS-PAGE profiles were analysed using Phoretix 1D software (TotalLab, Newcastle 
upon Tyne, UK). This software was used to determine the percentage of similarity of the 
protein profiles of C. concisus strains within each SDS-PAGE gel profiles and to cluster the 
lanes based on banding patterns using the Unweighted Pair Group method with Mathematical 
Averages (UPGMA) clustering. The images were firstly saved in TIFF format for analysis. A 
gel image for the C. concisus protein profiles for isolates from each family were analysed 
separately. Figure 3.1 shows the procedures followed to isolate and identify C. concisus after 
collecting the gum swabs from participants in this study. 
 
3.2.7 Ethics statement 
 
Ethical approval was granted by The RMIT University Human Research Ethics Committee 
HREC and the approval number was 57/13. A written consent form was obtained from adult 
participants and from the parents on behalf of their children. Informed assent was also 
obtained from older children who were able to understand the nature of the study. 
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Figure 3. 1 Diagram showing workflow for processing C. concisus isolates. 
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3.3 Results 
 
3.3.1 C. concisus isolation and phenotypic analysis 
 
A total of 47 C. concisus strains were isolated from all participants in this study including 26 
strains from healthy adults, and 21 strains from healthy children, 9 of whom were from 
infants before teething. All C. concisus oral isolates were oxidase positive and catalase 
negative. C. concisus cells were Gram-negative with curved-rod shape and pale pink colour. 
The C. concisus RMIT-O17 strain which was isolated from a 5 year old healthy boy was 
observed to have a unique golden colour on HBA (data not shown). The normal colour of C. 
concisus colonies on HBA is greyish colour. 
 
3.3.2 C. concisus molecular identifications  
 
3.3.2.1 PCR amplification of C. concisus species-specific 0.5-kb fragment (gyr B gene) 
 
A 0.5 kb PCR product observed with all C. concisus strains except one strain (RMIT-O30) 
which was isolated from a 29 year old male in family 4 (Figure 3.2). This strain was further 
analysed in the following section (3.3.2.2). No PCR product was detected for other 
Campylobacter spp. strains including C. mucosalis ATCC 43264, C. jejuni 81116 and C. coli 
NCTC 11136 strains that were used as controls in this PCR experiment. All C. concisus 
species-specific 0.5-kb fragment PCR amplification (gyr B gene) results are shown in Table 
3.2. 
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Figure 3. 2 PCR amplification of the C. concisus specific-specific 0.5 kb fragment (gyrB 
gene) of oral isolates for Family 4. M, Lambda/ PstI marker. Lane 1, C. concisus ATCC 
51561 (Positive control as genomospecies B grouping). Lane 2, C. concisus ATCC 51562 
(Positive control as genomospecies A grouping). Lanes 3-8, C. concisus oral strains RMIT-
O28 - RMIT-O33. Lane 9, C. mucosalis ATCC 43264. Lane 10, C. jejuni 81116. Lane 11, C. 
coli NCTC 11136. 
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3.3.2.2 C. concisus molecular typing by 23S rDNA PCR amplification 
 
Figure 3.3 shows examples of PCR amplification of 23S rDNA using forward primer; MUC1 
and reverse primer, CON1 to detect genomospecies A strains, and forward primer, MUC1 
and reverse primer, CON2 to detect genomospecies B strains. A 306 bp PCR product was 
amplified in all C. concisus isolates. Overall, 60% of the isolates were from genomospecies 
A. Only 19 C. concisus oral isolates (40%) belonged to genomospecies B. Genomospecies B 
was dominant in children with 13 C. concisus isolates (13/21, 62%) from children belonging 
to genomospecies B. From C. concisus strains isolated from infants before teething, 
genomospecies B was also dominant with 89% (8/9), while only 1 C. concisus strain was 
isolated from genomospecies A. Among older children, only 5 of 12 strains were from 
genomospecies B (41.5%) and the other 7 strains belonged to genomospecies A. In adults, the 
majority of C. concisus strains isolated were from genomospecies A (20/26, 77%), while only 
6 strains belonged to genomospecies B. Table 3.2 lists all 47 C. concisus oral strains isolated 
from healthy volunteers with their information.  
 
The two C. concisus reference strains, ATCC 51561 from genomospecies B and ATCC 
51562 from genomospecies A were used with all PCR tests for this grouping.  There were no 
PCR products obtained with C. mucosalis ATCC 43264, C. jejuni 81116 or C. coli NCTC 
11136. All C. concisus strains grouped in genomospecies A or B by 23S rDNA PCR 
amplification are shown in Table 3.2. 
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Figure 3. 3 PCR amplification of genomospecies A and B grouping for C. concisus oral 
isolates for family 4. M, Lambda/ PstI marker. Lane 1, C. concisus ATCC 51561 (Positive 
control as genomospecies B grouping). Lane 2, C. concisus ATCC 51562 (Positive control as 
genomospecies A grouping). Lanes 3-8, C. concisus oral strains RMIT-O28 - RMIT-O33. 
Lane 9, C. mucosalis ATCC 43264. Lane 10, C. jejuni 81116. Lane 11, C. coli NCTC 11136. 
A, genomospecies A grouping using Con 1 reverse primer. B, genomospecies B grouping 
using Con 2 reverse primer. 
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3.3.2.3 Further analysis of C. concisus RMIT-O30 strain 
 
A colony with an expected identity of C. concisus was grown on HBA from a sample isolated 
from a 29 year old man in family 4 that was Gram-negative and positive for oxidase. 
However, PCR amplification for the species-specific 0.5-kb fragment (gyr B gene) was found 
to be negative (Figure 3.2). Further study using 23S rDNA PCR amplification showed it to 
belong to genomospecies A (Figure 3.3). 
3.3.3 Follow up studies 
 
Four C. concisus strains were isolated from 3 newborn babies from families 5, 6 and 7 when 
they were followed up from week 1 after birth. The C. concisus RMIT-O37 strain was 
isolated after 4 weeks from the newborn baby of family 5, while C. concisus RMIT-O40 and 
RMIT-O41 strains were isolated after 6 weeks from the newborn baby of family 6. 
Furthermore, this infant was the only infant colonised by both genomospecies (A and B). C. 
concisus RMIT-O45 strain was isolated after 9 weeks of follow up from the newborn baby of 
family 7. 
 
Three infants who have genomospecies B strains, being infant of family 1 (RMIT-O19) and 
the twin infants of family 2 (RMIT-O22 and RMIT-O23), were also followed up after 
teething (when they became 2 years old) to detect whether they were colonised by other C. 
concisus genomospecies (genomospecies A). Interestingly, genomospecies A was 
successfully isolated from all of three children, as well as genomospecies B which had 
already been isolated. C. concisus RMIT-O46 strain was isolated from the follow up of 
family 1 volunteer, while C. concisus RMIT-O47 and RMIT-O48 strains were isolated from 
family 2 twins, respectively. 
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Table 3. 2 Characteristics of C. concisus oral strains isolated from healthy individual 
volunteers including 36 C. concisus oral strains isolated from 7 different families.  
Family Individual Strain Age & 
Gender 
Genomospecies 
typing (23S rDNA) 
 gyrB 
gene 
Family 1 1 RMIT-O4 31Y, M A + 
2 RMIT-O18 25Y, F A + 
3 i RMIT-O19 3M, F B + 
3 ii RMIT-O46 2Y, F A + 
4 RMIT-O20 
RMIT-O21 
4Y, M A 
B 
+ 
+ 
Family 2 1 RMIT-O2 39Y, M A + 
2 RMIT-O8 
RMIT-O9 
3Y, F B 
A 
+ 
+ 
3 RMIT-O10 
RMIT-O11 
26Y, F A 
B 
+ 
+ 
4 RMIT-O12 
RMIT-O13 
5Y, M A 
B 
+ 
+ 
5 i RMIT-O22 2M, M B + 
5 ii RMIT-O47 2Y, M A + 
6 i RMIT-O23 2M, F B + 
6 ii RMIT-O48 2Y, F A + 
Family 3 1 RMIT-O24 
RMIT-O25 
27Y, M A 
B 
+ 
+ 
2 RMIT-O26 23Y, F A + 
3 RMIT-O27 2M, F B + 
Family 4 1 RMIT-O28 
RMIT-O29 
RMIT-O30 
29Y, M B 
A 
A 
+ 
+ 
- 
2 RMIT-O31 26Y, F B + 
3 RMIT-O32 3Y, F B + 
4 RMIT-O33 2M, M B + 
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Table 3.2, Characteristics of C. concisus oral strains, continued 
Family 5 1 RMIT-O34 27Y, M A + 
2 RMIT-O35 
RMIT-O36 
24Y, F A 
B 
+ 
+ 
3 RMIT-O37 4W, F B + 
Family 6 1 RMIT-O38 28Y, M A + 
2 RMIT-O39 26Y, F A + 
3 RMIT-O40 
RMIT-O41 
6W, F A 
B 
+ 
+ 
Family 7 1 RMIT-O42 33Y, M A + 
2 RMIT-O43 
RMIT-O44 
30Y, F 
 
A 
B 
+ 
+ 
3 RMIT-O45 9W, F B + 
Other 
isolates 
 RMIT-O1 38Y, M A + 
RMIT-O3 38Y, M A + 
RMIT-O5 30Y, M A + 
RMIT-O6 30Y, M A + 
RMIT-O7 50Y, M A + 
RMIT-O14 26Y, M A + 
RMIT-O16 5Y, M B + 
RMIT-O17 5Y, M A + 
 
Y; Years, M; Months, W; Weeks of age, A; Genomospecies A, B; Genomospecies B, M; 
Male, F; Female, i; First isolation before teething, ii, Second isolation after teething. 
 
 
 
 
 
 
96 
 
Chapter Three - Oral Colonisation of C. concisus in healthy adults and children 
 
3.3.4 SDS-PAGE analysis of OMPs protein profiles of C. concisus isolates from different 
families 
 
The C. concisus oral strains isolated from members of the same family were compared using 
SDS-PAGE to demonstrate protein profiles within their outer membrane proteins (OMPs). 
The same was performed for the 7 different families. Precision Plus Protein™ 
Kaleidoscope™ Standards (Bio-Rad, Australia) were also run with each gel to measure the 
molecular weight sizing on SDS-PAGE gels. There were variations in the outer membrane 
protein profiles (OMPs) for C. concisus oral isolates within each family. The variations found 
show that C. concisus strains have diverse OMP profiles. The C. concisus protein profiles 
were then clustered according to their banding patterns. Figures 3.4 and 3.5 show an example 
of SDS-PAGE of protein profiles for the C. concisus oral isolates from family 4 and gel for 
all genomospecies B strains (8 strains) isolated from the seven infants with no teething. 
 
Furthermore, protein profiles for outer membrane proteins (OMPs) were carried out by SDS-
PAGE and the analysis of similarity within each family was performed using Dendrogram 
clustering by Phoretix 1D software. The dendrogram analysis was performed separately for 
each family to detect the similarities through the members of each family (Figure 3.6 and 
Figure 3.7). The dendrogram analysis of protein profiles of all genomospecies B strains that 
were isolated from the seven infants with no teething is also shown separately in Figure 3.8. 
The outer membrane protein profiles (OMPs) for C. concisus oral isolates were not identical 
in all gels. The only exception was the twin infants in family 2 and they belonged to 
genomospecies B. 
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Figure 3. 4 SDS-PAGE of OMP profiles of C. concisus oral isolates visualized by 
coomassie blue stain. M; SDS-PAGE Marker (Precision Plus Protein™ Kaleidoscope™ 
Standards from Bio-Rad, Australia). Lanes 1-6, family 4 C. concisus oral strains RMIT-O28 - 
RMIT-O33. 
 
 
 
 
Figure 3. 5 SDS-PAGE of OMP profiles of C. concisus oral isolates visualized by 
coomassie blue stain. M; SDS-PAGE Marker (Precision Plus Protein™ Kaleidoscope™ 
Standards from Bio-Rad, Australia). Lane 1-8, all genomospecies B C. concisus strains 
isolated from healthy infants before teething, RMIT-O19, RMIT-O22 - RMIT-O23, RMIT-
O27, RMIT-O33, RMIT-O37, RMIT-O41 and RMIT-O45, respectively. 
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In family 1, RMIT-O21 and RMIT-O19 had 83% similarity, although they both were from 
genomospecies B. Genomospecies A isolates, RMIT-O18 (mother) RMIT-O20 (4 years boy) 
had less similarity with 71%. Two major clusters were found, a cluster included 
genomospecies B strains (2 strains), while the other cluster was for genomospecies A strains 
(3 strains) (Figure 3.6 A). Like family 1, two clusters were also found in family 2, and each 
genomospecies strains were in separate cluster. The OMP protein profiles of the twins 
(RMIT-O22 and RMIT-O23) were 100% identical. The C. concisus isolate RMIT-O12 was 
highly divergent from the other isolates in this family, as it had less than 40% similarity from 
all other isolates. The closest isolate to the father’s (RMIT-O2) was RMIT-O10 with 82.5% 
similarity (Figure 3.6 B). 
 
In family 3, C. concisus RMIT-O24 strain (the father’s genomospecies A) had a unique 
pattern 43% similarity with other strains. The isolate RMIT-O25 (the father’s genomospecies 
B) was 84% similar to RMIT-O27, the infant (Figure 3.6 C). The OMP profiles of family 4 
were completely divergent and this family was the only one had 3 clusters within their OMP 
profiles. The highest similarity in this family was 75% between RMIT-O30 and RMIT-O31. 
There were 2 clades with 52% similarity (lowest similarity found), one containing RMIT-
O28 and the other containing all other isolates (Figure 3.6 D).  
 
All family 5, family 6 and family 7, C. concisus strains had 2 major clusters (Figure 3.7). 
Each cluster within each family included only one genomospecies strain. In the family 5, the 
C. concisus isolate from the infant, RMIT-O37 was the most identical isolate to the parents 
among the tested families, with 96% similarity to her mother. On the other hand, other C. 
concisus isolate of mother, RMIT-O35 was a divergent from all other isolates within this 
family with 48% similarity (Figure 3.7 E). In family 6, the infant isolate, RMIT-O40 
(genomospecies A) was found to be 74% similar with her father’s isolate, RMIT-O38. 
99 
 
Chapter Three - Oral Colonisation of C. concisus in healthy adults and children 
 
However, the other infant isolate, RMIT-O41 (genomospecies B) was different from all other 
isolates with only 34% similarity with them (Figure 3.7 F). In the last family tested (family 
7), the highest similarity was found between RMIT-O42 and RMIT-O43 strains, both 
genomospecies A with 77%. The isolate from the infant female, RMIT-O45 was divergent 
from all other C. concisus isolates with only 39% similarity them (Figure 3.7 G). 
 
 These results show that all infants were only colonised by C. concisus genomospecies B with 
the exception of the infant from the sixth family who was colonised by 2 C. concisus strains, 
one from genomospecies A (RMIT-O40) and the other from genomospecies B (RMIT-O41). 
A separate analysis that included all the C. concisus strains from infants characterised as 
genomospecies B (8 isolates) was performed to investigate the similarities within these 
strains (Figure 3.8). As mentioned, in family 2, the OMP profiles of twin infants (RMIT-O22 
& RMIT-O23) were the only exception with 100% identity. All OMP profiles of other infants 
were found to be divergent from each other. C. concisus RMIT-O19 had the lowest similarity 
with isolates from all other infants with only 18% (Figure 3.8). 
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Figure 3. 6 Dendrogram clustering analysis for OMPs of C. concisus oral strains 
isolated from different families. A is family 1; RMIT-O4 and RMIT-O18 - RMIT-O21, B is 
family  2; RMIT-O2, RMIT-O8 - RMIT-O13 and RMIT-O22 - RMIT-O23, C is family 3; 
RMIT-O24 - RMIT-O27 and D is family 4; RMIT-O28 - RMIT-O33. A, genomospecies A. 
B, genomospecies B. 
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Figure 3. 7 Dendrogram clustering analysis for OMPs of C. concisus oral strains 
isolated from different families. E is family 5; RMIT-O34 - RMIT-O37, F is family 6; 
RMIT-O38 - RMIT-O41, G is family 7; RMIT-O42 - RMIT-O45. A; genomospecies A. B; 
genomospecies B.  
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Figure 3. 8 Dendrogram clustering analysis for OMPs of C. concisus oral strains isolated 
from infants (B). All C. concisus strains were genomospecies B isolated from healthy 
infants, RMIT-O19, RMIT-O22 - RMIT-O23, RMIT-O27, RMIT-O33, RMIT-O37, RMIT-
O41 and RMIT-O45. 
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3.4 Discussion 
 
To our knowledge, this is the first study that isolated C. concisus from gum swab samples of 
all participants using a culture method, and also from gum swab samples of infants before 
teething. In the present study, 47 C. concisus isolates were successfully cultured from 28 
healthy volunteers (100%). C. concisus has previously been detected in 97% of saliva 
samples of healthy individuals and 100% of IBD patients; using nested PCR only. This is 
notably higher than the same study that used the culture method by filtration technique (Cape 
Town Protocol) achieved only from 75% of healthy individuals and 89% (16/18) from IBD 
patients (Zhang et al., 2010). The high prevalence of C. concisus in the mouths of healthy 
individuals found in this study supports the idea that C. concisus is part of the human 
commensal microbiota, although it has also been isolated from gingivitis and periodontitis 
cases (Kamma et al., 1999, Macuch et al., 2000, Tanner et al., 1981). 
 
None of the volunteers in this study were smokers or had any symptomatic disease. A number 
of previous studies have associated the isolation of C. concisus with oral diseases (Macuch et 
al., 2000, Moore et al., 1987, Tanner et al., 1981, Tanner et al., 1987). The results of this 
study suggest that this is however not the case, as all participants were healthy. C. concisus 
can be isolated effectively using Cape Town Protocol (Lastovica, 2006), and this study shows 
that this protocol is a highly effective way to isolate C. concisus from gum swabs. This study 
also confirmed that this protocol can increase the number isolated C. concisus.  
 
Two groups of children were included in the study, children with primary dentition (3 - 5 
years) and infants before teething (4 weeks - 3 months old), which has not been performed 
previously. C. concisus was isolated in greater proportion in molar teeth than other type of 
teeth in children aged 4-5 years, and was also isolated in greater numbers in permanent than 
deciduous teeth in children aged 7-8 years (Kamma et al., 2000a, Kamma et al., 2000b), 
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suggesting that C. concisus can be isolated from the mouth after teeth eruption. However, the 
results of this study showed that C. concisus can be found in the mouth even before teething, 
possibly because of contact with surrounding environment or with family members (parents 
or siblings). It is suggested that getting milk or food prepared by parents, kissing or coughing 
are a likely source of infection. 
 
There is currently not enough evidence to support a causative role for C. concisus in oral 
diseases. Most of the previous studies isolated C. concisus from sites of oral disease without 
comparison to healthy controls. Therefore, it is not well known if C. concisus is an oral 
pathogen, an opportunistic bacterium, or just part of the normal flora in the mouth (Kaakoush 
et al., 2012). The results of this study support the view that C. concisus is normal flora. 
However, there is not yet enough information on possible variations in virulence between 
strains. 
 
In this study, a C. concisus 0.5 kb species-specific PCR fragment of gyr B gene was used to 
detect and confirm C. concisus isolation. This C. concisus species-specific PCR product was 
detected in all C. concisus oral isolates used in this study except RMIT-O30 C. concisus 
strain, genomospecies A (46/47, 98%). The colonies of RMIT-O30 were firstly predicted as 
C. concisus colonies on HBA; however its DNA could not be detected with gyr B gene PCR 
test. C. concisus RCH26 strain, isolated from faecal sample of patient suffering from 
diarrhoea, was previously found not to amplify this 0.5 kb C. concisus species-specific 
fragment (Istivan, Personal communication), suggesting that this gene is heterogeneous in 
different C. concisus isolates or genomospecies, or there is a mutation in the location of this 
gene. Therefore, the DNA was then tested for C. concisus grouping by 23S rDNA PCR 
amplification and was successfully identified as a C. concisus genomospecies A strain. The 
gyrB PCR method has been successfully used in a number of previously published studies 
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(Istivan et al., 2004, Matsheka et al., 2001); however the results of the current study suggest 
that it may be necessary to combine this approach with 23SrDNA analysis to avoid missing 
potential isolates.  
 
In order to group oral C. concisus isolates into genomospecies A and B, we used the 23S 
rDNA PCR following the method of Istivan et al. (2004). In this study, 60% of oral isolates 
belonged to genomospecies A, while genomospecies B C. concisus oral isolates was only 
40%. Overall, the majority of the isolates were genomospecies A, however genomospecies B 
was the dominant in C. concisus isolated from children. Among 21 C. concisus isolates from 
children, 13 isolates (62%) belonged to genomospecies B. It was also found that 89% (8/9) of 
C. concisus isolated from infants before teething belonged to genomospecies B. In a previous 
study performed in Australia on faecal samples from children with gastroenteritis, 
genomospecies A had also the higher percentage (71.5%) than genomospecies B (28.5%) 
(Istivan et al., 2004). However, a following study in Demark on faecal samples obtained from 
diarrhoeic and healthy individuals found that genomospecies B C. concisus isolates were the 
dominant (67%) comparing to genomospecies A isolates (33%) (Engberg et al., 2005). The 
same percentages were also found in a later study in Canada with 67% in genomospecies B 
and 33% in genomospecies A (Kalischuk et al., 2011). Taken together, these studies suggest 
that the abundance of C. concisus genomospecies varies between sources to and geographical 
locations. Thus, further studies are required to form an understanding of this relationship.  
 
In this study, some interesting results were obtained. For example, each family has at least 
one member has more than one strain or genomospecies in the mouth. This finding is 
consistent with a previous study suggested that more than one C. concisus strain can be 
isolated from the oral cavity of one individual (Zhang et al., 2010). Interestingly, all strains 
collected from infants before teething belonged to genomospecies B, except the newborn 
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from family 6 who had both genomospecies (isolated after 6 weeks). Three newborn babies 
were followed up by taking samples weekly, from week 1 after birth to isolate this bacterium. 
C. concisus was successfully isolated from the toddlers after few weeks (4, 6 and 9 weeks, 
respectively) from the first sample during the follow up process. Three children were 
followed up after teething to determine if the babies were colonised by other C. concisus 
genomospecies. It was only possible to obtain samples from the infants of family 1 and 
family 2 after teething at this time, and both genomospecies A and B were successfully 
isolated at this time. The findings suggest that genomospecies B may colonise the human oral 
cavity before genomospecies A. It could be that the environment in the mouth is more 
suitable for the colonisation and survival of geneomospecies B due to an optimal pH or to the 
nature of nutrients relevant to the food consumed in that age. 
 
This study used OMPs from C. concisus strains to demonstrate protein profiles within their 
OMPs using SDS-PAGE. Previous studies on C. concisus used the SDS-PAGE technique to 
investigate similarities between protein patterns of the tested C. concisus strains as a 
surrogate for the phylogenetic relationship between isolates (Aabenhus et al., 2002, Istivan et 
al., 2004, Zhang et al., 2010). Unlike our study that used OMPs with SDS-PAGE, most 
previous studies used the whole cell proteins. Istivan et al. (2004) was only study on C. 
concisus that used SDS-PAGE to study outer membrane protein profiles (OMPs) along with 
whole cell lysates of 19 C. concisus clinical strains isolated. Based on the protein profiles, C. 
concisus strains were allocated into more than five groups (Istivan et al., 2004). Given the 
obvious variations between C. concisus strains after SDS-PAGE, we used Phoretix 1D 
software to analyse the relationship of SDS-PAGE profiles within 7 families and 
genomospecies B strains of all infants before teething. 
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Based on dendrogram analysis, we found that all families had two major clusters (Figures 
3.6-8). Each cluster included one C. concisus genomospecies (A or B) strains. The only 
exception was family 4 that had 3 clusters, being 2 clusters included genomospecies B 
strains, while genomospecies A strains were included in only one cluster. According to this 
analysis, even within the same family, the protein profiles were divergent; the only exception 
was the twin infants in family 2, which were 100% identical. These findings suggest that C. 
concisus strains are highly heterogeneous, even within same genomospecies, family or even 
within the same person who colonised by more than one strain. Kaakoush et al. (2011a) 
previously used the same approach to analyse SDS-PAGE profiles of 8 C. concisus strains. 
The highest similarity percentage was 75%, between C. concisus UNSWCD and C. concisus 
UNSW2, while the lowest percentage was 57% for C. concisus BAA-1457 with all other 
seven C. concisus strains (Kaakoush et al., 2011a), suggesting that C. concisus is a 
heterogeneous species.  
 
 
In conclusion, to our knowledge, this is the first study to isolate C. concisus from gum swab 
samples of all participants by culture, and from samples of infants before teething. Moreover, 
it is the first study that has compared C. concisus oral strains within healthy families. C. 
concisus isolate RMIT-O17 has a unique golden colour on HBA plate. More than one C. 
concisus strain can be isolated from the same subject. The results of this study are in 
agreement with previous studies that C. concisus has only two genomospecies based on 23S 
rDNA PCR amplification method. More than half of the isolates were genomospecies A 
(60%), consistent with the previous Australian study. Each family had at least one member 
colonised with both genomospecies. Interestingly, all strains collected from infants before 
teething belonged to genomospecies B, except C. concisus isolate RMIT-O40 from family 6 
which had both genomospecies. The results of the study also suggest that genomospecies B 
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can colonise the human oral cavity before genomospecies A. From the dendrogram analysis, 
it can be concluded that even within the same family, OMP profiles were not identical, the 
only exception being the twin infants who did have identical profiles. Analysis of whole 
genome sequence from oral strains of the same family will be required to precisely determine 
the relationship between strains. Other potential methods like AFLP and RAPD can also be 
used to type C. concisus isolates. 
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Chapter Four 
Detection of C. concisus flagellin genes in clinical and oral 
isolates 
 
4.1 Introduction 
 
It is well known that the flagella of Campylobacter spp. have an important role in their 
pathogenicity. C. jejuni mutants expressing either flaA or flaB differ in both motility and 
invasiveness in vitro and flaA-mutant strains were 50-fold less invasive than the wild type, 
but the expression of flaB is not essential for bacterial motility (Wassenaar et al., 1994, 
Wassenaar et al., 1993). A C. jejuni 81116 flaA/flaB double mutant and flaA (flaB+) mutant 
had significant differences in the invasive potential compared to the wild type (Konkel et al., 
2004). The current study is the first to investigate the flaA gene in a panel of C. concisus 
isolates.  Given the importance of the flagellin genes for pathogenicity in related species, 
these genes are potential candidates for virulence factors of C. concisus.  
 
C. jejuni was found to secrete FlaC protein and the invasion capability of a C. jejuni TGH 
911 flaC-mutant for HEp-2 cells was significantly reduced compared to the wild-type (Song 
et al., 2004). flaC is a highly conserved gene in C. jejuni NCTC 11168 and has 99% identity 
and 100% similarity to FlaC of C. jejuni  TGH9011 (Parkhill et al., 2000). A C. concisus 
UNSWCD strain was suggested to secrete flagellin B, which is encoded by ccc13826_2297 
by bioinformatics study (Kaakoush et al., 2010). Flagellin B (FlaB) was also found to be 
among the immune-reactive proteins that were detected in 10 C. concisus-positive CD 
patients. It was one of the predominant antigens that were recognised by patients’ sera 
(Kovach et al., 2011). The sequence of C. concisus flaB has been previously compared with 
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other Campylobacter members and found to have 83% identity with C. curvus, 78% with C. 
rectus, 60% with C. lari and 57% with both C. jejuni and H. pylori (Kovach et al., 2011). C. 
concisus UNSWCD was found to secrete flagellin-like protein FlaC, encoded by C. concisus 
gene ccc13826_2187 (Kaakoush et al., 2010). However, no molecular detection of C. 
concisus flagellin genes has previously been reported on a panel of C. concisus clinical or 
oral strains. Furthermore, the expressions of C. concisus flagellin genes studies have never 
been investigated. 
 
The experiments presented in this chapter were conducted to fulfil the following aims: 
 
 To detect the flagellin genes (flaA, flaB and flaC) in a panel of C. concisus clinical 
and oral isolates and to investigate the heterogeneity of the nucleotide sequences of 
these genes in strains from genomospecies A and genomospecies B. 
 
 To investigate the expression of flagellin genes (flaA, flaB and flaC) in selected C. 
concisus strains grown in broth cultures (BHI). 
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4.2 Methodology 
 
4.2.1 Bacterial Strains 
 
All C. concisus reference and clinical strains and other Campylobacter spp. strains used in 
this chapter were listed and described in Tables 2.1 and 2.2. The oral C. concisus strains used 
in this chapter were listed and described in Table 3.2.  
4.2.2 PCR 
 
4.2.2.1 C. concisus flagellin genes 
 
Three motility genes were selected and tested in this work. They were:  
• flaA (CCC13826_2298): encoding for flagellin A 
• flaB (CCC13826_2297): encoding for flagellin B 
• flaC (CCC13826_2187): encoding for flagellin like protein, FlaC 
 
They were obtained from publically available sequences of C. concisus 13826 and other C. 
concisus strains available at http://www.ncbi.nlm.nih.gov/genome/genomes/1439?.  
 
4.2.2.2 Primer design and sequence alignment  
 
All primers used in this work were designed as described in 2.4.5. The primer sets used are 
described in Table 4.1. Clone Manager was used to align and compare gene sequences.  
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Table 4. 1 Primer sequences for identification of flaA, flaB and flaC genes in C. concisus 
strains.  
Primer Primer Sequence Reference 
flaA-F 5’-CTCCAGGACTTATGGCATTC-3’ This study, RMIT University 
flaA-R 5’-GTGATAGCAGAGGTCGATAC-3’ 
flaB-F 5’-AACGCAGTTAGCAACAACG-3’ 
flaB-R 5’-CGTCCCTGATTTGTGATTC-3’ 
flaC-F 5’-CTCGTAGTGTCGTGAGCTTTAG-3’ 
flaC-R 5’-CAAACCAGGCTTCAGGAAAC-3’ 
 
4.2.2.3 PCR and Agarose gel electrophoresis performance 
 
PCR was performed using the PCR Master Kit (Bioline, Australia) as recommended by the 
manufacturer. The details of the PCR reaction and cycle conditions are stated in 2.4.6. Gel 
electrophoresis was also used to investigate the purity and integrity of RNA. Agarose gels 
preparation was described in 2.5.1. The gel staining, de-staining, and visualising are fully 
described in 2.5.2. 
4.2.3 RT-PCR 
 
All RT-PCR experiments were performed in a biological safety cabinet class II to avoid 
environmental contaminants. Moreover, all reusable items such as glass bottles were treated 
with diethylpyrocarbonate (DEPC) prior to autoclaving in order to eliminate any chance of 
contamination with nucleases. RNAse-free water (Qiagen, Australia) was used to prepare all 
solutions in RNA experiments. These solutions were then stored in DEPC washed containers 
or in plastic sterilised RNAse-free containers. Sterile, RNAse-free disposable plasticware was 
used for RNA techniques. Pipettes were sterilised prior to use and all used tips were sterile 
and RNAse-free with filters. Formaldehyde 2% (2.2.3.7) was used for decontamination 
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purposes. All glassware and plasticware were treated before each experiment using UV for 
approximately 20 min to cross-link DNA and prevent contamination. 
4.2.3.1 C. concisus strains and growth conditions  
 
C. concisus strains used for gene expression experiments were RMIT-O2 and RMIT-O17 as 
representatives for genomospecies A, whereas RMIT-O16, RMIT-O22 and RMIT-O23 were 
representatives for genomospecies B. C. concisus ATCC 51561 was also used as a reference 
strain and it was from genomospecies B. C. concisus strains were grown in BHI broth under 
microaerophilic conditions (2.3.3) with shaking for 48 h. 
4.2.3.2 RNA extraction and cDNA generation 
 
RNA extraction was performed using ISOLATE II RNA Mini Kit (Bioline, Australia) 
following the manufacturer instructions after collecting RNA from bacteria grown in BHI 
broth by adjusting the OD600 reading to be 0.095 – 0.105 (~ 109 CFU/mL). At the end, RNA 
was eluted by placing the column in elution tube (clean 1.5mL) and then adding 80µL of 
RNase free water directly onto the membrane and incubated at RT for 60 sec. The column 
was centrifuged at 6000xg for 60 sec and the isolated RNA was cleaned by DNase treatment 
and then used to generate cDNA. 
 
Extracted RNA was treated to remove any genomic DNA residual contamination. Treatment 
was performed using Turbo DNA-freeTM kit (Life Technologies, Australia) following the 
manufacture instructions with minor modifications. Briefly, 5µL of 10X turbo DNase buffer 
and 1µL of Turbo DNase were gently mixed with 50µL of extracted RNA in a PCR tube. The 
mixture was incubated at 37ºC for 1 h to degrade any contaminant DNA within the extracted 
RNA. The reaction was then inactivated by adding 5µL of DNase inactivation and incubated 
at RT for 5 min with frequent mixing. The mixture was centrifuged at 10000xg for 2 min, and 
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the supernatant containing clean RNA was then collected. The cleaned RNA concentration 
was estimated and either used for cDNA synthetise or stored at –80ºC. 
 
The Tetro cDNA Synthesis Kit (Bioline, Australia) was used to generate cDNA from the 
cleaned RNA template following the manufacture instructions. At the end, the reaction was 
then terminated by incubation at 85ºC for 5 min followed by chilling in ice. The cDNA was 
stored at -20ºC for long-term storage. 
4.2.3.3 Flagellin genes’ primers 
 
The expression of the three flagellin genes (flaA, flaB, and flaC) was investigated. New 
primer sets from shorter genomic regions (<300 bp) were designed to find a conserved area in 
each gene and to be used for gene expression with RT-PCR. Some of RT-PCR primers 
included degenerate bases such as B, D, R, Y, W and M, which represent GCT, AGT, AG, 
CT, AT and AC, respectively. The primer sets used in this work are described in Table 4.2.  
 
ATP synthase F1 alpha subunit gene (atpA) was used as a house-keeping gene (Mr. 
Elshagmani, Personal communication). Figures 4.1, 4.2 and 4.3 show flaA, flaB and flaC 
sequences obtained from C. concisus 13826 with primer sets used for standard PCR and RT-
PCR. 
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Table 4. 2 Primers used in the RT-PCR for gene expression assay of motility virulence 
genes of C. concisus strains. Blue colours indicate degenerating bases. 
Primer Sequence Reference 
flaA-F 5’-CTAAABCCATCATCAACTAC-3’ This study, RMIT University, 
Melbourne, Australia 
 
flaA-R 5’-CACGGCCTTCTTGGTATGAC-3’ 
flaB-F 5’-CAAACAGCTGCAGATGAC-3’ 
flaB-F 5’-GTCAAGCTCCTCCATTAGAC-3’ 
flaC-F 5’-GADCCRATCTCYGAGCGAAGTG-3’ 
flaC-R 5’-MGGCGAGCTWTCAAGYAAG-3’ 
atpA-F* 5’-TGGCGCTATGGACTACACAA-3’ Mr. Elshagmani, Personal 
communication atpA-R* 5’-TCAAAGATCCAGCGCCTAGT-3’ 
* atpA was used as a House-Keeping gene. 
 
4.2.3.4 RT-PCR solutions 
 
RT-PCR for the gene expression assays was performed using the SensiFASTTM SYBR No-
ROX kit (Bioline, Australia). The total mixture of 12 µl reaction consisted of 6µL of the 
master mix, 5 pmol of each primer set (0.5µL from each) and 5µL from cDNA template 
(0.4µg). 
4.2.3.5 RT-PCR cycle conditions 
 
Thermal cycling was performed with a standard protocol according to the manufacturer's 
instructions (Bioline, Australia) with some modifications as follows: 
 
Number of cycles Temperature Duration 
1 (denaturation) 95ºC 5 min 
40 (denaturation) 95ºC 15 sec 
40 (annealing) 55ºC 15 sec 
40 (extension) 72ºC 1 min 
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The melting curve analysis was also performed to confirm the specificity of PCR using the 
standard protocol (Rotor-Gene Q software, Qiagen Rotor-Gene RT-PCR machine) 
4.2.3.6 Standard Curve and data analysis 
 
A standard curve was generated by performing with serial dilutions from the genomic DNA. 
Three dilutions (descending by 30 folds) were generated as 0.2, 0.00667 and 0.00002 µg/µL, 
respectively. When using 5 µL RT-PCR reactions; 1, 0.0335 and 0.0001 µg/5µL were used as 
final concentrations for each reaction. Relative gene expression was calculated using the 
method described by Pfaffl (2001) with the atpA gene. Prism6 software (GraphPad Software, 
Inc., USA) was used for statistical analysis to calculate the mean and standard deviation. It 
was also used to generate the graphs in RT-PCR experiment of all flagellin genes. A change 
of more than 2 fold relative to control was considered a real change in expression and  further 
statistical analysis using unpaired T-test was performed, a value of p<0.05 was considered 
statistically significant. 
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Figure 4. 1 Nucleotide sequence of flaA gene of C. concisus 13826. The blue colour font is 
for the standard PCR primer set and the green coloured font is for the RT-PCR primer set, 
while the red colour is for the nucleotide replaced by degenerate base in the forward RT-PCR 
primer flaA-F. 
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Figure 4. 2 Nucleotide sequence of flaB gene of C. concisus 13826. The blue colour font is 
for the standard PCR primer set and the green coloured font is for the RT-PCR primer set.  
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Figure 4. 3 Nucleotide sequence of flaC gene of C. concisus 13826. The blue colour font is 
for the standard PCR primer set and the green coloured font is for the RT-PCR primer set, 
while the red colour is for the nucleotide replaced by degenerate base in the forward RT-PCR 
primer flaC-F and flaC-R. 
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4.3 Results 
 
4.3.1 Detection of the presence of flagellin genes (flaA, flaB and flaC) 
 
The full sequence of flaA gene was only detected in some strains, regardless of 
genomospecies, with a PCR product of 0.55 kb. The flaA gene was detected in a total of 17 C. 
concisus strains (17/64, 26.5%); including 5 clinical strains (RCH) and 12 oral strains (Table 
4.3). No PCR product was detected for the two C. concisus reference strains (ATCC 51561 & 
ATCC 51562) or for the other Campylobacter spp. (C. jejuni, C. mucosalis and C. coli). C. 
concisus RCH6 was used as the positive control as no PCR product was detected with any of 
the two C. concisus reference strains. Figure 4.4 shows an example of flaA PCR results for 
some selected strains.  
 
On the other hand, the full sequence of flaB gene was only detected in C. concisus clinical 
and oral isolates belonging to genomospecies B, with a PCR product of approximately 1.5 kb. 
The flaB gene product was detected in a total of 22 C. concisus strains (22/64), being 2 
clinical strains (RCH strains), and 19 C. concisus oral strains (Table 4.3). The flaB gene was 
also detected in the reference strain C. concisus ATCC 51561, which was used as the PCR 
positive control but it was not detected in the reference strain C. concisus ATCC 51562 
(genomospecies A) or in strains from other Campylobacter spp. (Table 4.3). Figure 4.5 (A) 
shows an example of flaB PCR results for some selected strains.  
 
The flaC gene was detected in all tested C. concisus clinical and oral strains (100%). The size 
of the PCR product for this gene was approximately 0.75 kb in all C. concisus clinical and 
oral isolates, as well as in both C. concisus reference strains ATCC 51561 and ATCC 51562. 
flaC was not detected with any other Campylobacter spp (Table 4.3).  Figure 4.5 (B) shows 
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an example of flaC PCR results in some selected C. concisus strains. The results for all 
flagellin genes are summarised in Table 4.3. 
 
 
 
 
 
 
 
Figure 4. 4 PCR amplification of C. concisus flaA gene products. M, Lambda/ Pst I 
marker. Lane 1, C. concisus ATCC 51561. Lane 2, C. concisus ATCC 51562. Lane 3 , C. 
concisus RCH6. Lanes 4-9, C. concisus oral strains RMIT-O28 - RMIT-O33. Lane 10, C. 
mucosalis ATCC 43264. Lane, C. jejuni 81116. Lane 12, C. coli NCTC 11136. 
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Figure 4. 5 PCR amplification of C. concisus flaB and flaC genes products. M, Lambda/ 
Pst I marker. Lane 1, C. concisus ATCC 51561. Lane 2, C. concisus ATCC 51562. Lanes 3-
8, C. concisus oral strains RMIT-O28 - RMIT-O33. Lane 9, C. mucosalis ATCC 43264. Lane 
10, C. jejuni 81116. Lane 11, C. coli NCTC 11136. A, flaB gene results. B, flaC gene results. 
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Table 4. 3 Summary of flagellin genes (flaA, flaB and flaC) results of all tested C. 
concisus strains and other Campylobacter spp. 
strains Genomospecies  flaA  flaB  flaC  
ATCC 51561 B - + + 
ATCC 51562 A - - + 
RCH 3 A - - + 
RCH 4 A + - + 
RCH 5 A - - + 
RCH 6 B + + + 
RCH 7 A - - + 
RCH 9 A + - + 
RCH 11 B + + + 
RCH 12 A - - + 
RCH 15 A + - + 
RCH 19 A - - + 
RCH 20 A - - + 
RCH 23 A - - + 
RCH 24 A - - + 
RCH 25 A - - + 
RCH 26 A - - + 
RMIT-O1 A - - + 
RMIT-O2 A - - + 
RMIT-O3 A - - + 
RMIT-O4 A - - + 
RMIT-O5 A - - + 
RMIT-O6 A - - + 
RMIT-O7 A - - + 
RMIT-O8 B - + + 
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Table 4.3 Summary of flagellin genes (flaA, flaB and flaC) results of all tested C. concisus 
strains and other Campylobacter spp., continued. 
strains Genomospecies  flaA  flaB  flaC  
RMIT-O9 A - - + 
RMIT-O10 A - - + 
RMIT-O11 B + + + 
RMIT-O12 A - - + 
RMIT-O13 B + + + 
RMIT-O14 A - - + 
RMIT-O16 B + + + 
RMIT-O17 A - - + 
RMIT-O18 A - - + 
RMIT-O19 B - + + 
RMIT-O20 A - - + 
RMIT-O21 B + + + 
RMIT-O22 B + + + 
RMIT-O23 B + + + 
RMIT-O24 A - - + 
RMIT-O25 B - + + 
RMIT-O26 A - - + 
RMIT-O27 B - + + 
RMIT-O28 B - + + 
RMIT-O29 A - - + 
RMIT-O30 A - - + 
RMIT-O31 B + + + 
RMIT-O32 B - + + 
RMIT-O33 B + + + 
RMIT-O34 A - - + 
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Table 4.3 Summary of flagellin genes (flaA, flaB and flaC) results of all tested C. concisus 
strains and other Campylobacter spp., continued. 
strains Genomospecies  flaA  flaB  flaC  
RMIT-O35 A - - + 
RMIT-O36 B + + + 
RMIT-O37 B + + + 
RMIT-O38 A - - + 
RMIT-O39 A - - + 
RMIT-O40 A - - + 
RMIT-O41 B + + + 
RMIT-O42 A - - + 
RMIT-O43 A - - + 
RMIT-O44 B - + + 
RMIT-O45 B + + + 
RMIT-O46 A - - + 
RMIT-O47 A - - + 
RMIT-O48 A - - + 
C. mucosalis ATCC 43264 NA - - - 
C. jejuni 81116 NA - - - 
C. coli NCTC 11366 NA - - - 
 
Blue colour, C. concisus clinical isolates obtained from RMIT University stocks. Black 
colour, C. concisus oral isolates isolated in this study from healthy people as indicated in 
chapter 3. Red colour, other Campylobacter spp. isolates obtained from RMIT 
University stocks. 
 
ATCC; American Type Culture Collection, RCH; Royal Children Hospital, O; Oral, 
NCTC; National Collection of Type Cultures, A; Genomospecies A, B; Genomospecies B. 
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4.3.2 Sequence alignment of C. concisus flaA and flaB genes 
 
As indicated in the standard PCR results (4.3.1), the flaA gene was only detected in some C. 
concisus strains (17/64) and flaB gene was detected with all genomospecies B C. concisus 
strains (19/64). Therefore, two fragments of the flaA (516 bp) and flaB (501 bp) genes were 
aligned with sequences of C. concisus ATCC 51562 and UNSW1 to identify conserved 
regions. Primer sets were designed in the conserved regions and used for RT-PCR. The 
percentage similarity for flaA gene with C. concisus strains ATCC 51562 and UNSW1 were 
66% and 63%, respectively. However, the percentage similarity for flaB was higher, being 
99% and 96%, respectively. Figures 4.6 and 4.7 indicate the conserved regions and primer 
locations within flaA and flaB genes. The next part (4.3.3) shows the amplification results of 
C. concisus flagellin genes used in RT-PCR, which targeted shorter regions. 
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Figure 4. 6 Alignment of flaA gene nucleotide sequence of C. concisus 13826 with ATCC 
51562 & UNSW1, to obtain a conserved area within these strains. The first 516bp was used 
for the alignment. The conserved area used to construct the primer set was approx. 0.24 kb. 
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Figure 4. 7 Alignment of flaB gene nucleotide sequence of C. concisus 13826 with ATCC 
51562 & UNSW1, to obtain a conserved area within these strains. The first 501bp was used 
for the alignment. The conserved area used to construct the primer set was approximately 
0.26kb. 
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4.3.3 Amplification of C. concisus flagellin genes used in RT-PCR 
 
The flaA was not detected in C. concisus ATCC 51561 reference strains, RMIT-O2 and 
RMIT-O17. However, it was detected in RMIT-O16, RMIT-O22 and RMIT-O23 (Table 4.3). 
To investigate flaA gene expression by RT-PCR, a new primer set was designed in the 
conserved area (approx. 0.24kb). This primer set was tested by standard PCR prior to 
performing the RT-PCR. The flaA gene was detected in all selected strains including the 
strains which failed to produce a flaA PCR product  by standard PCR, including ATCC 
51561, RMIT-O2 and RMIT-O17 (Figure 4.8 A). 
 
On the other hand, the whole sequence of the flaB gene was detected in C. concisus 
genomospecies B strains only by standard PCR. This gene was not detected in RMIT-O2 and 
RMIT-O17, being from genomospecies A. However, it was detected in C. concisus ATCC 
51561, RMIT-O16, RMIT-O22 and RMIT-O23 (Table 4.3). To test flaB gene expression by 
RT-PCR, a new primer set was designed from a small conserved area of this gene (approx. 
0.26kb). This primer set was tested by standard PCR with the selected C. concisus strains 
before performing the RT-PCR. It was detected in all selected strains including RMIT-O2 
and RMIT-O17 (Figure 4.8 B). 
 
The flaC gene was the only gene detected by standard PCR, in all C. concisus strains (Table 
4.3). To test flaC gene expression by RT-PCR, primer set was designed from a small area of 
this gene (approx. 0.27kb) and then tested by PCR with all selected C. concisus strains before 
performing the RT-PCR. As previously described, the flaC gene was detected in all selected 
strains (Fig. 4.8 C). 
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Figure 4. 8 RT-PCR amplification of 3 flagellin genes products obtained from cDNA 
synthesised from extracted RNA from BHI broth for 6 C. concisus strains used in RT-PCR 
for gene expression. M, Lambda/ Pst I marker. Lanes 1, C. concisus ATCC 51561 reference 
strain. Lane 2, C. concisus RMIT-O2. Lane 3, RMIT-O16. Lane 4, RMIT-O17. Lane 5, 
RMIT-O22. Lane 6, RMIT-O23. Lane 7, negative control. A, flaA gene results (0.24kb). B, 
flaB gene results (0.26kb). C, flaC gene results (0.27kb). All tested C. concisus strains were 
detected when using a short targeted area. 
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4.3.4 Expression of flagellin genes 
 
4.3.4.1 Expression of flaA gene 
 
The flaA gene only was significantly up-regulated in C. concisus RMIT-O23 oral strain 
(3.063 fold) relative to the reference strain C. concisus ATCC 51561 ( Figure 4.9). flA 
expression was not significantly different from the reference in C. concisus RMIT-O22 (-
0.390, p=0.1416). The expression of this gene was significantly down-regulated within the 
other three C. concisus strains (RMIT-O2, RMIT-O17 and RMIT-O16). The most 
significantly down-regulation of this gene was in RMIT-O2 with -14.400 fold. Figure 4.9 
shows the results of flaA gene expression relative to the expression levels of the gene in the 
reference strain C. concisus ATCC 51561. 
 
4. 3.4.2 Expression of flaB gene  
 
The flaB gene was significantly up-regulated in 2 oral strains, RMIT-O22 and RMIT-O23 
relative to C. concisus ATCC 51561 (5.910 and 24.447 respectively). In the other C. concisus 
tested strains flaB was down-regulated compared to the reference. C. concisus RMIT-O2 was 
the most significantly down-regulated strain in the expression of  the flaB gene (-75.00, 
p<0.001), followed by C. concisus RMIT-O17 (-11.400, p<0.05), both belonging to 
genomospecies A. C. concisus RMIT-O16 was the only strain among genomospecies B that 
down-regulated the expression the flaB gene (-3.167, p<0.05). Figure 4.10 shows the results 
of flaB gene expression relative to the reference strain C. concisus ATCC 51561. 
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4. 3.4.3 Expression of flaC gene 
 
The flaC gene was significantly up-regulated by all tested oral strains relative to C. concisus 
ATCC 51561 reference strain. Remarkably, C. concisus RMIT-O17 had the highest levels of 
flaC gene expression (9.267, p<0.001). This gene was also significantly up-regulated by C. 
concisus RMIT-O22 and RMIT-O23 strains, being 6.990 and 6.627, respectively. The lowest 
flaC expression value was found in C. concisus RMIT-O2 (2.217). Although, RMIT-O16 
showed greater than 2-fold higher expression (3.110), this was not statistically different 
unpaired T-test analysis (p=0.0601). Figure 4.11 shows the full results of flaC gene relative to 
the the reference strain C. concisus ATCC 51561. 
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Figure 4. 9 RT-PCR of flaA gene expression in 6 C. concisus strains, ATCC 51561, 
RMIT-O2, RMIT-O16, RMIT-O17, RMIT-O22 and RMIT-O23. Expression was normalised 
to atpA, and expressed as relative to the C. concisus ATCC 51561 reference strain lines 
indicate 2-fold changes. The expression of the flaB gene was significantly up-regulated by 
only C. concisus RMIT-O23 strain compared to the reference strain ATCC 51561. * p<0.05 
and **p<0.01. 
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Figure 4. 10 RT-PCR of flaB gene expression in 6 C. concisus strains, ATCC 51561, 
RMIT-O2, RMIT-O16, RMIT-O17, RMIT-O22 and RMIT-O23. Expression was normalised 
to atpA, and expressed as relative to the C. concisus ATCC 51561 reference strain. Lines 
indicate 2-fold changes. The expression of the flaB gene was significantly up-regulated by 
only C. concisus RMIT-O22 & RMIT-O23 strains compared to the reference strain ATCC 
51561. * p<0.05, **p<0.01 and *** p<0.001 
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Figure 4. 11 RT-PCR of flaC gene expression in 6 C. concisus strains, ATCC 51561, 
RMIT-O2, RMIT-O16, RMIT-O17, RMIT-O22 and RMIT-O23. Expression was normalised 
to atpA, and expressed as relative to the C. concisus ATCC 51561 reference strain lines 
indicate 2-fold changes. The expression of the flaC gene was significantly up-regulated by all 
tested C. concisus strains compared to the reference strain ATCC 51561. * p<0.05 and 
**p<0.01. 
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4.4 Discussion 
 
The flagellum is known to be important for bacterial motility. The rapid motility and curved 
shape of Campylobacter spp. allows it to swim through the mucous layer of intestinal cells 
(Aguero-Rosenfeld et al., 1990). In the case of C. jejuni, the flagella  help the bacterium to 
penetrate the intestinal mucus and then adhere to, and invade the host intestinal epithelial 
cells (Szymanski et al., 1995). The Campylobacter spp. flagellum has two homologous 
flagellins, FlaA and FlaB (Dasti et al., 2010). 
 
C. concisus is a motile bacterium and it uses one polar flagellum for the motility (Mahendran 
et al., 2011, Man et al., 2010a). To date, there has been no thorough investigation on the 
flagellin genes flaA, flaB or flaC in C. concisus. Due to the importance of the flagellin genes 
in Campylobacter species and their role in pathogenicity, this study investigated the presence 
of three flagellin genes; flaA, flaB and flaC, in a total of 64 C. concisus clinical and oral 
strains. It has also studied the gene expression of these genes in selected C. concisus strains. 
A previous bioinformatics study performed on a number of putative virulence factors 
associated with disease outcomes in C. concisus UNSWCD suggested that this bacterium is a 
pathogen in GIT. These factors included the flagellin-like protein FlaC, encoded by 
ccc13826_2187 and the flagellin B, encoded by ccc13826_2297 (Kaakoush et al., 2010), 
however, the flagellin A gene (flaA) of C. concisus has never been studied.  
 
In this study, using primers designed from the publically available sequence of C. concisus 
13826, the whole flaA gene was detected in just 26.5% of C. concisus clinical and oral 
isolates regardless of genomospecies. The flaA gene was previously detected in 83% C. jejuni 
culture positive samples (Waegel et al., 1996). It was also found in all tested C. jejuni isolates 
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(74) and C. coli isolates (11) isolated from different sources, including children, pigs, dogs 
and chickens (Krutkiewicz et al., 2010). flaA was detected in 100% of C. jejuni tested isolates 
(65) isolated from 2 farms, retail carcasses, and a processing facility (Hanning et al., 2010). It 
was also detected in all tested Campylobacter spp. including 42 C. jejuni isolates and 23 C. 
coli isolates (Zhang et al., 2007).  
On the other hand, in this study, the whole flaB gene was only detected in all genomospecies 
B C. concisus clinical and oral strains, which was 34.4% (22/64) of strains in the study (Table 
4.3). A previous study found flaB in all tested C. jejuni (Muller et al., 2006), being very 
similar to the flaB size fragment used in our study, 1.5kb. It was also detected in 75 % of 
Campylobacter spp. isolated from children (Krutkiewicz et al., 2010). Since the whole flaA 
was detected in only 17 of 64 C. concisus strains used in this study and the whole flaB was 
detected in only 22 of these strains, these genes may have been absent, or have a variable 
nucleotide sequences. Shorter regions might be targeted by designing new primers within the 
conserved regions for the detection of these genes. Therefore sequence variation between 
strains, rather than absence of the gene may have accounted for this result. 
Unlike flaA and flaB genes, the flaC gene was detected in 64/64 (100%) of C. concisus tested 
strains. This gene was also found in 93% of C. jejuni isolates, from 2 farms, retail carcasses, 
and a processing facility (Hanning et al., 2010). As flaC was detected in all tested C. concisus 
strains in this study, this indicates that this gene is a conserved in this bacterium. Therefore, 
the flaC primer set designed in this study can be used as a species-specific primer set to 
detect C. concisus isolates by standard PCR rather than the previously used cisus primer set 
(Matsheka et al., 2001). As described in chapter 3 (3.3.4), the target of the cisus primer set 
may not be detected in all tested C. concisus isolates. 
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flaA, flaB and flaC genes were detected in all six tested C. concisus strains using primers 
designed from conserved regions. The failure to amplify flaA and flaB genes using primers 
from larger regions suggests that these genes are heterogeneous in different genomospecies. 
It was therefore of interest to determine whether the flagellin genes were differentially 
expressed in different isolates. Only few studies have previously investigated the expression 
of flagellin genes Campylobacter species (flaA, flaB and flaC). Here, the expression of these 
genes in selected C. concisus strains grown in BHI for 2 days under microaerophilic 
conditions was assessed. 
In this study, differences in flaA and flaB expression relative to the reference strain were 
observed under standard conditions. Only one C. concisus strain, (RMIT-O23) from 
genomospecies B has a significant up-regulated level of the flaA gene expression, while no 
statically significant difference was observed with RMIT-O22 from genomospecies B as 
well. This gene was down-regulated with all other C. concisus tested strains. flaA was 
previously found to be expressed at higher levels than flaB in C. coli VC167 strain (Guerry et 
al., 1990). An association between the expression of flaA gene and motility in C. jejuni was 
reported (Wassenaar et al., 1991). In in vitro growth conditions, the flaA gene was the only 
flagellin gene expressed by C. jejuni 81116 (Nuijten et al., 1990). The strains RMIT-O22 and 
RMIT-O23, both from genomospecies B exhibited up-regulation in the flaB gene expression. 
These two strains RMIT-O22 and RMIT-O23 were isolated from healthy twin infants. 
Generally, the flaB gene was down-regulated in genomospecies A C. concisus strains (RMIT-
O2 and RMIT-O17) (Fig. 4.10). These findings suggest that flaA and flaB expression is 
variable between C. concisus strains under this condition. 
Unlike flaA and flaB, we found that flaC was the only gene that was up-regulated in all C. 
concisus strains tested relative to the reference strain in this study, with the highest 
significantly up-regulation in RMIT-O17, from genomospecies A. There is little published 
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data on the flaC expression in Campylobacter spp. The flaC mutation of C. jejuni 81–176 
strain had less invasiveness to INT407 cells than wild-type strain (Goon et al., 2006). Two 
criteria were applied in this study to analyse gene expression results. Firstly, to reduce the 
risk of technical errors, only changes greater than 2-fold were considered. Secondly, fold 
changes relative to the reference strain were tested using unpaired T-test. Although, RMIT-
O16 showed higher than 2-fold (3.110), it did not show any significant result when using 
unpaired T-test analysis (p=0.0601). It may be due to that its error bar was high.  
 
 In conclusion, although sequence variation appears to be significant, the flaA gene was 
detected in selected C. concisus strains regardless of genomospecies, while flaB gene was 
amplified in all genomospecies B strains only. Unlike flaA and flaB, the flaC gene was found 
in all tested strains. These findings support the previous observations that C. concisus is a 
heterogeneous species, and suggests that there are variations in the flagellin genes within C. 
concisus strains and these genes are heterogeneous in different genomospecies. Given that the 
flaC gene was detected in all tested C. concisus strains but not in other tested Campylobacter 
spp., the primer set designed to detect flaC in this study can be used as a species specific 
primer set to detect new C. concisus isolates. After using primer sets from the conserved 
regions of flaA, flaB and flaC those genes were amplified in all selected strains. 
Under the condition tested, the flaA gene was significantly expressed by only one C. concisus 
strain, while lower expression was detected in all other tested strains compared to the 
reference strain, which was a pathogenic gut isolate. Only C. concisus RMIT-O22 and RMIT-
O23 strains had significantly higher expression of the flaB gene, whereas the other strains had 
significantly lower expression under the test conditions. In general, flaC was stronger 
expressed in the oral isolates tested compared to the reference strain. C. concisus RMIT-O17 
strain is the most significant up-regulated strain that expressed the flaC gene, which supports 
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that this oral strain has unique features and further investigations are required to characterise 
other virulence factors in this strain. It is suggested that the environmental factors, the 
presence of O2 in the oral cavity and Co2 in the gut could affect the expression of these genes. 
Further studies are also required to evaluate genetic variations and virulence of clinical 
isolates from the two genomospecies to assess the role of these genes in pathogenesis of C. 
concisus. As the flagella of Campylobacter spp. were found to have an important role in their 
pathogenicity, proteomic studies on the flaA, flaB and flaC genes in C. concisus are essential 
to investigate if there are any differences in the proteins’ characteristics between 
genomospecies A and B. A knock-out mutant in one or more of the flaA, flaB and flaC genes 
is also necessary to investigate the role of these genes in pathogenicity of C. concisus. 
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Chapter Five 
Motility and invasion capability as virulence factors in C. 
concisus 
 
5.1 Introduction 
 
A number of virulence factors have been investigated and detected in Campylobacter spp., 
these include factors associated with adherence, invasion, motility, and toxins (Ali et al., 
2012). Both adherence (mediated by the flagellum), and invasion are predicted to be critical 
for pathogenesis in C. concisus. There have been few studies to investigate the differences 
between strains isolated from healthy patients and from patients with disease, or those 
isolates from the oral cavity compared to the intestine. In in vitro studies, the polar flagellum 
of C. concisus was observed to facilitate attachment to the Caco-2 and HT-29 human 
intestinal cell lines. In these studies, C. concisus strain UNSWCD was reported to possess an 
increased ability to invade Caco-2 cells as compared with strains isolated from patients with 
acute gastroenteritis or healthy controls such as C. concisus ATCC 51561 (Man et al., 
2010a). Furthermore, C. concisus strains isolated from healthy individuals were able to attach 
to, but were unable to invade Caco-2 cells, unlike strains isolated from patients with intestinal 
diseases (Kaakoush et al., 2011b). Enteric invasive C. concisus (EICC) was detected in oral 
isolates from 50% of IBD patients but was not detected in the healthy controls (saliva 
samples). Oral isolates of IBD patients also had high invasion indexes (Ismail et al., 2012).  
 
Motility is an important virulence factor for Campylobacter spp., and there is little data on 
the relative motility in different strains of C. concisus. The flagellum of C. concisus is very 
important for motility for both movement through mucous (Lavrencic et al., 2012) and to 
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mediate adhesion onto the host cells. C. concisus uses the polar flagellum to adhere to host 
microvilli (Kaakoush et al., 2011b, Man et al., 2010a). Although differences in motility 
between strains have been reported by other authors (Lavrencic et al., 2012), there are to date 
no reports on a direct link between motility and disease outcome. 
Wilson et al. (2011) developed the Differential dynamic microscopy (DDM) technique for 
fast, high-throughput characterization of the dynamics of active particles. The DDM results 
were highly accurate compared to conventional tracking methods for motility characterisation 
(Wilson et al., 2011). This technique was applied for the first time to measure the swimming 
speed and motile cell fractions in E. coli suspensions and used to capture essential aspects of 
the dynamics of a mixed population of both non-motile and motile E. coli (Wilson et al., 
2011). In this study, the swarming motility assay and DDM were used to evaluate the 
relationship between motility and invasion in C. concisus strains isolated from gum swabs of 
healthy individuals. 
The aims of the experiments carried out in this chapter were to: 
 
I. Assess the interaction between C. concisus strains from both genomospecies in an in 
vitro model using INT407 intestinal epithelial cells using adhesion and invasion 
assays. 
II. Investigate motility ratios of different C. concisus strains (oral and intestinal)  
III. Investigate the motility and invasion as potential virulence factors in C. concisus 
strains. 
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5.2 Methodology 
 
5.2.1 Bacterial strains isolation and growth conditions  
 
C. concisus strains used in this experiment were RMIT-O2, RMIT-O16, RMIT-O17, RMIT-
O22 and RMIT-O23. C. concisus ATCC 51561 was used as a reference strain (2.3.1). 
Isolation methods for oral strains are explained in section 3.2.1. All C. concisus strains were 
grown and maintained on HBA for 48-72 h at 37ºC under microaerophilic conditions as 
described in 2.3.3. BHI broth or BB semi-sold agar were also used in specific assays.  
  
5.2.2 In vitro intestinal epithelial cell model 
 
5.2.2.1 Culture of intestinal epithelial cells  
 
Tissue culture media composition and preparations are described in 2.7.1. Human embryonic 
intestinal cell line (INT407), obtained from RMIT tissue culture stock collection was used for 
the in vitro analysis. The preparation of cell lines was as follows; the cells were seeded in 
large flasks (75 cm2) and allowed to reach pre-confluent monolayer over 48-72 hours. 
DMEM medium (Thermofisher, Australia) was used for maintenance of INT407 cells. Cells 
were subcultured every 2 days by trypsinising. To maintain and harvest the cells, after 
reaching the target confluence, the cells were washed 2 times using PBS. Two millilitres of 
trypsin were then added and the flask was incubated for 10min. The cells were collected and 
transferred to 10ml tube that includes 3-5ml DMEM. The tube was then centrifuged at 
1000xg for 3min. The supernatant was discarded and repeated this step. After discarding the 
supernatant, 2ml of DMEM/FBS were added to the pellet. The mixture was used for 
subculturing, cells storage or in vitro assays. The cells were counted using the Countess® 
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Automated Cell Counter (Life Technologies. Australia) and the viability was determined 
using trypan blue stain.  
 
5.2.2.4 Adhesion/Invasion Assays 
 
The capability of C. concisus strains to adhere and invade INT407 in vitro, was determined 
according to the method described by Elsinghorst (1994) and modified by Chang (2002). 
INT407 cells (viability of ≥95%) were diluted in fresh DMEM/FBS to reach 2x105/mL of 
concentration and then 0.5mL seeded per well into a 24 well plate (i.e. 105cells/well). The 24 
well plates containing INT407 were incubated for 10-16 h to allow the cells to attach. On the 
day of the procedure, the old medium was discarded and the cells were washed 3 times in 
PBS. Fresh media (400µL of DMEM/FBS) was added to each well after washing. 
 
 
Several bacterial colonies were collected from HBA culture (48-72 h) and suspended into 
Columbia broth. The suspension was then measured and adjusted to be 0.1 OD600 reading 
using spectrophotometer (Eppendorf, Australia). Serial dilutions, being 105, 106 and 107 were 
performed from the original OD600 inoculum of each strain and plated onto HBA and then 
incubated under microaerophilic conditions to count the live cells and to determine the CFU.  
 
5.2.2.4.1 Infection of INT407 cultures and adhesion assay 
 
A 100µL (~107 CFU) of bacterial suspension was inoculated into each well containing 
INT407 to perform multiplicity of infection (MIO) of 10 – 100 (bacterial cells/infected cell). 
The plates were centrifuged 5 min at 200xg to enhance bacterial contacts with intestinal cells. 
The inoculated plates were then incubated at 37ºC under microaerophilic conditions for 6 h to 
allow the bacterial strains to adhere and invade the cell line. 
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Wells were washed 3 times with PBS after 6 h incubation to remove non-adherent bacterial 
cells. The intestinal cells were lysed by adding 200 µL of 0.3% triton-X-100 /well, to release 
the attached and intracellular bacterial cells, and then diluted by adding 800 µL PBS. The 
plates were incubated in 5% CO2 at 37ºC for 15 min. The bacterial cell number measured as 
colony forming units (CFU). A 100µL from several dilutions including 101, 103 and 105 was 
then inoculated onto HBA. The viable bacterial cells adhering onto the intestinal cells were 
calculated using the following formula: 
 Adhesion% = No. of recovered bacterial cellsNo. of total bacterial cells initially used/ml X100 
 
5.2.2.4.2 Invasion Assay 
 
After 6 hours incubation as above, wells were washed 3 times with PBS. One mL of 
DMEM/FBS containing of 400µg gentamycin was added to each well and incubated in 5% 
CO2 at 37ºC for 60 min to kill non invaded bacterial cells as gentamycin is acting in 
extracellular to kill the bacterial cells. The cells were then washed 3 times by PBS after the 
treatment to remove the gentamycin. The intestinal cells were lysed by adding 200 µL of 
0.3% triton-X-100 and diluted by adding 800 µL PBS to release the invaded bacterial cell 
from the intestinal cell. The plate was incubated in 5% CO2 at 37ºC for 15 min. The dilutions 
101, 102 and 103 were made. An inoculum of 100µL from each of these dilutions was cultured 
onto HBA. Viable bacterial cells invaded into intestinal cells line was calculated by the 
following formula:  
 invasion% = No. of recovered bacterial cells/mlNo. of total bacterial cells initially used/ml X100 
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The invasion/adhesion ratio was also calculated according to the following formula: 
 
Invasion/Adhesion Ratio = No. of invaded bacterial cells%No. of adhered bacterial cells% X100 
 
5.2.4 Data analysis 
  
All experiments were performed with three independent experiments and the results reported 
as the average value ± Standard Error of the Mean (SEM). Statistical analysis was performed 
using GraphPad Prism 6 software (GraphPad Software, Inc., USA) using unpaired T-test to 
calculate P value and to also generate to graphs in both experiments (adhesion & invasion). A 
value of p<0.05 was considered statistically significant. 
 
5.2.5 Measurement of bacterial motility by Differential Dynamic Microscopy (DDM)  
 
5.2.5.1 Bacterial strains and culture conditions 
 
C. concisus strains ATCC 51561, RMIT-O2, RMIT-O16, RMIT-O17, RMIT-O22 and 
RMIT-O23 were grown in Brain-heart infusion (BHI) broth medium in a microaerophilic 
environment with shaking for 48 h as described in 2.3.3. The concentration of suspension was 
adjusted to be ~0.3 (OD600). 
 
5.2.5.2 Sample preparation and video capture  
 
The video capture for DDM analysis was performed using a modification of a method 
described by Wilson et al. (2011). Briefly, 150µl of a 48 h bacterial suspension (~0.3 OD600) 
grown in BHI broth were loaded into a capillary tube (Bioscientific Pty Ltd, Australia) and 
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placed on an Inverted Optical ix71 microscope (Olympus, Japan). Videos were recorded at 
1024x1024 frame rate using a high speed camera (EoSens MC1362 camera) from 
MIKROTRON (Germany). Two different videos were recorded for analysis. The first video 
was 30 sec with 60x magnification and 100 FPS (Frame per second) with bright field 
illumination to observe the presence of motile cells. The second video was 60 sec with 10x 
magnification and 100 FPS on phase contrast for DDM analysis. 
 
5.2.5.3 DDM data analysis 
 
The video file was processed using a custom written program in LabVIEW. The processing 
stage calculated the Differential Intensity Correlation Functions (DICF) from each input 
video. For a 1024x1024 video, 511 DICF were obtained and the DICFs were fitted using 
MATLAB software (Mathworks, USA) with a double exponential model. In a previous study 
that used DDM to characterise motility in E. coli (Wilson et al., 2011), the DICF values were 
found to scale when replotted against q × t (q is scattering vector and t is the time). If data 
scales to 𝒒𝑡, the detected motions are isotropic ballistic motion. Therefore, in that case it was 
possible to fit a model which describes ballistic motion and calculate the speed of the 
bacteria. For Campylobacter bacteria, the calculated DICF scale in accordance to 𝒒𝟐𝑡, which 
implies that the motility is diffusive in nature, rather than ballistic as is the case for E. coli; 
therefore a model must be fitted which describes diffusion motion 𝑒𝑥𝑝(−𝐷1𝒒𝟐𝑡), where exp 
indicates an exponential and D1 is the diffusion coefficient for the fast motility process. The 
best fit required a double exponential (exp) due to the background Brownian motion that all 
cells experience. Therefore a double exponential fit was fitted and retrieved two fitting 
parameters D1 and D2. The fitted data was checked for goodness of fit using the normalize 
root mean squared error (NRMSE) function from MATLAB software. Data was only 
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accepted if the NRMSE was above 0.95. These results were averaged, and a standard 
deviation calculated. 
 
5.2.6 Motility swarming assay on semi-solid media 
 
Motility swarming assay on semi-solid media (Takata et al., 1992) was performed using a 
modification of a method described by Adler et al. (2014). Briefly, brucella broth (BB) 
containing 0.4% agar (BBA) was used. The swarming ability of 6 C. concisus strains (ATCC 
51561, RMIT-O2, RMIT-O16, RMIT-O17, RMIT-O22 and RMIT-O23) was investigated at 
37ºC on semi-solid agar medium plates (BB). Three day old cultures of 6 C. concisus strains 
were adjusted to 108 CFU/ml (OD600 = 0.1) and 3.8 µl dropped on semi-solid medium plates. 
The diameters of the swarming halos (zones of motility around the inoculation points) were 
then measured after 72 h incubation period at 37ºC. The data were generated from three 
independent experiments and the mean was taken. 
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5.3 Results 
 
5.3.1 In vitro 
 
5.3.1.1 Adhesion assay 
 
All the C. concisus oral strains tested were able to adhere to INT407 cells. The adhesion 
assay statistical analysis was in comparison with the reference strain C. concisus ATCC 
51561. C. concisus RMIT-O2 and RMIT-O17, had a lower proportion of adherence 
compared to C. concisus strains RMIT-O22 and RMIT-O23 with 1.028, P= 0.0004 and 
0.933, P= 0.0004, respectively. C. concisus RMIT-O16 adherence proportion was similar to 
RMIT-O2 and RMIT-O17 results, being 0.943, with a P value of 0.0011. The highest 
adherent proportions in the oral isolates were detected in C. concisus RMIT-O22 and RMIT-
O23, being 2.070, P= 0.0027 and 2.110, P= 0.0021, respectively. The proportion of adherent 
bacteria for all the isolates was significantly lower than C. concisus ATCC 51561 (Figure 
5.1). 
 
5.3.1.2 In vitro invasion assay 
 
All tested C. concisus strains had the ability to invade INT407 (Figure 5.2). C. concisus 
RMIT-O17 strain was found to be more invasive than the reference strain ATCC 51561 and 
other tested strains. It had a significantly higher invasion proportion (0.087, P=0.0030) than 
the reference strain ATCC 51561(0.0337). All other oral strains were significantly lower in 
invasion proportion than the reference strain, with C. concisus RMIT-O16 producing the 
lower invasion proportion (0.001, P=0.0050), followed by C. concisus RMIT-O2 strain 
(0.007, P=0.0100). The invasion proportions of C. concisus RMIT-O22 and RMIT-O23 were 
0.007, P=0.0106 and 0.009, P=0.0129, respectively. 
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Figure 5. 1 Proportion of adherent bacteria from five C. concisus oral isolates and the 
reference strain ATCC 51561. The oral strains were; RMIT-O2 and RMIT-O17 from 
genomospecies A. RMIT-O16, RMIT-O22 and RMIT-O23 were from genomospecies B. The 
data shown represent the mean number of adherent bacteria from 3 independent experiments 
± SEM. * p<0.05, **p<0.01, *** p<0.001 
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Figure 5. 2 Proportion of invasive bacteria from five C. concisus oral isolates and the 
reference strain ATCC 51561. The oral strains were; RMIT-O2 and RMIT-O17 from 
genomospecies A. RMIT-O16, RMIT-O22 and RMIT-O23 were from genomospecies B. The 
data shown represent the mean number of invasive bacteria from 3 independent experiments 
± SEM. * p<0.05, **p<0.01. 
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5.3.1.3 Invasion/Adhesion ratio 
 
The results of the adhesion and invasion assays above showed that, C. concisus strains were 
more likely to adhere rather than to invade INT407. Except RMIT-O17, all tested strains 
including the reference strain ATCC 51561 had a value less than 1.00 in their invasion index 
which was calculated as:  
Invasion/Adhesion Ratio = No. of invaded bacterial cells%No. of adhered bacterial cells%𝑋100 
No statistically significant difference was found in the invasion index of C. concisus RMIT-
O2 strain (0.659, P=0.5003), whereas C. concisus RMIT-O16 strain had a significantly lower 
invasion index (0.162, P=0.0053). The invasion indexes of C. concisus RMIT-O22 and 
RMIT-O23 were also significantly lower than the reference strain ATCC 51561, 0.363, 
P=0.0131 and 0.410, P=0.0209, respectively (Figure 5.3). Bacterial strains with invasion 
indexes >1 were considered to be enteric invasive strains (EICC) (Larson et al., 2008). 
Therefore, only one enteric invasive C. concisus strain (EICC) was detected from oral strains 
and it was RMIT-O17, with 9.313, P <0.0001. 
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Figure 5. 3 Invasion index (invasion/adhesion ratio) of five C. concisus oral strains 
compared to C. concisus ATCC 51561 reference strain. The oral strains RMIT-O2 and 
RMIT-O17 from genomospecies A and RMIT-O16, RMIT-O22 and RMIT-O23 were from 
genomospecies B. The data shown represent the mean number of invasive/adherent ratio of 
bacteria from 3 independent experiments ± SEM. * p<0.05, **p<0.01, **** p<0.0001. 
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5.3.2 Differential Dynamic Microscopy (DDM) 
 
5.3.2.1 Calculation of the Differential Intensity Correlation Functions (DICF) 
 
The table below shows the average and standard deviations for the D1 and D2 values 
obtained. D1 is the active diffusion of the motile cells, and D2 is the Brownian diffusion 
coefficient. All D1 values of C. concisus oral tested strains were found to be significantly 
higher than the reference strain. In the reference strain C. concisus ATCC 51561 and the oral 
strain C. concisus RMIT-O16, the D1 and D2 are close together, indicating that the motility is 
not much faster than normal Brownian motion. However, the D1 value for RMIT-O16 was 
significantly higher than the reference strain (P=0.0067). All other oral C. concisus strains 
were also significantly higher than the reference strain and RMIT-O16, and had the same P 
values, <0.0001. However, C. concisus RMIT-O17 was found to be the most motile strain 
compare to all tested strains, 11 times faster than the background Brownian motion, followed 
by C. concisus RMIT-O2. C. concisus RMIT-O22 and C. concisus RMIT-O23 strains have 
motilities which are well above the Brownian motion background, but lower than C. concisus 
RMIT-O17 and C. concisus RMIT-O2. The diffusion value for the motile component (D1) 
was converted to a mean squared displacement (MSD) to determine the motility speed of 
each C. concisus strain (Figure 5.4). 
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Table 5. 1 Differential Intensity Correlation Functions (DICF) of six C. concisus strains. 
D1 (Motility, µm*2/s) and D2 (Brownian motion, µm*2/s). **p<0.01, **** p<0.0001. 
C. concisus strains D1 ± SD D2 ± SD 
ATCC 51561 0.46 ± 0.35 0.12 ± 0.04 
RMIT-O2 2.12 ± 1.83**** 0.3 ± 0.07 
RMIT-O17 4.19 ± 1.61**** 0.38 ± 0.02 
RMIT-O16 0.51 ± 0.23** 0.11 ± 0.02 
RMIT-O22 1.12 ± 0.43**** 0.4 ± 0.79 
RMIT-O23 1.6 ± 0.22**** 0.18 ± 0.07 
 
 
 
 
Figure 5. 4 The mean squared displacement (MSD) as a representation of velocity for six 
C. concisus strains, ATCC 51561 reference strain, RMIT-O2, RMIT-O17, RMIT-O16, 
RMIT-O22, RMIT-O23. The fitted data was the checked for goodness of fit using the 
normalise root mean squared error (NRMSE) function. MSD unit was µm2 and the time (t) 
unit was second (s). Strain RMIT-017 had the highest calculated MSD. 
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5.3.3 Motility swarming assay on semi-solid media 
 
The six C. concisus tested strains produced different size swarming zones around the 
inoculation points as shown in Figure 5.5. C. concisus ATCC 51561 reference strain and C. 
concisus RMIT-O16 were found to have the smallest swarming zones (≥0.65 cm) while C. 
concisus RMIT-O23 and C. concisus RMIT-O22 exhibited bigger swarming halos (~0.70 
cm).  C. concisus RMIT-O2 exhibited a swarming zone of (0.75 cm). Interestingly, C. 
concisus RMIT-O17 produced the biggest swarming halo (~1.00 cm) compared to C. 
concisus ATCC 51561 reference strain and the other oral strains in this test. Figure (5.5) 
shows the swarming zone of 3 days old cultures of 6 C. concisus tested strains on BB semi-
solid agar. 
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Figure 5. 5 Swarming zone of 3 days old cultures of six C. concisus tested strains on 
brucella semi-solid agar (0.4% agar). 1; ATCC 51561. 2; RMIT-O2. 3; RMIT-O16. 4; RMIT-
O17. 5; RMIT-O22. 6; RMIT-O23. RMIT-OO17 strain (Genomospecies A) isolated from 
young healthy boy had the biggest swarming zone compared to ATCC 51561reference strain 
and other tested strains. ATCC 51561 and RMIT-O16 had the smallest swarming zones. The 
zone was measured as centimetre (cm). 
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5.4 Discussion 
 
Motility and invasiveness are considered to be important virulence factors in Campylobacter 
spp. A number of oral and enteric C. concisus strains have been reported to have adhesion 
and invasion abilities, and to stimulate epithelial apoptosis in intestinal epithelial cells in 
vitro. Adhesion to the host epithelial cells was found to be an important stage in the 
pathogenesis of several bacteria (Pizarro-Cerda et al., 2006). The highest reported invasion 
level of C. concisus strains in an in vitro in Caco-2 cells was reported to be at minimum of six 
hours (Ismail et al., 2012, Kalischuk et al., 2011, Man et al., 2010a, Nielsen et al., 2011). We 
here assessed the interaction between five C. concisus oral isolates from both genomospecies 
(A and B) with enteric cells in an in in vitro model of INT407 cell line using adhesion and 
invasion assays and compared them with C. concisus ATCC 51561 reference strain. 
 
The motility of E. coli was previously measured by the DDM technique and the diffusivity of 
non-motile cells was found to be enhanced in proportion to the concentration of motile cells 
(Wilson et al., 2011). The swarming assay has recently been used to determine the swarming 
ability of C. jejuni wild-types and mutant isolates (Adler et al., 2014). In this study, DDM 
was applied to determine the swimming speed of 6 C. concisus. Motility was also assessed 
using a standard swarming motility assay. Furthermore, we investigated the relationship 
between the motility and the invasion in the same tested strains. 
 
In this study, adhesion and invasion assays were performed to determine the capability of the 
oral isolates to adhere to and invade INT407 cell compared to the C. concisus ATCC 51561 
reference strain. The INT407 cell line model has previously been used to assess invasion and 
adhesion for other Campylobacter spp. (Konkel et al., 2004, Neal-Mckinney et al., 2012). 
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The proportion of C. concisus ATCC 51561 reference strain that were adherent INT407 cell 
was 4.41% (Figure 5.1). This is higher than what reported by Kaakoush et al. (2011b), 
0.11%, for the same strain in Caco-2 cells. The adhesion result obtained for the ATCC 51561 
reference strain in this study was however similar to that of 5 C. concisus strains isolated 
from intestinal biopsies and faeces of patients in Caco-2 cells (Kaakoush et al., 2011b). 
Furthermore, all of oral isolates were found to be significantly less adherent than the 
reference strain. C. concisus RMIT-O23 was found to be the most adhesive oral strain (2.110, 
P=0.0021), followed by RMIT-O22 (2.070, P= 0.0027) and both were from genomospecies 
B.  Genomospecies A strains, RMIT-O2 and RMIT-O17 were found to be lowest adherent 
tested strains, being 1.028, P=0.0004 and 0.933, P=0.0004, respectively. Our findings 
suggest that the tested strains from genomospecies B could be more adherent than 
genomospecies A strains. This finding indicates that healthy individuals have the possibility 
of being colonised with oral C. concisus strains that have the ability to adhere to the intestinal 
epithelial cells. 
 
Interestingly, although RMIT-O17 was weakly adherent in this assay, it was found to be the 
only oral strain that had significantly higher proportion of invasion (0.087, P= 0.0030) than 
the reference strain (0.0337) (Figure 5.2). C. concisus ATCC 51561 reference strain was able 
to invade the INT407 cell line in this study, but did not invade the Caco-2 cell line in 
previously reported studies (Kaakoush et al., 2011b, Man et al., 2010a). The invasion index 
was calculated as a measure of enteric invasive ability. C. concisus strains that have invasion 
indexes >1 are considered to be enteric invasive strains (EICC) and as previously reported 
that C. jejuni strains that had invasion indexes of >1 showed clinical symptoms in infected 
piglets with similar to human symptoms, including bloody diarrhoea (Larson et al., 2008). 
The oral isolate RMIT-O17 (9.313, P <0.0001) was the only strain to have a significantly 
higher invasion index than the reference strain (0.752) (Figure 5.3). These findings indicate 
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that the invasion is conditions-dependant, and further that different cell lines can greatly 
affect the outcome. No oral EICC isolated from a healthy control has previously been 
reported. EICC oral strains were previously investigated in oral isolates from 50% of IBD 
patients and none of the control isolates (Ismail et al., 2012). Our study supports previous 
studies that indicated that C. concisus strain may be an enteric invasive pathogen (Ismail et 
al., 2012, Nielsen et al., 2011). Our findings also suggest that healthy individuals can carry 
invasive C. concisus strains in their oral cavity. In the future, it is suggested to use other types 
of cell line like Caco-2 and Hep-2 cells to study the adhesion and invasion of these C. 
concisus strains. 
 
DDM has not been previously applied on any bacteria other than E. coli. In this work, DDM 
was used to measure the swimming speed of 6 C. concisus strains and also to differentiate 
between motile and non-motile cells within each strain. The motility of tested strains varied 
from strain to another and also from genomospecies to another, as differentiation between the 
motility speed of genomospecies A and genomospecies B strains was noted.  All oral C. 
concisus tested strains were found to be significantly more motile than the reference strain, 
ATCC 51561. C. concisus RMIT-O17 had the highest motility speed (D1=4.19 µm*2/s ± 
1.61) compared to the reference strain and other tested oral strain, followed by RMIT-O2 
(D1=2.12 µm*2/s ± 1.83), and both only belong to genomospecies A. RMIT-O16 was also 
significantly higher than the reference strain but had the lowest significant result, P=0.0067, 
although both C. concisus ATCC 51561 reference strain and RMIT-O16 were found to have 
the lowest motility speed (D1 for both 0.46±0.35 and 0.51±0.23, respectively). Our findings 
suggest that genomospecies A strains could be more motile than strains from genomospecies 
B.  
 
161 
 
Chapter Five - Motility and invasion capability as virulence factors in C. concisus 
 
Moreover, variations in the swarming zone were detected between C. concisus tested strains. 
C. concisus RMIT-O17 had the largest swarming zone followed by RMIT-O2, both are from 
genomospecies A. The reference strain ATCC 51561 and RMIT-O16 had the smallest zones; 
both belong to genomospecies B (Figure 5.5). These findings indicate that isolates from 
different genomospecies may have different growth characteristics, including growth 
swarming zone. The swarming ability of a number of C. jejuni strains have recently been 
studied on BB and MH semi-solid media. No significant differences were found between the 
wild types in either media. However, a C. jejuni NCTC 11168 luxS-mutant had reduced 
swarming ability 42% of wild-type on BB (Adler et al., 2014). Differences in swarming 
zones were previously found between different strains or the same strains growing in BB and 
MH, or growing in different temperatures (37ºC and 42ºC) (He et al., 2008). Therefore, type 
of media, temperature, bacterial genomospecies and the source of strains affect the swarming 
and growth characteristics and therefore interpretation of the comparison between different 
studies is limited. In this study, genomospecies A strains exhibited larger swarming zones 
than genomospecies B strains. Taken all results together; the data from the motility and 
invasion assays also suggests that genomospecies A may be more virulent than 
genomospecies B. It is noteworthy however that although C. concisus RMIT-O17 strain had 
the fastest motility, and was the most invasive strain, it was isolated from healthy young boy 
with no intestinal symptoms. 
 
In summary, the C. concisus RMIT-O17 strain isolated from a healthy young boy is unique 
and has some different virulence characteristics. It was found to be significantly more 
invasive than the reference strain and other tested strains, and was observed to be more motile 
than other tested strains and had the largest swarming zone, as reported in DDM and 
swarming assay, respectively. This strain also produced a unique golden colour on HBA 
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(3.3.1) and had the highest levels of flaC gene expression (Figure 4.11). As reported, healthy 
individuals can carry invasive C. concisus strains in their oral cavity. Furthermore, 
genomospecies A strains was faster than genomospecies B strains in motility tests. These 
results may suggest that genomospecies A are more potentially virulent than genomospecies 
B.  
In conclusion, this is the first time that INT407 cell lines were used in adhesion and invasion 
assays with C. concisus oral isolates. This is also the first report of isolation of an enteric 
invasive C. concisus strain (EICC) from the oral cavity of a healthy individual (RMIT-O17). 
The motility of isolates as measured using the DDM method also correlated with adhesion 
and invasion capacity of the isolates, consistent with a role for these characteristics as 
virulence factors. Further studies are however required to confirm the relationship between in 
vitro measures of virulence and in vivo virulence. 
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Chapter Six 
General Discussion 
 
C. concisus is a fastidious hydrogen-requiring bacterium that was first described by Tanner et 
al. (1981) from a periodontitis lesion. It constitutes a part of the normal flora of the human 
oral cavity; however several studies suggested the possible role of this bacterium in gum 
diseases (Macuch et al., 2000, Moore et al., 1987, Tanner et al., 1981). C. concisus has been 
isolated from non-oral sources since 1989, and from faecal samples of children and adults 
suffering from diarrhoea (Lauwers et al., 1991). The first isolation and identification of C. 
concisus in Australia was performed by Russell (1995) on gastroenteritis cases from children 
at RCH in Melbourne (Russell, 1995).  
 
The aim of this study was to investigate the colonisation and virulence characteristics of C. 
concisus. In this study, a total of 47 C. concisus oral strains were successfully isolated from 
healthy volunteers among 7 families and other non-related healthy individuals, including 12 
children (8 being infants before teething). Of the 47 C. concisus oral strains, 26 strains were 
isolated from healthy adults, and 21 strains were from healthy children, 9 of which were from 
infants before teething. C. concisus oral strains were confirmed by biochemical and 
molecular identification methods. The identity of the isolated strains was confirmed by the 
0.5 kb C. concisus species-specific PCR product for gyr B gene following the method 
described by Matsheka et al. (2001). The species-specific PCR product was not detected for 
one C. concisus oral strain (RMIT-O30). However, this strain was confirmed to be C. 
concisus when further investigated by PCR amplification of the 23S rDNA (Bastyns et al., 
1995b). All C. concisus isolated strains were then grouped into two major genomospecies (A 
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and B), following the method described by Istivan et al. (2004) as a modification of the 23S 
rDNA amplification method previously used by Bastyns et al. (1995b). 
 
In general, genomospecies A was dominant (60%, 28/47); however, genomospecies B was 
more dominant in infants (89%, 8/9). In older children aged between 2 and 5 years, 5 of the 
12 isolates belonged to genomospecies B, and the other 7 strains belonged to genomospecies 
A. A previous Australian study on faecal samples from gastroenteritis cases in children found 
that genomospecies A were in the majority (71.5%), with genomospecies B only accounting 
for 28.5% (Istivan et al., 2004). Other studies have reported a predominan of genomospecies 
B (Engberg et al., 2005, Kalischuk et al., 2011) and it is suggested that the prevalence of C. 
concisus relevant to genomospecies to be studied to determine if there are any biological 
basis for these differences. 
 
To our knowledge, this is the first report of the isolation of C. concisus from the gum swabs 
of healthy infants before teething. It is also the first study to isolate C. concisus from all 
participants using the culture method. All strains collected from infants before teething 
exclusively belonged to genomospecies B, except the infant of family 6, who had both 
genomospecies. Among 2 families, three children were followed up after teething and 
genomospecies A strain was successfully isolated. The findings suggest that genomospecies 
B may colonise the human oral cavity before genomospecies A. Each family has at least one 
member with more than one strain or genomospecies in the mouth, which means more than 
one C. concisus strain can be isolated from the same volunteer, consistent with the previous 
study (Zhang et al., 2010).  
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Gram-negative bacterial outer membrane proteins (OMPs) are the interface between the 
pathogen and its host, and may play a role in pathogenesis (Istivan, 2005). No previous study 
attempted to analyse the relationship between the OMPs of isolates of members of the same 
family. In this study, OMPs were extracted from 36 C. concisus strains isolated from 7 
different families. Analysis of SDS-PAGE profiles showed differences between C. concisus 
oral strains within each family. These results supported the ideas of the heterogeneity and 
complex nature of C. concisus as a species. The heterogeneity of C. concisus OMP profiles 
was also reported by Istivan et al. (2004), and six groups were detected based on SDS-PAGE 
profiles for these 21 C. concisus isolates (Istivan, 2005). Likewise, Aabenhus et al., (2002b) 
were able to identify and differentiate between C. concisus strains isolated from 
immunocompromised patients with diarrhoea, grouping them into two groups based on the 
whole cell lysates (WCL) protein profile patterns, with 85% of C. concisus isolates being 
from the same group.  
 
In this study, Phoretix 1D software was used to assess the relationship between protein 
profiles of C. concisus strains. All families were found to have 2 clusters, with exception of 
family 4, which had 3 clusters. Each cluster included one C. concisus genomospecies (A or 
B) strains. Family 4 had 2 different clusters for genomospecies B strains, while the third 
cluster included genomospecies A strains. The similarity percentage range was 18-100%. In 
family 2, the OMP profiles of twin infants (RMIT-O22 and RMIT-O23) were 100% identical. 
However, C. concisus RMIT-O19 had the lowest similarity percentage with the strains from 
all other infants with only 18%. Based on this analysis, the protein profiles were different 
even within the same family. These findings are in agreement with previous reports 
(Kaakoush et al., 2011a) and show that C. concisus strains are heterogeneous and have a 
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complex nature, even within the, same family or individual multiple strains or genomospecies 
may be present. 
 
Flagellin genes are essential for motility and virulence in Campylobacter spp. To date, no 
thorough molecular studies on C. concisus flagellin genes have been conducted. In this study, 
the presence of three genes related to bacterial motility (flaA, flaB and flaC) was studied in 
selected C. concisus strains using PCR, in addition the expression of these genes in liquid 
environment (BHI broth) was performed using RT-PCR. The whole flaA gene region was 
detected in just 26.5% of C. concisus clinical and oral isolates, regardless of genomospecies. 
On the other hand, the whole region of flaB gene was detected in all genomospecies B C. 
concisus clinical and oral strains (22/64). Therefore, the flaB primer set used in this study can 
be used to confirm the identity of genomospecies B strains.  The flaC gene was the only gene 
detected in all tested C. concisus strains. Few studies on these genes have previously been 
conducted on C. jejuni and C. coli isolates to detect their presence, and also to determine their 
expressions. flaA was detected in 83% of C. jejuni culture positive samples (Waegel et al., 
1996), and in 100% of Campylobacter spp., being 42 C. jejuni isolates and 23 C. coli isolates 
(Zhang et al., 2007). flaB was found in all tested C. jejuni (11 strains), and was also detected 
in 75% of Campylobacter spp. isolated from children (Krutkiewicz et al., 2010, Muller et al., 
2006). Hanning et al. (2010) found the flaC gene in 93% of C. jejuni isolates. The flaC 
primer set used in this study is suggested to be used as species-specific primer to detect C. 
concisus rather than using the 0.5 kb C. concisus species-specific fragment (gyrB) (Istivan et 
al., 2004, Matsheka et al., 2001), which was not amplified in strain RMIT-O30 isolated in 
this study and in RCH26 from a previous study by Istivan (Personal communication). 
 
 Since the whole flaA was detected in only 17 C. concisus strains, and the whole flaB was 
detected only in genomospecies B strains, two fragments of the flaA (516 bp) and flaB (501 
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bp) genes were aligned with sequences of C. concisus ATCC 51562 and UNSW1 to identify 
conserved regions. Given that sequence variation between strains (rather than absence of the 
gene) may have accounted for this result, new primer sets were designed within conserved 
regions of the genes and used to investigate expression of these genes. The conserved regions 
of flaA, flaB and flaC were detected in all selected strains when targeting a smaller fragment 
(<300 bp). PCR products from the conserved regions of flaA and flaB genes were detected in 
C. concisus strains that were not previously amplified by the previous PCR method which 
targeted the full gene, suggesting that these genes are heterogeneous in different 
genomospecies.  
 
No studies have been published on the expression of the flagellin genes of C. concisus. In this 
study, we used RT-PCR to determine the motility of gene expression for selected C. concisus 
strains, being the same strains tested in in vitro and in motility experiments. The flaA gene 
was significantly up-regulated in only one C. concisus strain from genomospecies B (RMIT-
O23). No significant difference was found with RMIT-O22, while this gene was down-
regulated in all other C. concisus tested strains. The results from this study show that flaA 
was expressed in higher proportions in genomospecies B strains than in genomospecies A 
strains. On the other hand, both C. concisus RMIT-O22 and RMIT-O23 strains possessed 
significantly up-regulated flaB expression, while other tested strains were significantly down-
regulated. The flaA was previously found to be expressed at higher levels than flaB in C. coli 
VC167 strain (Guerry et al., 1990). Generally, flaA and flaB were expressed by C. concisus 
genomospecies B more than genomospecies A strains. We found that flaC was the only gene 
up-regulated by all C. concisus strains tested, with a higher level of expression detected in the 
RMIT-O17 strains belonging to genomospecies A. The expression of flaC was previously 
found to be up-regulated in the C. jejuni biofilms (Guerry, 2007). This study is the first to 
investigate the presence and expression of the flagellin genes in C. concisus in relation to the 
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genomospecies. Further studies on the presence and expression other putative motility-related 
virulence genes known to be related to C. concisus are required. 
 
Motility and invasiveness are considered to be important virulence factors. The highest 
reported invasion level of C. concisus strains in vitro was noticed at a minimum of six hours. 
C. concisus strains isolated from healthy individuals were able to attach, but were unable to 
invade, unlike the strains isolated from CD patients (Man et al., 2010a, Nielsen et al., 2011). 
Other virulence characteristics in C. concisus, including motility, adhesion and invasion, 
were also investigated. Adhesion and invasion assays were performed using INT-407 
epithelial cell line. In general, all tested C. concisus strains were able to adhere to INT407. 
However, all oral strains were significantly lower in adherence proportion than the reference 
strain ATCC 51561 which was originally isolated from faeces of a healthy individual. 
Notably, while C. concisus ATCC 51561 was poorly adherent to Caco-2 cells (Kaakoush et 
al., 2011b), it did adhere better to INT407 cells in this study. C. concisus RMIT-O23 and 
RMIT-O22 were the most adhesive oral strains (2.110 and 2.070 respectively), and both were 
from genomospecies B. 
 
All of oral strains tested were significantly less invasive than the reference strain ATCC 
51561, with the exception of C. concisus RMIT-O17 strain. C. concisus ATCC 51561 was 
found to be invasive to INT407 in this study, but it was not considered as enteric invasive 
strain. This strain did not previously invade Caco-2 cells (Man et al., 2010a). The C. concisus 
RMIT-O17 strain (genomospecies A) was the only enteric invasive C. concisus strain (EICC) 
amongst the other isolated oral strains in this study. The EICC term has previously been used 
to describe the relationship between C. concisus oral strains and enteric epithelial cells 
(Ismail et al., 2012). RMIT- O17 had an invasion index >1 (9.313), which fits the criteria of 
Larson et al. (2008). All other tested strains, including the reference strain ATCC 51561, 
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have invasion indexes <1. This is the first report to find EICC from healthy individuals, as 
EICC oral strains were previously reported in 50% (4/8) of C. concisus oral strains isolated 
from IBD patients only, and none of the healthy controls’ isolates using Caco-2 cells (Ismail 
et al., 2012). Therefore, healthy individuals may carry enteric invasive C. concisus strains 
(EICC) in their oral cavity. Comparison between this study and other published reports 
suggests that the cell line used can significantly impact the results. It is suggested to use other 
types of cell lines like Caco-2 and Hep-2 cells to investigate the adhesion and invasion 
capabilities of these C. concisus strains and compare the results with current findings. 
 
Motility was also measured using a modified method from Differential Dynamic Microscopy 
(DDM). This method has not been applied to bacteria other than E. coli. DDM was used to 
measure the swimming speed and motile cell fraction of E. coli (Wilson et. al., 2011). In this 
study, DDM was employed on selected C. concisus strains grown in BHI broth. The D1 
(motile cells) and D2 (Brownian motion) for C. concisus ATCC 51561 and RMIT-O16, are 
close together, indicating that the motility is not much faster than normal Brownian motion. 
However, D1 values of RMIT-O16 and all other oral C. concisus strains were significantly 
higher than the reference strain and considered to be motile. C. concisus RMIT-O17 was the 
most motile strain compared to the reference strain and the other tested strains (11 times 
faster than the background Brownian motion), followed by C. concisus RMIT-O2. Both 
strains are from genomospecies A. This finding suggests that genomospecies A could be 
more motile than genomospecies B. 
 
Motility swarming on brucella semi-solid medium was performed. After 3 days of incubation, 
a halo zone of motility was observed around the inoculation point using motility swarming 
assay on BB semi-solid medium. Interestingly, C. concisus RMIT-O17 has the biggest 
swarming zone (~1.00 cm) compared to the other tested strains, followed by RMIT-O2 
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(~0.75 cm), both belonged to genomospecies A (Figure 5.5). This finding is consistent with 
the DDM findings that genomospecies A is faster than genomospecies B. In previous studies, 
C. jejuni mutant strains had smaller swarming halos than wild type strains (Adler et al., 
2014), and variations were also noted within different C. jejuni strains growing in different 
media (BB and MH), or growing in different temperatures (37ºC and 42ºC) (He et al., 2008), 
suggesting that motility is affected by a number of environmental factors, which is probably 
true for C. concisus. The finding of the current study suggests that genomospecies A strains 
were more motile than genomospecies B and may therefore be more capable of swimming 
through intestinal mucus and reaching the epithelium. 
 
To summarise, this is the first study to isolate C. concisus from gum swab samples of all 
participants by culture method. It is also the first study to isolate this bacterium from samples 
of infants before teething. Genomospecies A (60%) was represented more than B (40%); 
however, genomospecies B was dominant in children. We found that the oral cavity is firstly 
colonised by genomospecies B strains. Healthy individuals can carry enteric invasive C. 
concisus strains in their oral cavities, raising questions about what might trigger these strains 
to cause infection. Analysis of the DDM method indicated that the motility speed of C. 
concisus strains was different and genomospecies A was more motile than genomospecies B. 
C. concisus RMIT-O17 is a unique strain, in that it was isolated from a healthy child. It had 
unusual colony morphology, and a higher expression level of flaC gene, and was found to 
have greater motility speed than others. This strain was also found to be significantly more 
invasive than the other tested strains. It was also the only enteric invasive C. concisus strain 
(EICC). 
 
Further studies are required to isolate C. concisus from healthy infants before teething to 
confirm which genomospecies firstly colonise their mouths. Future studies should be 
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expected to include more families to differentiate between C. concisus strains within the same 
family. It is recommended to study people and families from different backgrounds to 
confirm which molecular group is dominant. Another technique like MALDI-TOF MS can be 
developed and used to identify C. concisus. MALDI-TOF MS has been only applied to 
identify C. concisus from stool samples by Casanova et al. (2015), although it does not 
always identify two different species present in the same sample (Bessede et al., 2011). 
It is suggested that additional whole genome sequencing for oral strains is required to 
facilitate the detection and investigation of C. concisus potential virulence genes. Knock-out 
mutants of flaA, flaB and flaC genes will be required to investigate the role of these genes in 
C. concisus motility. Moreover, C. concisus strains isolated from healthy volunteers should 
also be screened for the presence of other possible virulence genes related to motility to 
determine the role of these virulence genes. If possible, another study could be conducted to 
follow up on the same participants when they become ill to isolate C. concisus from their 
stool or biopsies, and compare these isolates with the original isolates from their mouths. In 
vitro and in vivo virulence related assays may also be used to determine if the gut isolates are 
more pathogenic. The expression of motility genes (flaA, flaB and flaC) should also be 
studied in different conditions to investigate which factors influence expression, and therefore 
motility. The DDM is a reliable method to compare the motility of Campylobacter spp. and 
can provide insight into more virulent strains. Although some individuals can carry enteric 
invasive C. concisus strains in their oral cavities, these strains cannot become pathogens 
because the hosts are healthy and presumably have effective immune control of these 
potential pathogens. However, it is likely that these enteric invasive C. concisus strains could 
be significant pathogens in immune suppressed persons. 
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